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The Road Not Taken 
Two roads diverged in a yellow wood, 
And sorry I could not travel both 
And be one traveler, long I stood 
And looked down one as far as I could 
To where it bent in the undergrowth; 
Then took the other, as just as fair, 
And having perhaps the better claim 
Because it was grassy and wanted wear, 
Though as for that the passing there 
Had worn them really about the same 
And both that morning equally lay 
In leaves no step had trodden black. 
Oh, I marked the first for another day! 
Yet knowing how way leads on to way 
I doubted if I should ever come back. 
I shall be telling this with a sigh 
Somewhere ages and ages hence: 
Two roads diverged in a wood, and I, 
I took the one less traveled by, 
And that has made all the difference. 
By Robert Frost 
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ABSTRACT 
 
This thesis aimed to elucidate the structure-function relationships determining the 
differential fidelities of the dnaE1- and dnaE2-encoded mycobacterial PolIIIα subunits under 
conditions of genotoxic stress. To this end, the role in DnaE1 intrinsic fidelity of highly 
conserved PHP domain residues was explored by site-directed replacement of targeted 
amino acids, resulting in a panel of Mycobacterium smegmatis mutants carrying selected 
dnaE1 alleles. A complementary approach investigated the contribution of the 
mycobacterial proofreading DnaQ subunit homolog to the maintenance of DnaE1-
dependent replicative fidelity by generating a targeted dnaQ knockout mutant. The third 
component of this study focused on the inferred role of a highly-conserved N-terminal 
extension and C-terminal pentapeptide motif in the function of the alternative, error-prone 
DNA PolIIIα subunit, DnaE2.  
Replacement of wild-type dnaE1 with mutant dnaE1E133A and dnaE1D228N alleles resulted in 
reproducible increases in the spontaneous mutation rate of 3-fold and 10-fold, respectively. 
This result confirmed the predicted role of highly conserved PHP-domain residues in DnaE1 
intrinsic fidelity and, significantly, provided the first evidence of mutator alleles in 
mycobacteria. A reproducible, but not significant, loss in fidelity (~1.4-fold increase in 
mutation rate) was observed for a dnaQ knock-out mutant compared with the wild-type 
strain; moreover, DnaQ was shown to be dispensable for DNA damage-induced mutagenesis 
and damage tolerance. In contrast, a second dnaQ homolog, dnaQ-uvrC, which comprises an 
N-terminal 3’-5’ exonuclease domain and a C-terminal UvrC-like endonuclease domain, was 
shown to be required for DNA damage survival, suggesting a role in SOS-mediated DNA 
repair. Finally, targeted deletion of conserved N- and C-terminal regions in DnaE2 had no 
effect on DNA damage tolerance or induced mutagenesis, indicating that these domains are 
not crucial for the function of the error-prone polymerase under conditions of genotoxic 
stress. In summary, these results reinforced the notion that the mycobacterial replisome 
differs in key respects from the well-characterised E. coli model, and so urge further work to 
elucidate the composition and regulation of the protein complex which governs DNA 
replication and repair in a major human pathogen. 
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CHAPTER 1: Literature Review 
 
1.1 Introduction 
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is exposed to 
multiple host-derived reactive oxygen and nitrogen species which are genotoxic and pose a 
major threat to the integrity of the genome (Darwin and Nathan, 2005, Dutta et al., 2010, 
Sassetti and Rubin, 2003, Gorna et al., 2010). Moreover, Mtb has the ability to persist for 
decades in a poorly understood subclinical state, in some cases reactivating decades later to 
cause post-primary TB (Lillebaek et al., 2002). This suggests that active DNA repair is critical 
to maintain genome integrity and bacterial viability during long-term infection. 
Furthermore, unlike many other bacterial pathogens, drug resistance in Mtb arises 
exclusively from mutations in chromosomal genes that are associated with drug action 
(Almeida Da Silva and Palomino, 2011, Sandgren et al., 2009). This implies that 
chromosomal mutagenesis drives the microevolution of this pathogen within the human 
host and, in turn, suggests that a balance between DNA repair and damage tolerance 
pathways is critical for genome maintenance.  
Although crucial for bacillary survival and strain evolution, the mechanisms governing 
mycobacterial genome maintenance and DNA damage tolerance remain poorly understood. 
The fact that there is no evidence of a single polymorphism in an essential component of 
the DNA replication machinery that significantly impacts replication fidelity (that is, there 
are no known mycobacterial “mutator” alleles) further suggests that multiple functional and 
regulatory interactions interact to enable DNA replication and genome maintenance in Mtb 
(Werngren and Hoffner, 2003). For example, mycobacteria have developed several 
mechanisms to enable adaptation to hostile and fluctuating host environments; these 
include the regulation of deoxyribonucleoside-5′-triphosphates (dNTP) (Mathews, 2014) and 
ribonucleoside triphosphates (rNTP) levels (Clausen et al., 2013, Makarova et al., 2014, Nick 
McElhinny et al., 2010) during DNA replication, as well as co-ordination of chromosomal 
replication with mycobacterial cell segregation and division (Aldridge et al., 2012, Kieser and 
Rubin, 2014, Joyce et al., 2012, Santi et al., 2013). In support of this notion, the unique 
mode of mycobacterial cell elongation and division has been implicated in the phenotypic 
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heterogeneity observed in mycobacterial populations and, by implication, the emergence of 
multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains (Aldridge et al., 2012, 
Joyce et al., 2012, Kieser and Rubin, 2014, Santi et al., 2013, Singh et al., 2013). However, 
further research is required to determine accurate estimates of intracellular dNTP 
concentrations in the different phases of the mycobacterial cell cycle, as well to determine 
the speed and processivity of the mycobacterial replicase. Also, the relationship between 
dNTP pools and the replication rate of M. tuberculosis at different stages of infection 
remains to be established. Among numerous factors, an improved understanding of the 
molecular mechanisms by which M/XDR strains emerge and propagate (Warner and 
Mizrahi, 2006) could aid the design of control programmes aimed at preserving the efficacy 
of new and existing drugs.  
 
1.2 Drug resistance in Mtb 
TB remains a global health problem. In 2013, the World Health Organisation (WHO) 
reported 9 million new cases and 1.5 million deaths due to this pathogen (WHO, 2014). 
MDR TB – defined as resistance to two of the first-line drugs, rifampicin (RIF) and isoniazid 
(INH) – was identified in 3.5% of new cases and 20.5% of previously treated TB cases (WHO, 
2014). On average, 9.0% of patients with MDR-TB had XDR-TB, which is defined as MDR-TB 
plus resistance to a fluoroquinolone and any second-line injectable agent. So-called “totally 
drug-resistant (TDR)” cases have also been reported, however this form of resistance is still 
to be defined by WHO (WHO, 2012). 
 
Infection with Mtb follows inhalation of aerosolized bacteria, and leads to either active 
disease or, in most individuals, latent infection (Cosma et al., 2004, Barry et al., 2009). 
Patients who are actively infected with TB present with a large bacterial burden at diagnosis 
and are treated with multiple antibiotics to prevent the emergence of drug resistance 
mutations. In contrast, latently infected individuals, when diagnosed or as part of INH 
preventative therapy (IPT) (Balcells et al., 2006, Lincoln, 1954), are treated with a single 
antibiotic since latent infection is thought to have little capacity for mutation (Lincoln, 1954, 
Balcells et al., 2006). 
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The emergence of strains that are resistant to first- and second-line treatment has made the 
treatment of TB complex. To compensate for the loss of the two most potent drugs, RIF and 
INH, the treatment regimen for MDR- and XDR-TB requires prolonged administration of 
second- and third-line agents that are expensive, difficult to administer, and are often 
associated with severe toxicities and increased side effects (WHO, 2010). Additionally, in 
comparison with the 6 months required to treat drug-susceptible TB, drug-resistant TB 
generally requires prolonged treatment of at least 18 months. These factors contribute to 
patient non-adherence or premature discontinuation of therapy, leading to treatment 
failure and the emergence of strains with additional drug resistance.  
 
The common mechanisms by which most bacteria achieve antimicrobial resistance are: (i) 
barrier mechanisms (decreased permeability or efflux), (ii) degrading or inactivating 
enzymes, (iii) modification of pathways involved in drug activation or metabolism, and (iv) 
drug target modification or target amplification. Mtb uses all of these mechanisms to 
achieve antimicrobial resistance. Efflux mechanisms only allow the bacteria to tolerate 
higher levels of drugs but do not necessarily result in clinically relevant levels of resistance 
to multiple antibiotics (Schmalstieg et al., 2012, Machado et al., 2012, Li and Nikaido, 2009, 
Borrell and Gagneux, 2011). In most bacteria, genetically-encoded drug resistance can be 
mediated by plasmids, horizontal gene transfer and chromosomal mutations (Gillespie, 
2001). However, in Mtb, there is little evidence of horizontal gene transfer and no 
epigenetic information in the form of plasmids; instead, genetic diversity is principally driven 
by chromosomal mutations and rearrangements (Hershberg et al., 2008). All drug resistance 
in Mtb is associated with mutations in target or related genes, the majority of which are 
single nucleotide polymorphisms (SNPs) (Sandgren et al., 2009) – suggesting that strain 
variation and the emergence of antibiotic resistance in Mtb are dependent on mutagenesis. 
For a pathogen probably exposed to multiple genotoxic stresses during infection (Darwin 
and Nathan, 2005, Dutta et al., 2010, Sassetti and Rubin, 2003), this observation suggests 
that DNA repair pathways might be crucial to both bacillary survival and the adaptive 
evolution of Mtb within its obligate human host (Gorna et al., 2010, Warner, 2010). 
Furthermore, by implication, it also highlights the importance of developing compounds to 
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inhibit repair pathways in Mtb, especially those associated with induced mutagenesis (Smith 
and Romesberg, 2007).  
 
Recent studies have provided insight into individual genes in which mutations confer 
resistance in Mtb (Farhat et al., 2013, Safi et al., 2013, Sandgren et al., 2009, Zhang et al., 
2013). However, some resistance cannot be accounted for by the current models, 
suggesting that sequential acquisition of multiple small-to-moderate effect drug-resistance 
and compensatory mutations can reduce the innate susceptibility of the organism to 
antibiotics while maintaining strain fitness (Warner and Mizrahi, 2013). This notion is 
supported by the work of Safi and colleagues who applied a combination of in vitro selection 
and molecular genetic techniques to demonstrate that the acquisition of high-level 
ethambutol resistance occurs as a multi-step process, contradicting the notion that drug 
resistance in Mtb arises exclusively through single-step mutations (Safi et al., 2013). 
Moreover, recent studies involving drug-resistant Mtb strains used whole-genome 
sequencing (WGS) to identify genetic loci that are associated with resistance, including 
genes involved in the synthesis or regulation of surface exposed lipids (Farhat et al., 2013, 
Zhang et al., 2013). Both studies detected resistance-associated mutations that were also 
present in drug-sensitive strains, suggesting that these might represent early mutation 
events in the sequential acquisition of resistance. Most importantly, they also reinforced the 
notion that XDR-TB arises through the accumulation of non-synonymous mutations that are 
associated with resistance to second-line drugs rather than mutations in a small number of 
genes conferring resistance. These observations, combined with those of Safi et al., imply 
that, while prevalent, low-level resistance might be undetected by current diagnostic 
methods. This could have serious clinical implications, especially in TB endemic regions, and 
so reinforces the idea that replacing current clinical microbiology methods for routine 
diagnosis and drug-susceptibility testing with high-throughput WGS approaches might be of 
significant benefit (Koser et al., 2013). 
 
As sequencing of Mtb strains becomes more common and affordable, it is hoped that the 
expansion of genotype-phenotype databases will enable the identification and definition of 
additional drug-resistance signatures with improved potential to inform new tools for 
diagnosing drug-resistant TB. Understanding the factors which drive the emergence and 
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transmission of Mtb strains that are resistant to one or more frontline anti-tubercular drugs 
will, however, require elucidation of molecular mechanisms governing mycobacterial DNA 
replication fidelity and DNA damage tolerance at every stage of the infection process.  
 
1.3 DNA replication in prokaryotes and genomic distribution of C-family polymerases  
DNA polymerase III (PolIII) holoenzyme (HE) is a tripartite protein machine responsible for 
replication of the bacterial genome (Kornberg and Baker, 2005, Kurth and O'Donnell, 2013, 
McHenry, 2011b, McHenry, 2011a, Robinson et al., 2012). It consists of the PolIII core, the 
β2 processivity factor, and a clamp loader complex. The PolIII core is further divided into 
three subunits: a) dnaE-encoded α subunit, b) dnaQ-encoded ε subunit possessing 3’-5’ 
exonuclease proofreading activity, and c) holE-encoded θ subunit, whose function is to 
stabilize the ε subunit. DNA synthesis is performed by the α subunit (PolIIIα). PolIIIα 
subunits are classified into the C-family of DNA polymerases (Ito and Braithwaite, 1991), and 
come in two major forms: DnaE-type (Bailey et al., 2006, Lamers et al., 2006) and PolC-type 
(Evans et al., 2008). PolC is present in low-GC Gram-positive bacteria such as Bacillus 
subtilis, whereas DnaE is PolIIIα of the widely studied Gram-negative model organism, E. 
coli. 
 
In a major recent study, Venclovas and colleagues analysed the distribution of C-family 
polymerases among ~2000 sequenced bacterial genomes, demonstrating that the majority 
of bacterial genomes sequenced to date contain two, three or even four putative C-family 
polymerases (Timinskas et al., 2014). According to their results, most genomes encode a 
single replicative polymerase of the DnaE1 type – which is the sole high-fidelity replicative C-
family DNA polymerase in the cell (Zhao et al., 2006, Timinskas et al., 2014). DnaE1 was 
found to be the only polymerase that could exist either alone or in combination with DnaE2 
and PolC (Zhao et al., 2006), whereas the other members always occur in combination with 
representatives from at least one of the other different groups. PolC was found to co-occur 
with either DnaE1 or the third DnaE-type polymerase, DnaE3, with DnaE3 found in Bacilli 
and DnaE1 in Clostridia and Negativicutes. DnaE3 always co-occurs with PolC, whereas the 
second DnaE-type polymerase, DnaE2, does not conform to phylogenetic boundaries and 
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can co-exist with DnaE1 or PolC (Timinskas et al., 2014). Interestingly, the analysis also 
suggested that non-essential DnaE2 polymerases are common among oxygen-using bacteria 
with large GC-rich genomes. Consistent with this observation, Mtb contains two DnaE-type 
PolIIIα subunits, DnaE1 and DnaE2 instead of a PolC-type polymerase (Boshoff et al., 2003, 
Timinskas et al., 2014). 
 
1.4 The composition and the arrangement of structural/functional domains in distinct C-
family polymerases 
Members of the C-family of DNA polymerases contain a set of four highly conserved and 
ordered domains within a single polypeptide in the following sequence: Polymerase and 
Histidinol Phosphatase (PHP) domain, Palm domain, Thumb domain, and Fingers domain. 
DnaE and PolC subfamilies can be distinguished within the C-family of DNA polymerases 
depending on the arrangement of additional accessory domains such as the 
oligonucleotide/oligosaccharide binding (OB) domain that binds single-stranded DNA 
(Huang and Ito, 1999, Lamers and O'Donnell, 2008, McHenry, 2011b). DnaE and PolC share 
some degree of sequence homology with other DNA polymerases, in both bacterial and 
eukaryotic replicative DNA polymerases. Interestingly, the crystal structures of E. coli PolIII 
(Lamers et al., 2006), T. aquaticus PolIII (Bailey et al., 2006) and G. kaustophilus PolC (Evans 
et al., 2008) have shown that the active sites of these polymerases are structurally related 
to the X-family of DNA polymerases, which are typically slow and exhibit low fidelity and 
processivity. This is in contrast to the high-fidelity replicative C-family polymerases which 
are amongst the fastest polymerases known. In addition, DnaE and PolC polymerases are 
unique in that they contain a PHP domain that is not found in other polymerases, except for 
some bacterial PolX family members (Aravind and Koonin, 1998). 
 
The role of the PHP domain in DnaE and PolC polymerases remains unclear. The PHP 
domains of T. thermophilus PolIII and T. aquaticus PolIII are functional exonucleases 
possessing a complete set of metal co-ordinating residues [H H D/H H E H C/H D/N H] that 
appear to be essential for this activity (Stano et al., 2006, Wing et al., 2008). Similarly, the 
PHP domains of PolX from both B. subtilis (Banos et al., 2008) and T. thermophilus (Nakane 
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et al., 2009) have exonuclease activity. In contrast, no exonuclease activity could be 
detected for the PHP domain of G. kaustophilus PolC (Evans et al., 2008) which contains an 
almost intact active site with the exception of an aspartate to asparagine substitution at 
position 8 (Barros et al., 2013). Mtb DnaE1 contains a complete set of the metal co-
ordinating residues, suggesting that the intrinsic exonuclease is functional in the 
mycobacterial replicative polymerase. In contrast, similar to G. kaustophilus PolC, DnaE2 
contains an almost intact active site, with a substitution at position 8, though in this case it 
is a glycine that replaces the canonical aspartate residue. The PHP domain in E. coli PolIII 
represents a significant variant: five of the metal co-ordinating residues are replaced by 
amino acids that are not compatible with this function. However, despite the apparent loss 
of catalytic function, the structural scaffold of the PHP domain is conserved, and has been 
shown to be critical for the stability and activity of the E. coli PolIII (Barros et al., 2013).  
 
A detailed study by Lamers and colleagues demonstrated an apparent correlation between 
the presence of a variant PHP domain and the possession of separate proofreading 
exonucleases (Barros et al., 2013); that is, bacterial genomes which do not possess an intact 
DnaE PHP domain containing all conserved metal co-ordinating residues appear to encode a 
separate exonuclease subunit which functions as proofreader during replication. The 
analysis by Timinskas et al. (2014) further observed that, in organisms in which PolC occurs 
with DnaE3, PolC is the main high fidelity polymerase since DnaE3 contains a disordered and 
degraded PHP domain which may be catalytically inactive. However, Clostridia - in which 
PolC co-occurs with DnaE1 - lack the integral exonuclease domain, suggesting that DnaE1 
performs high fidelity synthesis in these organisms (Timinskas et al., 2014). This raises 
questions about organisms like Mtb whose genome encodes a DnaE1 protein with an intact 
PHP domain, as well as two separate dnaQ homologs: what is the relative contribution of 
the DnaE1 PHP domain versus either (or both) of the dnaQ homologs to replication fidelity? 
Is there an evolutionary advantage associated with the presence of both intrinsic (DnaE1-
associated) exonuclease and separate DnaQ-type proofreading subunits? Unlike in 
organisms such as E. coli (Gerdes et al., 2003), Haemophilus influenza (Akerley et al., 2002), 
or Streptococcus pneumoniae (van Opijnen et al., 2009), where the ε subunit is essential for 
viability, both dnaQ homologs in Mtb are dispensable for growth (Griffin et al., 2011, 
Sassetti et al., 2001, Sassetti and Rubin, 2003). This raises additional questions that require 
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further investigation, including: 1) What is the role of the dnaQ homologs in Mtb, and 2) 
given that DnaE2 contains an almost complete set of metal co-ordinating residues, is the 
PHP domain in the non-essential PolIIIα subunit active and 3) if so, does DnaE2 PHP 
contribute to relative α subunit fidelity? In turn, these questions, suggested the need for 
studies focused on the contribution of intrinsic fidelity and proofreading to overall 
replication fidelity in Mtb.   
 
In their paper, Venclovas and colleagues showed that PolC and DnaE-type polymerases also 
diverge in their domain composition and arrangement; for example, the OB domain is 
located in the C-terminal region of DnaE, while in PolC it is situated in the N-terminus 
(Timinskas et al., 2014). DnaE2 polymerases differ from both DnaE1 and DnaE3 in that not a 
single DnaE2 possesses the C-terminal domain whereas the DnaE3-type polymerases are 
characterised by a similar domain organization as the DnaE1 group, albeit with a totally 
disordered and smaller (degraded) PHP domain (Timinskas et al., 2014). Instead of the C-
terminal τ domain that is critical for connecting DNA to the rest of the replisome during DNA 
replication, DnaE2 contains a C-terminal pentapeptide tail, SRDF[H/R]), that is conserved 
amongst 77% of bacterial species containing a DnaE2-type polymerase (Timinskas et al., 
2014). It has been hypothesized that this motif is required for mediating protein-protein 
interactions during function of the mutasome – thought to comprise ImuA’, ImuB and 
DnaE2 proteins (Warner et al., 2010) - however this remains to be demonstrated.  
 
1.5 The mycobacterial DNA replication machinery 
PolIII functions in the context of a replisome complex containing the PolIII HE, DnaB 
helicase, DnaG primase and SSB (single-stranded DNA-binding) proteins (Figure 1.1) 
(Johnson and O'Donnell, 2005, O'Donnell, 2006). Together with numerous interacting 
partners, these proteins function in bacterial DNA replication (Johnson and O'Donnell, 
2005). Most of the replisome components are conserved across different bacteria, but they 
have been most thoroughly characterised in E. coli (Reyers-Lamothe et al., 2010) and B. 
subtilis (Sanders et al., 2010). Based on these organisms, models for the bacterial replisome 
have been constructed; these consist of the primosome, which includes the replicative 
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helicase that unwinds the duplex DNA; the primase, which is activated by DnaB to produce 
short RNA primers for discontinuous lagging-strand synthesis (McHenry, 2011b); and the 
PolIII HE, which consists of a PolIII core polymerase, the β2 sliding clamp, and the clamp-
loader complex (Figure 1.1). Recent studies have shown that three, instead of two, PolIII 
core polymerases are required for concurrent leading and lagging strand synthesis at a 
single replication fork to form a tri-polymerase replisome (Georgescu et al., 2011, 
McInerney et al., 2007). A single PolIII core is required for leading strand synthesis while the 
other two PolIII cores extend multiple Okazaki fragments on the lagging strand (Georgescu 
et al., 2011). Three β2 sliding clamps are present at each replication fork, with the third 
associated with either the clamp loader or the third PolIII core (Robinson et al., 2012).  
 
Current models of the E. coli replisome are based on a PolIII HE that contains three principal 
subunits: a seven-subunit DnaX clamp loader complex (τ3δδ′χψ) which binds three PolIII 
cores through the τ-α interaction, and the β2 sliding clamp processivity factor which 
connects the PolIII core to the DNA through a separate interaction with PolIIIα. Of the 
remaining DnaX subunits, δ and δ’ serve to load and unload the β2 sliding clamp, while χ and 
ψ stabilize the interactions between DnaX, δ, and δ’ (McHenry, 2011b). The genes predicted 
to be involved in DNA replication in Mtb are shown in Table 1.1 and, based on this list, it 
appears that the mycobacterial replisome lacks obvious homologs of several components 
which perform key functions in the model organism (Warner et al., 2014). Comparative 
genomic analyses established, however, that this gene complement is typical of many 
bacteria and, therefore, it was among the genomes which contributed to the definition of a 
basic bacterial replication module that contains the replication initiator protein, DnaA, the 
DnaB helicase, DnaG primase, PolIIIα, the β2 sliding clamp, ε proofreading subunit, τ
3, δ and 
δ’, SSB, DNA ligase, and PolI (McHenry, 2011b, Robinson et al., 2012) (Figure 1.1).  
 
Although in vitro studies have provided some insight into the mycobacterial replisome, it is 
poorly characterised relative to model organisms (Johnson and O'Donnell, 2005, O'Donnell, 
2006). The working model of a mycobacterial replisome proposed in this study is therefore 
based on insights provided by the E. coli system (Figure 1.1) and a number of studies 
focused on the mycobacterial replisome components (Table 1.1). However, there are still 
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gaps that require to be addressed. For example, the stoichiometry and architecture of the 
mycobacterial replisome are still unknown: how many additional copies of specific 
replisome components are present at the replication fork, for example? It is also unclear 
where the second dnaE-encoded α subunit, DnaE2, “sits” within the replisome. Similarly, 
further work is required to determine whether the ε subunit forms part of the PolIII core, as 
observed in E. coli. Moreover, additional cellular factors which may affect (or modify) the 
composition of replisome - such as the relative dNTP/rNTP levels present at the replication 
fork, as well as the role of protein-protein interactions at the replication fork - are still 
unclear. Again, much additional work is required to address these gaps.  
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Figure 1.1: Schematic representation of the "model" bacterial replisome consisting of the 
PolIII core polymerase, the homodimeric β2 sliding clamp, the τ3δδ’ clamp-loader complex, 
DnaB helicase (red hexamer), DnaG primase (blue), PolI (pink) DNA ligase (purple) and SSB 
(orange). Stoichiometry and architecture of the mycobacterial replisome have been poorly 
characterised. It is unclear whether the mycobacterial replisome functions as a di- or tri-
polymerase system or where DnaE2 sits within the replisome and also whether the ε 
subunit forms part of the mycobacterial PolIII core. 
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1.6 A model for DNA replication in mycobacteria 
Despite the genetic diversity between E. coli and Mtb, they are assumed to share essentially 
the same mechanisms of chromosomal replication given that most of the replisome 
components are conserved (Robinson et al., 2012, Warner et al., 2014). Briefly, the DnaB 
replicative helicase, which is loaded onto the lagging strand template, separates the two 
templates that are subsequently copied by the PolIII core. PolIII core activation follows 
binding of the β2 sliding clamp, which encircles double-stranded DNA. Sliding clamps are 
added and removed by the γ/τ complex clamp loader, whose τ component oligomerises the 
PolIII core. The leading PolIII core-β2 complex continuously extends DNA in the direction of 
unwinding. DnaG primase binds to DnaB during cycles of priming and DNA synthesis on the 
lagging strand template. Discontinuous synthesis on the lagging strand requires PolIII to 
move from the finished fragment, rapidly dissociate from the β2 clamp and DNA, and re-
associate with a new clamp for extension. The β2 clamp also interacts with PolI and DNA 
ligase to convert RNA to DNA and seal the finished fragment (Figure 1.1) (Reyers-Lamothe et 
al., 2010, O'Donnell, 2006). Similarities and deviations between the mycobacterial and E. 
coli replication systems are discussed in detail in a recent review (Warner et al., 2014) and 
so will be summarized briefly in this section. 
 
Bacteria have evolved rigorous control mechanisms to regulate the initiation of DNA 
replication, and to ensure that it does not occur at random sequences throughout the 
chromosome (Reyes-Lamothe et al., 2012). Instead, replication is initiated at a single site 
(oriC) and proceeds bi-directionally around the chromosome until the two replication forks 
meet in the replication terminus (ter), a region located approximately opposite oriC. The 
two strands of the template DNA are separated at the origin, yielding two fork structures. 
Replicative DNA polymerases and accessory proteins are assembled onto each of these 
forks, and synthesize new DNA bi-directionally around the circular chromosome until the 
two replication forks meet in the ter, yielding two copies of the bacterial chromosome, each 
containing one strand from the parental chromosome and one nascent strand. Moreover, 
since this must occur only once during the cell cycle, a diverse array of regulatory 
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mechanisms ensures that the assembly of the replication machinery is triggered at the 
appropriate stage (Warner et al., 2014, Robinson et al., 2012).   
 
As in E. coli, key features of bacterial replication are retained in Mtb: the DNA-ATP 
interaction is critical for replication initiation, since it results in the opening of the DNA 
duplex to allow loading of DnaB, and the dnaA promoter remains active during replication 
to ensure progression through the cell cycle (Nair et al., 2009). Mtb oriC is located in the 527 
bp intergenic region between dnaA and dnaN, and contains multiple predicted and 
confirmed DnaA-binding sites. Interestingly, this region also serves as a common locus for 
the insertion of IS6110 transposable elements. To date, however, there is no evidence to 
suggest the insertions have any effect on the replication process, including the timing of 
replication initiation. Instead, these sites have been used as markers for RFLP fingerprinting 
of clinical Mtb isolates (Turcios et al., 2009).  
 
In E. coli, DnaA recruits the hexameric DnaB replicative helicase to the origin to initiate 
strand separation. Recent work has confirmed the physical interaction of Mtb DnaA and 
DnaB, and has further implicated DnaB in controlling DnaA complex formation and the 
interaction with oriC (Xie and He, 2009). In contrast, Mtb does not possess a homolog of the 
DnaC helicase loader, which is required for loading DnaB helicase onto the DNA in E. coli 
(Table 1.1). This suggests that the DnaC function is performed by another protein or that, 
alternatively, DnaA alone might be sufficient for DnaB loading, a possibility that is supported 
by recent insights into the structure of DnaB from H. pylori – another organism lacking a 
DnaC helicase loader (Stelter et al., 2012). 
 
PolIII HE is loaded onto each of the two replication forks following strand separation and 
unwinding of the parental chromosomal DNA by the DnaB replicative helicase, with two 
PolIII HEs acting on the lagging strand (Georgescu et al., 2011). Leading strand synthesis is 
highly processive and involves the continuous extension of DNA, in contrast to lagging-
strand synthesis, which requires discontinuous replication via the extension and ligation of 
Okazaki fragments. DnaG primase produces short RNA primers for extension by PolIII. Owing 
to its essential role, Mtb DnaG was recently expressed and applied in a novel high-
throughput enzyme assay to identify inhibitors of the priming reaction (Biswas et al., 2013). 
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Following completion of Okazaki fragment synthesis, a second switch occurs so that PolIII is 
replaced by PolI, the polymerase which catalyses high-fidelity DNA synthesis across the 
resulting gap. Consistent with previous predictions, Mtb Rv2228c has been shown to be 
essential for growth of Mtb in vitro (Griffin et al., 2011) and encodes a bi-functional protein 
that fuses RNase HI and CobC-like α-ribazole phosphatase activities in a single polypeptide. 
The protein is unusual in that, in addition to functioning as a classic RNase HI in cleaving 
RNA/DNA hybrids, it also has double-stranded RNase activity (Watkins and Baker, 2010, 
Minias et al., 2015). Replisome components are highly conserved amongst mycobacteria 
(Table 1.1), including M. leprae, another obligate pathogen whose genome displays 
evidence of extensive decay (Cole et al., 2001).  
 
1.7 Targeting replisome components for drug development 
The predicted role of DNA metabolism in pathogenesis suggests the possibility of targeting 
selected mycobacterial pathways with novel chemotherapeutic agents. Existing 
antimicrobial drugs have been identified from phenotypic screens on the basis of their 
ability to inhibit pathways or functions that are essential for bacterial growth and survival; 
for this reason, components of the DNA replication machinery represent the preferred 
targets (Robinson et al., 2012, Warner, 2010). With the exception of DNA gyrase inhibitors, 
targeting the replisome components has failed to yield candidate drugs, identifying DNA 
replication among the most underexploited targets (Robinson et al., 2012) and prompting a 
call for the application of new technologies including structure-based drug design and 
fragment-based lead generation to identify replication components for chemical inhibition 
(Sanyal and Doig, 2012). Recent evidence implicating the lethal incorporation of oxidized 
guanine into DNA as a major cause of antibiotic-induced bacterial cell death (Foti et al., 
2012) suggests that DNA replication and repair pathways might contribute significantly to 
intrinsic drug resistance and, for that reason, further supports the call for DNA metabolic 
pathways to be targeted aggressively as potentially novel antimicrobial therapies. 
 
As for most other major bacterial pathogens, DNA replication and repair proteins in Mtb 
have been investigated for their potential exploitation as targets for antimycobacterial 
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agents. Type II topoisomerases are well conserved across bacteria, and inhibition of DNA 
gyrase by fluoroquinolones (FQ) has provided an attractive option for treatment of TB. A 
number of studies have shown the clinical benefit of FQs such as ofloxacin and moxifloxacin 
in the treatment of TB (Duong et al., 2009). However, the emergence of Mtb strains 
resistant to FQs poses a threat to their continued use – emphasizing the need of 
identification of novel GyrA inhibitors with unique binding mechanisms. A recent study 
identified a group of novel gyrase inhibitors, benzimidazoles and N-linked aminopiperidinyl-
based gyrase inhibitors with anti-TB activity (Hameed et al., 2014a, Hameed et al., 2014b). 
Moreover, Karkare and colleagues (Karkare et al., 2013) demonstrated enhanced activity for 
the naphthoquinones, diospyrin and 7-methyljuglone, particularly against Mtb. 
Furthermore, researchers at GlaxoSmithKline (GSK) identified an additional panel of novel 
Mtb DNA gyrase inhibitors with antimycobacterial activity (Blanco et al., 2015).  
 
Insights from other organisms suggest that Mtb DnaE1 could be a profitable target for drug 
development, since it is essential for DNA synthesis and conserved across all bacteria. For 
example, 6-anilinouracils and their derivatives have been shown to inhibit DNA PolIII and 
have antibacterial activity against low GC Gram positive bacteria (Xu et al., 2011, Zhi et al., 
2003). In addressing this gap, a recent study by Harris and colleagues identified a panel of 
novel imidazoline compounds that have bactericidal activity against both replicating and 
non-replicating Mtb and other Gram positive cocci (Harris et al., 2014). The bacterial β2 
sliding clamp is also emerging as a potential drug target due to its central role in DNA 
replication, serving as a protein− protein interaction hub (Yin et al., 2014, Georgescu et al., 
2008). Small molecule inhibitors (Georgescu et al., 2008) and tetrahydrocarbazole 
derivatives have been shown to inhibit DNA replication in vitro, in E. coli, A. baylyi, B. subtilis 
and S. aureus (Yin et al., 2014) – emphasizing the need to test these compounds in Mtb.  
 
Consistent with their inferred importance for mycobacterial pathogenesis, tolerance 
pathways might offer an additional option for novel antibacterial therapies. There has been 
considerable discussion of the possibility of inhibiting tolerance mechanisms, particularly 
inducible mutagenesis pathways, in order to protect current drugs by targeting the 
mechanisms that underlie the evolution of resistance (Smith and Romesberg, 2007). In some 
respects, this approach can be considered analogous to inhibiting efflux pathways (Adams et 
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al., 2011): on its own, a specific efflux pump(s) is not an attractive target but, in combination 
with the appropriate frontline drug, its inhibition might be critical to efficacy by ensuring 
that the active compound is maintained at an elevated intracellular concentration (Adams et 
al., 2014, Adams et al., 2011, Gupta et al., 2015). Mtb DnaE2 represents a good candidate 
for this approach since it is not essential for normal growth in vitro, yet loss of DnaE2 
activity attenuates virulence in vivo and reduces the frequency of drug resistance mutations 
during chronic infection (Boshoff et al., 2003). Furthermore, DnaE2 has been demonstrated 
to function in association with other DNA damage response proteins as a split ‘mutagenic 
cassette’ (Warner et al., 2010), suggesting an alternative strategy of targeting the other 
pathway components, for example by disrupting the protein–protein interactions that are 
essential to mutasome function (Georgescu et al., 2008, Yin et al., 2014).  
 
Understanding which parts are conserved when targeting any system for drug development 
is critical, since this has implications for the spectrum of activity of any new inhibitors 
against bacterial species, as well as the potential for development of drug resistance 
(Robinson et al., 2012). This will be challenging in Mtb since there are still knowledge gaps 
on the conservation and architecture of the mycobacterial replisome, which may further 
complicate attempts of identifying possible replisome components as potential drug targets. 
Moreover, there are limited data supporting the creation of comprehensive maps of protein 
networks and interactions for Mtb (Wang et al., 2010).  
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Table 1.1: Components of the mycobacterial replisome 
Gene Mtb Msm M. leprae Function Catalytic 
activity 
Essentiality in vitroa / 
Comments 
References 
Initiation complex 
dnaA Rv0001 MSMEG_6947 ML0001 Replication initiator ATPase Essential; required for 
regulation of DNA replication 
(Leonard and 
Grimwade, 
2011, Xie and 
He, 2009) 
dnaB Rv0058 MSMEG_6892 ML2680 Replicative helicase ATPase Essential; controls DNA 
complex formation and 
interaction with oriC 
(Xie and He, 
2009) 
Primosome 
dnaG Rv2343c MSMEG_4482 ML0833 DNA primase RNA primase Essential; required for 
regulation of DNA replication 
(Klann et al., 
1998) 
priA Rv1402 MSMEG_3061 ML0548 Primosome replication 
factor, replication 
restart 
ATPase Essential  
DNA PolIII core 
dnaE1 Rv1547 MSMEG_3178 ML1207 α subunit, polymerase 
activity 
DNA 
polymerase 
Essential; high fidelity 
replicative polymerase 
(Boshoff et 
al., 2003) 
dnaQ Rv3711c MSMEG_6275 Absent ε subunit, 
proofreading activity 
Exonuclease Non-essential; associated with 
drug resistance  
(Farhat et al., 
2013) 
dnaQ-
uvrC 
Rv2191 MSMEG_4259 Absent Fusion/chimeric 
protein; N-terminal 3’-
5’ exonuclease 
domain, C-terminal 
UvrC-like 
endonuclease domain 
Exonuclease/ 
Endonuclease 
 
Non-essential; role in bacillary 
persistence 
(Kesavan et 
al., 2009) 
DNA PolIII clamp loader complex 
dnaZX Rv3721c MSMEG_6285 ML2335 τ and γ subunits ATPase Essential  
holA Rv2413c MSMEG_4572 ML0603 δ subunit  Non-essential  
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holB Rv3644c MSMEG_6153 ML0202 δ’ subunit ATPase Essential  
The mycobacterial replication complex 
dnaN Rv0002 MSMEG_0001 ML0002 β2 sliding clamp  Essential  
ssb Rv0054 MSMEG_6896 ML2684 Single-stranded DNA 
binding protein 
 Essential b  
polA Rv1629 MSMEG_3839 ML1381 DNA PolI DNA 
polymerase 
Essential; lacks a proofreading 
3’-5’ exonuclease activity, 
polA mutant displayed a DNA 
damage phenotype following 
UV irradiation and hydrogen 
peroxide treatment 
(Mizrahi and 
Huberts, 
1996, 
Gordhan et 
al., 1996) 
ligA Rv3014c MSMEG_2362 ML1705 DNA ligase, DNA 
replication 
NAD-dependent 
DNA ligase 
Essential (Srivastava et 
al., 2007) 
ligB Rv3062 MSMEG_2277 Absent DNA ligase ATP-dependent 
DNA ligase 
Non-essential; role in DNA 
repair 
(Gong et al., 
2005) 
ligC Rv3731 MSMEG_6304 Absent DNA ligase ATP-dependent 
DNA ligase 
Non-essential; role in Ku-
dependent non- homologous 
end joining (NHEJ) DSB repair 
pathway 
(Gong et al., 
2005)  
ligD Rv0938 MSMEG_5570 Absent DNA ligase, DSB repair ATP-dependent 
DNA ligase 
Non-essential; plays a central 
role in the mutagenic NHEJ 
pathway of DSB repair  
(Gong et al., 
2004, Heaton 
et al., 2014) 
gyrA Rv0006 MSMEG_0006 ML0006 DNA gyrase, subunit A 
(DNA topoisomerase 
II) 
Topoisomerase, 
ATPase 
Essential (Merens et 
al., 2009) 
gyrB Rv0005 MSMEG_0005 ML0005 DNA gyrase, subunit B 
(DNA topoisomerase 
II) 
Topoisomerase, 
ATPase 
Essential (Merens et 
al., 2009) 
topA Rv3646c MSMEG_6157 ML0200 DNA topoisomerase I Topoisomerase, 
ATPase 
Essential; role in DNA repair (Yang et al., 
2012) 
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rnhA-cobC Rv2228c MSMEG_4305 ML1637 Chimeric protein; N-
terminal RNase HI 
domain, C-terminal 
CobC-like α-ribazole 
phosphatase domain 
RNase/ α-
ribazole 
phosphatase 
Essential; deletion of rnhB in 
Msm does not alter genome 
stability 
(Watkins and 
Baker, 2010) 
rnhB Rv2902c MSMEG_2442 ML1611 RNase HII RNase Non-essential (Minias et al., 
2015) 
Other DNA replication proteins 
dnaE2 Rv3370c MSMEG_1633 pseudogene α subunit, TLS 
polymerase activity 
DNA 
polymerase 
Non-essential; involved in 
adaptive mutagenesis and 
contributes to the emergence 
of drug resistance 
(Boshoff et 
al., 2003, 
Warner et al., 
2010) 
dinB1 Rv1537 MSMEG_3172 Absent DNA PolIV.I DNA 
polymerase 
Non-essential; required for 
ribonucleotide discrimination 
during DNA synthesis 
(Ordonez et 
al., 2014) 
dinB2 Rv3056 MSMEG_2294 Absent DNA PolIV.II DNA 
polymerase 
Non-essential; dispensable for 
DNA damage tolerance in 
mycobacteria but instead 
required for ribonucleotide 
incorporation 
(Ordonez et 
al., 2014) 
polX Rv3856c MSMEG_6445 Absent DNA PolX Unknown c Non-essential  
 
a 
In vitro essentiality, as determined by transposon site hybridization (TraSH) (Griffin et al., 2011, Sassetti et al., 2003). 
b
 Rv0054 did not satisfy the strict criterion for essentiality in the study by Griffin et al. (Griffin et al., 2011); however, no transposon (Tn) insertions were identified in any of 
the five possible TA dinucleotides in the ORF, suggesting that it is likely to be essential. 
c
 A natural truncation in the polymerase domain of Rv3856c is predicted to preclude catalytic activity (Warner et al., 2010). 
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1.8 Is there a role for other proteins at the replication fork? 
Even though the α subunit has been demonstrated to be the dominant replicase in bacterial 
DNA replication, there is increasing evidence to suggest that chromosomal replication is 
characterised by dynamic DNA polymerase exchange (Fijalkowska et al., 2012). For example, 
of the four accessory DNA polymerases in E. coli, PolI (polA) and PolII (polB) contribute 
directly to replication fidelity during normal chromosomal replication (Fijalkowska et al., 
2012) through their respective roles in high-fidelity maturation of Okazaki fragments during 
lagging strand synthesis (PolI), and as a back-up replicative polymerase during transient 
dissociation of the PolIII HE from either leading or lagging strand (PolII). The remaining 
accessory polymerases, DNA PolIV (dinB) and PolV (umuD2C), are both members of the Y-
family of specialist translesion (TLS) polymerases that function primarily in the DNA damage 
response, but can also access the lagging strand under conditions of elevated expression 
(Fijalkowska et al., 2012).  
 
Mtb does not contain a PolII enzyme, but instead has two homologs of PolIV, DinB1 and 
DinB2 (Kana et al., 2010). Only DinB1 possesses a consensus β2 clamp binding motif (Kana et 
al., 2010), suggesting that DinB2 must interact with another protein(s) in order to access the 
replication fork. Therefore, while studies have demonstrated that the Msm homolog of Mtb 
DinB2 is a functional DNA polymerase with a tendency to promote G:T and T:G mismatches 
(Sharma and Nair, 2012), the role of DinB2 in mycobacterial DNA metabolism is unknown. 
Similarly, although recent work has provided important insight into the activity and function 
of the DinB-type Y-family polymerases in Mtb (Ordonez et al., 2014), the biological roles of 
the mycobacterial DinBs remains speculative (discussed in sections below).  
 
1.9 The mycobacterial replication rate 
There are limited data on both replication and mutation rates of Mtb bacilli during host 
infection, especially during latency. Evidence from molecular epidemiological studies 
demonstrated endogenous reactivation of Mtb after three decades of latent infection 
(Lillebaek et al., 2002) and this risk increases 10% per year in HIV-infected patients relative 
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to immune-competent individuals (Nahid and Daley, 2006). Previous models of latent TB 
infection (LTBI) suggested that, during the latent phase, Mtb enters a very slowly replicating 
or non-replicating (but perhaps metabolically active) state in which bacilli are insensitive to 
killing by the host immune effector molecules and anti-TB drugs (Wayne, 1977). In contrast, 
alternative models by Sherman and colleagues, which are based on the use of a “clock” 
plasmid which is lost from daughter cells during division, instead propose a stable balance in 
vivo between bacillary replication and death, probably as a consequence of active immune 
surveillance (Gill et al., 2009). In support of this notion, recent studies suggest that latency 
involves a disease spectrum that extends from non-replicating persisting organisms, to 
replicating but asymptomatic infections, to low-level disease with higher numbers of 
actively replicating bacteria (Ernst, 2012, Gupta et al., 2012, Lin et al., 2014). 
 
To gain insight into LTBI and define the mutational capacity of Mtb during different stages of 
infection, Ford and colleagues used WGS to measure the mutation rate of Mtb isolates from 
cynomolgus macaques with active, latent and reactivated disease (Ford et al., 2011). Given 
that the generation time of Mtb in vivo is unknown, the mutation rate in this study was 
calculated allowing for a broad range of generation times (between 18 and 240 h). 
Interestingly, the authors observed similar replication and mutation rates in Mtb isolates 
from latent, reactivated, and actively-infected macaques. In addition, they demonstrated 
that macaques with clinically latent infection acquire mutations at a similar rate to rapidly 
replicating bacteria in vitro (Ford et al., 2011) - an intriguing finding since these would be 
expected to differ on the basis that mutation rates determined in vitro often involve large 
bacterial populations either at exponential or stationary phases of growth (Gillespie, 2002) 
which do not represent in vivo conditions. Instead, the findings from this study suggest that 
Mtb continues dividing actively during the entire course of prolonged clinical latency, and 
this active replication is balanced by robust killing, at least in this model. The authors further 
concluded that the mutation rates observed during latency are likely attributable to 
oxidative DNA damage rather than replicative errors. In summary, these observations were 
interpreted as suggesting that the mutational capacity of Mtb during latent infection is 
determined primarily by the length of time the organism spends in the host environment 
rather than the replicative capacity and replicative errors of the organism during infection 
(Ford et al., 2011).  
22 
 
 
In contrast to the results of Ford et al. (2011), Alland and colleagues reported different 
findings in humans: specifically, their data suggested the possibility that the non-human 
primate model might not appropriately recapitulate latent TB in humans (Colangeli et al., 
2014). Again using WGS, Alland and colleagues calculated the replication and mutation rates 
of latent Mtb by comparing the genome sequence of a single strain that had been 
transmitted from a single, incident TB case and resulted in TB disease in close contacts over 
a period of twenty years. In contrast to findings in macaques, these authors observed lower 
mutation rates during latency, for any given generation time, even after adjusting for the 
predicted higher mutation rate that was considered likely to occur during the final stage of 
infection, as the individual progressed to active TB (Colangeli et al., 2014). Moreover, 
analysis of the mutation spectrum in the human LTBI model did not reveal a higher 
proportion of mutations associated with oxidative damage (GC>AT or GC>TA mutations) as 
observed in macaques; instead, there were fewer mutations associated with oxidative 
damage, suggesting that, during latent infection in humans, the bacterium’s mutational 
capacity is driven by replicative mutagenesis rather than oxidative stress, contrary to the 
interpretation of Ford et al. based on the non-human primate model.  
 
These findings by Colangeli et al. also suggest that the mycobacterial mutation rate is 
altered during different stages of infection – in turn implying that there is possibly less host 
pressure on the organism during latency, and therefore, a reduced requirement to replicate 
and mutate to facilitate adaptation. Importantly, the results of this study might counter 
suggestions that INH monotherapy for latent TB is a risk factor for the emergence of INH 
resistance (Ford et al., 2011), given that the rate at which clinical drug resistance emerges 
depends on the number of bacteria in a latently-infected individual and this has been shown 
to be very low (Colangeli et al., 2014). However, the small number of samples used in this 
study, coupled with the fact that the replication and mutation rates which occur during 
latency are difficult to verify experimentally, reinforces the need for further research to 
address this issue definitively. 
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1.10 Replication fidelity and the Mtb mutation rate 
The in vitro mutation rate in Mtb has been estimated at ~2.9 x10-10 per base pair per round 
of replication (Ford et al., 2011). This figure, which was derived from fluctuation analyses 
that utilized rpoB as the target for rifampicin resistance and were corrected for the 
mutational target size (Ford et al., 2011), is comparable to E. coli. In that organism, it is 
estimated intrinsic replication fidelity by the replicative polymerase, the removal of any mis-
incorporated nucleotides by the 3’-5′ exonuclease activity of the replicative polymerase 
itself or its interacting proofreading subunit, and post-replicative mismatch repair (MMR), 
contribute 10-5, 10-2, and 10-3, respectively, to the overall error rate of 10-10 (Fijalkowska et 
al., 2012). However, Mtb lacks the MMR system, suggesting that intrinsic fidelity and/or 
proofreading are able to maintain overall mycobacterial replication fidelity, or that 
alternative mechanisms exist for the correction of replication errors, perhaps including a 
non-orthologous system for MMR (Mizrahi and Andersen, 1998).  
 
While the possibility exists that mycobacteria encode a non-orthologous alternative to the 
canonical, and widely spread MutHLS-based MMR system (Mizrahi and Andersen, 1998), 
multiple lines of evidence instead suggest that other repair components have enabled Mtb 
to mitigate the lack of MMR function (Springer et al. 2004; Machowski et al. 2007; Wanner 
et al. 2008). For example, Springer and colleagues demonstrated that the key NER helicase, 
UvrD1, fulfils a critical role in limiting recombination-associated mismatches in mycobacteria 
(Guthlein et al., 2009). In addition, intrinsic features of the genome itself might limit the risk 
of replication errors: although short sequences of nucleotide repeats pose a significant 
problem to replicative DNA polymerases and can result in frameshift mutations, the GC-rich 
Mtb genome appears to have been under strong selective pressure to restrict the number of 
repeat regions through context-dependent codon choice (Wanner et al., 2008). The 
maintenance of genome stability within the host during long-term persistence is crucial for 
survival and propagation of Mtb. However, that fundamental must be balanced against the 
evolutionary need to adapt genetically to the stresses and fluctuating environments 
encountered during infection, including those imposed by anti-tubercular drug 
administration (Dos Vultos et al., 2009, Gorna et al., 2010). Acquisition of foreign DNA can 
accelerate adaptation in bacteria which reproduce asexually; in Mtb, however, evolution 
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appears to be limited to the selection and maintenance of chromosomal mutations and 
rearrangements (Hershberg et al., 2008) and is, therefore, dependent on the generation of 
mutant alleles which provide the genetic diversity for selection. Proof of adaptation in Mtb 
is demonstrated by the emergence of MDR and XDR strains; moreover, recent 
epidemiological data indicate a high degree of genetic diversity between clinical strains that 
correlates well with human demography (Hershberg et al., 2008). These observations 
suggest that there is a balance between the activity of error-free DNA repair mechanisms in 
maintaining genomic integrity, and the operation of mutagenic pathways which might 
generate diversity during host infection (Warner et al., 2010, Warner et al., 2013). This 
balance is set by the fidelity of the DNA replication, repair, and recombination (or “3R”) 
system.  
 
The high-fidelity operation of 3R pathways favours genome stability, whereas relaxed 
fidelity - or loss of specific 3R functions (Dos Vultos et al., 2008) - might facilitate genetic 
adaptation (Warner et al., 2010, Warner et al., 2013). Evidence demonstrating that other 
bacterial pathogens are associated with strains exhibiting elevated mutation rates as a 
result of defective DNA repair functions, most commonly the MMR system (Sundin and 
Weigand, 2007), suggests that increased mutability might facilitate adaptation to dynamic 
hostile environments. However, consistent with the idea that most mutations are 
deleterious, mutator strains are not found in all bacterial populations and, in most cases, 
the benefits of a mutator phenotype for colonization and the development of drug 
resistance are likely to be outweighed by negative effects on survival and virulence (Warner 
et al., 2015). Again, this suggests the need to maintain a balance between stability and 
mutagenesis. In a provocative study, Gicquel and colleagues found high numbers of 
polymorphisms in genes of the 3R system of Mtb compared with housekeeping genes, 
thereby identifying strong selection pressure on 3R genes as a common component in the 
modern evolutionary history of different strain lineages (Dos Vultos et al., 2008). It is 
tempting to speculate that the identified polymorphisms result in a relaxation of 3R fidelity 
that facilitates the adaptation of Mtb to genotoxic conditions and, perhaps, drives the 
expansion of a clonal infecting bacillus into a microdiverse bacillary population (Warner et 
al., 2015); however, this has not been demonstrated and so remains speculative.  
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1.11 Using Msm as a model organism for generating mutator strains 
M. smegmatis mc2155 (Msm) was used in this study as the parental strain for generating 
mycobacterial mutants containing site-directed substitutions in key active-site and protein-
binding domains of the relevant replisome components. Msm is a fast-growing, non-
pathogenic mycobacterium widely used as a model organism to study the biology of other 
virulent and slow-growing species like Mtb (Snapper et al., 1990). However, Msm is not an 
appropriate model for studying virulence or pathogenesis of Mtb. Important observations 
with regards to virulence factors of this pathogen should, therefore, be confirmed in Mtb 
(Reyrat and Kahn, 2001). Prior work in the Warner and Mizrahi laboratory has demonstrated 
the value of using Msm as model mycobacterium, primarily since the DNA replication and 
repair systems are highly similar (Table 1.1). As such, corresponding phenotypes have been 
observed for mutants generated in Mtb and Msm (Boshoff et al., 2003, Warner et al., 2010). 
In addition, given legitimate concerns about the potential biosafety implications contingent 
on generating mutator strains of Mtb, Msm represents an ideal model for studying 
mutational dynamics and replication fidelity in mycobacteria.  
 
1.12 Mutagenesis in Mtb 
Mtb is not a natural mutator (Ford et al., 2011). Moreover, since drug resistance in this 
organism occurs primarily through chromosomal mutation, it seems fair to conclude that 
mutational capacity is the key determinant in developing drug resistance. Numerous studies 
have provided both experimental and clinical evidence demonstrating that Mtb strains from 
different lineages vary in their capacity to cause disease (de Jong et al., 2008, Coscolla and 
Gagneux, 2010, Kato-Maeda et al., 2012, Glynn et al., 2002) and to acquire drug resistance 
(Anh et al., 2000, Huang et al., 2010, Sun et al., 2012, Johnson et al., 2010). However, the 
evidence for an association between specific Mtb strains and an elevated mutation rate is 
mixed. Gicquel and colleagues demonstrated that Mtb strains from the Beijing family 
contain mutations in genes whose disruption in other bacteria confers a mutator phenotype 
(Ebrahimi-Rad et al., 2003). Moreover, strains from this lineage have also been shown to 
have polymorphisms in DNA replication, recombination and repair genes, raising the 
possibility that they have higher mutation rates (Mestre et al., 2011). Also consistent with 
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these observations, Fortune and colleagues used WGS to demonstrate strain-based 
differences in mutation rates between lineage 2 (East Asian) and lineage 4 (Euro American) 
strains (Ford et al., 2013). Specifically, the authors reported that Mtb lineage 2 strains 
acquire drug resistance in vitro more rapidly than lineage 4 strains and, further, that the 
observed differences were not due to the enhanced ability of lineage 2 strains to adapt to 
antibiotic pressure but rather due to a higher basal mutation rate in the presence of the 
drug. Nevertheless, the mechanism underlying the inferred difference in mutation rates 
between the selected lineages remains to be determined (Ford et al., 2013).  
 
In contrast to these studies, previous in vitro analyses observed no differences between the 
mutation rates of the Beijing versus non-Beijing strains (Werngren and Hoffner, 2003), 
consistent with the idea that multiple factors other than the mutation rate contribute to the 
apparent success of the Beijing clade (Parwati et al., 2010). It is possible that the differences 
observed between these studies are due to the representative Beijing versus non-Beijing 
strains that were used. In this respect, whilst findings from Fortune and colleagues offer 
compelling evidence of strain-based differences in mutation rates, it is worth noting that: 1) 
the CDC155 strain employed as an exemplar lineage 4 strain represents a minor branch 
within this lineage, with its own mode of evolution (Mokrousov, 2014); and 2) HN878, as 
representative lineage 2 strain, has similarly separated from other Beijing family members 
(Mokrousov, 2014). This suggests that the isolates studied by Fortune and colleagues might 
not necessarily be truly representative of their lineages and, in turn, implies that further 
studies are required to address this important question adequately.   
 
In addition to errors made by the replicative polymerase during DNA replication, mutations 
can also arise as a consequence of DNA damage by endogenous and exogenous DNA-
damaging agents. Damage repair and reversal in mycobacteria have been investigated using 
genetic and biochemical approaches; however, there are relatively few examples of studies 
which have utilized a combination of both (Gupta et al., 2011, Warner, 2010, Warner and 
Mizrahi, 2011). Given the threat the DNA lesions pose to viability, mycobacteria contain 
multiple, conserved mechanisms for detecting, processing and repairing these lesions. This, 
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again, emphasizes the potential contribution of DNA repair and/or tolerance pathways to 
the evolution and pathogenesis of Mtb.  
 
1.13 The mycobacterial complement of Y-family polymerases 
Specialized TLS DNA polymerases allow bypass of replication-blocking lesions that have 
escaped detection and repair, and so provide a mechanism for tolerating DNA damage (Yang 
and Woodgate, 2007). Most TLS polymerases belong to the Y-family of DNA polymerases 
which comprises a wide range of structurally related proteins present in bacteria, archaea, 
and eukaryotes (Ohmori et al., 2001). Many Y-family homologs are upregulated in response 
to stress, suggesting a potential role in induced mutagenesis (Andersson et al., 2010). The E. 
coli genome contains three TLS polymerases, all of which are upregulated in the DNA 
damage or SOS response: the B-family polymerase PolII, and the Y-family polymerases PolIV 
and PolV which are encoded by dinB and umuDC, respectively, (Goodman, 2002). In contrast 
to E. coli, the Mtb genome does not encode a B-family DNA polymerase, suggesting that all 
specialist bypass function in Mtb depends on the two PolIV polymerase homologs, originally 
annotated as DinP (DinB2) and DinX (DinB1) (Mizrahi and Andersen, 1998). In contrast to 
most bacterial systems, neither dinB1- nor dinB2-encoded PolIV homolog is upregulated in 
the mycobacterial damage response (Boshoff et al., 2003, Davis et al., 2002, Rand et al., 
2003, Warner et al., 2010); instead, both genes are expressed constitutively during 
logarithmic growth and stationary phase (Kana et al., 2010). Deletion of dinB1 and dinB2 had 
no effect on the sensitivity of Mtb to multiple DNA damaging agents (Kana et al., 2010), 
suggesting the dispensability of these polymerases for DNA damage tolerance. Furthermore, 
overexpression of either Mtb dinB1 or dinB2 in WT mc2155 did not increase the 
spontaneous mutation rate (Kana et al., 2010). This evidence suggests that DinB homologs 
from mycobacteria do not behave like their counterparts from other organisms.  
 
In addition to DinB1 and DinB2, Msm encodes a third DinB paralog, DinB3, which is not 
present in the proteome of Mtb. Shuman and colleagues recently demonstrated that Msm 
DinB1 and DinB3 are distantly related to DinB2 and, further, that both proteins function as 
typical DNA-dependent DNA polymerases with very poor to no ability to incorporate rNTPs 
(Ordonez et al., 2014). Further analysis showed that an aromatic steric gate side chain - 
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absent in DinB2 - enables rNTP discrimination and so enables DinB1 and DinB3 to 
differentiate between dNTPs and rNTPs during DNA synthesis (Ordonez et al., 2014). All 
previously characterised DinB polymerases have aromatic steric gates. Phylogenetic analysis 
of the phylum Actinobacteria revealed that this family consists of DinB2-like polymerases 
that lack the canonical aromatic steric gate residue and instead have a leucine side chain 
which governs the naturally strong RNA polymerase activity of this enzyme in mycobacteria 
(Ordonez et al., 2014). 
 
Of the three DinB paralogs, only dinB3 is upregulated in the Msm SOS response. The fact 
that DinB2, which is able to incorporate rNTPs, is not included in the Msm SOS regulon 
seems to imply that, following DNA damage, repair is primarily directed toward dNTP-
dependent repair. In addition to rNTP discrimination, the steric gates of Y-family E. coli PolIV 
(Jarosz et al., 2006) and PolV (Shurtleff et al., 2009) as well as human polymerase κ (Niimi et 
al., 2009) have been shown to be required for bypassing DNA lesions during TLS. In contrast, 
this function is performed by the C-family polymerase, DnaE2, in mycobacteria, 
demonstrating further deviations from model organisms.  
 
In E. coli, the Y-family DNA PolV is a functional homolog of Mtb DnaE2 and it is encoded by 
the umuD2C gene complex. UmuD’ and UmuC proteins play a role as part of a DNA damage 
check-point control in response to replication-blocking DNA damage (Murli and Opperman, 
2000, Opperman et al., 1999). This check-point involves the interactions of UmuD and UmuC 
with the β2 clamp and ε proofreading subunit of DNA PolIII (Sutton et al., 2001a, Sutton et 
al., 2001b). The equivalent function for Mtb would, therefore, include interaction of ImuB 
with DnaE1 and DnaE2 as well as the β2 clamp. In support of this notion, ImuB has been 
shown to be highly expressed under conditions of DNA damage (Warner et al., 2010). 
Interactions of UmuD’ with the α and β subunits of DNA PolIII are crucial for the TLS DNA 
synthesis activity of DNA PolV in vivo (Bridges 2001; Walker 2001) and in vitro (Tang et al., 
2000). By interacting differently with components of DNA PolIII, the two different forms of 
the umuD gene product play a role in managing the actions of UmuC (Sutton et al., 2001a, 
Sutton et al., 2001b, Sutton et al., 1999).  
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In addition to TLS, E. coli DinB is involved in adaptive mutagenesis (McKenzie et al., 2001, 
Tompkins et al., 2003, Yeiser et al., 2002), catalysing efficient and accurate TLS across 
certain N2-dG bulky adducts (Jarosz et al., 2006, Jarosz et al., 2007b, Kumari et al., 2008, 
Minko et al., 2008) as well as tolerance of alkylation damage (Bjedov et al., 2007). 
Furthermore, overexpression of PolIV significantly increases mutation rates in E. coli 
(Goodman, 2002, Jarosz et al., 2007a). The dinB gene is under the transcriptional control of 
the LexA repressor and is the only SOS-regulated gene required at induced levels for stress-
induced mutagenesis in this organism (Courcelle et al., 2001). In addition, PolIV has been 
shown to catalyse TLS-mediated recovery of stalled replication forks at DNA lesions. 
Following replication stalling, PolIV replaces PolIII through the β2 clamp-mediated increase 
in PolIV-dNTP affinity as a strategy for cell survival during stressful conditions (Wagner et al., 
2000, Bertram et al., 2004). This function has been shown to be performed by DinB2 in 
mycobacteria (Ordonez et al., 2014), however, the exact mechanism still needs to be 
established.  
 
1.14 Damage tolerance in Mtb 
Mtb is unusual in that it contains both SOS-dependent (Smollett et al., 2012) and SOS-
independent (Gamulin et al., 2004) DNA damage responses, with some repair components 
induced by both mechanisms (Rand et al., 2003). In contrast to model organisms, neither 
dinB homolog is included in the mycobacterial DNA damage response (Boshoff et al., 2003). 
Instead, the mycobacterial SOS regulon is limited to the dnaE1 and dnaE2-encoded catalytic 
α subunits of PolIII (Boshoff et al., 2003, Warner et al., 2010). Loss of DnaE2 activity renders 
Mtb hypersensitive to DNA damage and eliminates induced mutagenesis. In addition, 
inactivation of dnaE2 attenuates virulence and reduces the frequency of drug resistance in a 
mouse model (Boshoff et al., 2003). Coupled with the induction of dnaE2 during stationary 
infection, these observations implicate a DnaE2-mediated mutagenic mechanism in both 
pathogenesis and the adaptive evolution of drug resistance during persistence (Boshoff et 
al., 2003). 
 
Recent studies demonstrated that DnaE2 operates in a novel mutagenic pathway 
comprising two additional accessory proteins, ImuA’ and ImuB. These proteins are often 
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encoded in bacterial genomes as a mutagenic gene “cassette”, which is widely distributed 
across bacteria that do not encode the umuD2C gene complex (Erill et al., 2006, Galhardo et 
al., 2005). ImuB is one of three putative Y-family polymerase homologs in the Mtb genome 
but it appears from sequence analysis to be catalytically inactive (Warner et al., 2010). 
Although this predication requires formal demonstration, the current model for the 
mycobacterial “mutasome” holds that DnaE2 functions as the TLS polymerase with ImuB 
acting as hub protein that interacts with both ImuA’ and DnaE2 via the C-terminal domain, 
and with the β2 clamp via a β2 clamp binding motif (Warner et al., 2010). These observations 
suggest that the split imuA’-imuB/dnaE2-encoded system constitutes a non-orthologous 
replacement of the E. coli UmuD’2C-RecA-ATP PolV mutasome (Jiang et al., 2009).  
 
The basis for the functional specialization of C-family replicative and TLS polymerases in Mtb 
and other Gram-positive bacteria remains unclear (Bruck et al., 2003, Le Chatelier et al., 
2004). Unlike Y-family polymerases whose structures are adapted to specialist lesion bypass 
(Yang and Woodgate, 2007), sequence analysis reveals few clues as to DnaE2 function. 
Structural determinants such as active site architecture are likely to contribute significantly 
to inherent fidelity; however, it is also possible that differential interactions with other DNA 
metabolic proteins modulate polymerase function.  
 
1.15 Structural and functional differences between the mycobacterial dnaE-encoded α 
subunits  
Although DnaE1 and DnaE2 are similar in terms of amino acid identity, they perform 
different functions (Boshoff et al., 2003). DnaE1 is an essential, high fidelity replicative 
polymerase in Mtb, whereas DnaE2 functions in non-essential, error-prone TLS. Table 1.2 
highlights some of the differences between DnaE1 and DnaE2. Previous studies identified 
DnaE2 as central player in the DNA damage response in Mtb and, importantly, 
demonstrated a critical role for the TLS polymerase in virulence and the emergence of drug 
resistance in vivo (Boshoff et al., 2003), as mentioned above. However, the role for DnaE2 as 
an error-prone TLS polymerase is not general across bacterial phyla; for example, 
Pseudomonas putida DnaE2 has been shown to have antimutator properties (Koorits et al., 
2007) whereas the homologous protein in P. aeruginosa has been shown to be dispensable 
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for damage tolerance (Cirz et al., 2006) but not for induced mutagenesis (Sanders et al., 
2006). In addition, in Streptomyces coelicolor, dnaE2 was shown to be SOS-inducible, but 
dispensable for DNA replication, linear chromosome end patching, ultraviolet resistance and 
mutagenesis (Tsai et al., 2012).  
 
All major DNA PolIIIα structural features are readily identifiable in both DnaE1 and DnaE2, 
except for the C-terminal τ-interacting domain which is absent in DnaE2 (Table 1.2) 
(Timinskas et al., 2014, Warner et al., 2010). A strong α-τ interaction enables simultaneous 
leading and lagging strand synthesis by PolIII HE in E. coli (Johnson & O'Donnell 2005); the 
absence of this region might, therefore, account for the inability of DnaE2 and other non-
essential polymerases to substitute essential replicative function (Boshoff et al., 2003, Bruck 
et al., 2003, Le Chatelier et al., 2004). Evidence implicating a defective τ-PolIIIα interaction in 
a mutator phenotype (Gawel et al., 2008) suggests that the ability to bind τ might contribute 
to relative polymerase activity. In addition, DnaE2 lacks a consensus β2 clamp binding motif, 
QL[S/D]LF, that is required for accessing DNA during DNA synthesis (Table 1.2) (Dalrymple, 
2001) as well as the complete set of PHP domain metal co-ordinating residues that are 
required for intrinsic proofreading (Baños et al., 2008, Stano et al., 2006).   
 
Another critical interaction in the E. coli replisome is that which occurs between PolIIIα and 
the dnaQ-encoded ε subunit. In E. coli, disruptions to proofreading activity enable PolIII-
mediated TLS in the absence of specialist DNA repair polymerases IV and V (Borden et al., 
2002, Vandewiele et al., 1998). Moreover, in organisms such as S. pyogenes, the essential 
DnaE subunit that catalyses error-prone TLS does not bind DnaQ (Bruck et al., 2003). In 
combination, these observations suggest that differential interactions with the DnaQ-like 
Rv3711c and Rv2191 might determine α subunit function in Mtb. Additionally, a Zn2+-
dependent  3’-5’ exonuclease activity was recently located to the PHP domain of DnaE-type 
polymerases (Barros et al., 2013, Stano et al., 2006). As detailed above, one of the key 
objectives of the current study was to evaluate the relative contributions of both PHP 
domain and DnaQ mediated exonuclease activity to PolIII function and replicative fidelity.  
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In conclusion, while comparative genomic surveys of DNA replication and repair proteins in 
Mtb have identified components of most major pathways, at the inception of this project, 
no studies had been conducted to investigate the functional contribution of key replisome 
components and interacting proteins to DNA replication fidelity. In particular, the structural 
and functional basis for the differences between DnaE1 and DnaE2 were poorly understood. 
This project was therefore formulated to address this gap. 
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Table 1.2: Structural and/or functional differences between DnaE1 and DnaE2 polymerases of Mtb 
Structural and/or functional properties DnaE1 DnaE2 References 
Function High fidelity chromosomal 
replicase 
Error prone TLS 
polymerase 
(Boshoff et al., 2003) 
β2 clamp binding motif Yes No (Boshoff et al., 2003, 
Warner et al., 2010) 
In vitro essentiality a Yes No (Boshoff et al., 2003) 
τ-binding domain Yes No (Warner et al., 2010) 
Intrinsic proofreading domain Yes Unknown  
Complete set of metal co-ordinating residues b Yes No (Warner et al., 2010, 
Timinskas et al., 2014) 
Partners during replisome function DnaN (β2 clamp)  - (Warner et al., 2010) 
Partners during damage response -  ImuA’ and ImuB  
 
a In vitro essentiality, as determined by TraSH (Griffin et al., 2011, Sassetti et al., 2003). 
b These residues were determined by sequence alignment using protein sequences from E. coli (Barros et al., 2013, Lamers et al., 2006) and T. 
aquaticus (Bailey et al., 2006) PolIIIα subunits as reference.  
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CHAPTER 2: AIMS AND OBJECTIVES 
 
As noted above (Table 1.2 and Figure 1.2), previous work from the Warner and Mizrahi 
laboratory (Boshoff et al., 2003, Warner et al., 2010) and others (Timinskas et al., 2014) has 
identified at least four major differences in the structural organizations of the DnaE1 versus 
DnaE2 α subunits, specifically:  
 
1. The presence in DnaE1 of conserved residues that are predicted to be required for 
proofreading; 
2. A pentapeptide C-terminal motif, SRDFR, that is present in DnaE2 and other non-
essential DnaE-type polymerases; 
3. An extended N-terminal region in DnaE2 that is conserved in DnaE2 homologs in 
Actinobacteria only 
4. The absence in DnaE2 of the τ binding domain that is essential for co-ordinated 
leading and lagging strand DNA synthesis by the replisome 
 
 
 
Figure 1.2: Schematic representation of key differences in the structural organizations of 
DnaE1 and DnaE2 PolIIIα subunits. The asterisk denotes mutations in conserved residues in 
the PHP domain of DnaE2. τ binding domain = tau-binding domain. See text for details.  
 
2.1 Aim 
The overall aim of this study was to investigate possible factors contributing to the 
differential functions of DnaE1 and DnaE2 under conditions of genotoxic stress.  
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2.2 Objectives 
 
The specific objectives of this study were: 
 
1. To determine the contribution of conserved PHP domain residues to the fidelity of 
the dnaE1-encoded α subunit;  
2. To investigate the role of the mycobacterial proofreading DnaQ subunit homologs in 
maintaining the fidelity of DnaE1-dependent DNA replication; and  
3. To determine the role of the C-terminal pentapeptide motif and N-terminal 
extension in the activity of the dnaE2-encoded error-prone TLS polymerase 
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CHAPTER 3: MATERIALS AND METHODS 
 
All culturing and DNA manipulations were performed according to standard protocols 
(Parish and Stoker, 2000, Snapper et al., 1990, Sambrook et al., 1989, Sambrook and Russell, 
2001). Details of growth media and general solutions used in this study are outlined in 
Appendix A. Basic microbiological and molecular genetics work was carried out using 
standard methods that are well established in the Molecular Mycobacteriology Research 
Unit (MMRU).  
 
3.1 Mycobacterial strains, plasmids and growth conditions 
All plasmids and bacterial strains used in this study are listed in Tables 3.1 and 3.2. Bacterial 
strains were stored in 33% (v/v) glycerol and stored at -80°C.  
 
3.1.1 Bacterial culturing conditions 
 
E. coli strains 
E. coli strains used for cloning procedures were grown in Luria Bertani (LB) broth 
supplemented with an appropriate antibiotic, either standing at 30°C for 48 h in an 
IncoTherm incubator (Labotec) or overnight with vigorous shaking at 37°C in an IncoShake 
incubator (Labotec), depending on the size of the plasmid. For growth on solid medium, 
cells were streaked on Luria Bertani agar (LA) plates containing the relevant supplements, 
and incubated at 37°C or 30°C in the case of knockout constructs. Antibiotics were used at 
the following concentrations: 100 μg/ml ampicillin (Ap), 200 μg/ml hygromycin (Hyg), and 
50 μg/ml kanamycin (Km). For blue/white selection, 40 μg/ml of 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-gal) was added to the growth medium.  
 
Mycobacterial strains 
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Msm strains were grown in Middlebrook 7H9 medium (Difco, Becton Dickinson, USA) 
supplemented with 10% Middlebrook Oleate-Albumin-Dextrose-Catalase (OADC), 0.05% 
Tween 80 and 0.05% glycerol (7H9 OADC) or Middlebrook 7H10 solid medium 
supplemented with 10% OADC and 0.05% glycerol (7H10 OADC). Antibiotics were used at 
the following concentrations: 50 μg/ml Hyg and 20 μg/ml Km.  
 
Saccharomyces cerevisiae (Yeast) strains  
Yeast strains were grown in rich YPD broth (0.1% Yeast extract, 0.2% Peptone and 0.2% 
Glucose) or on YPD agar (YPDA, 0.15% agar) supplemented with 0.003% adenine. Selection 
of strains carrying plasmids was on minimal synthetic drop-out (SD) medium without leucine 
and tryptophan. SD medium (0.67% yeast nitrogen base without amino acids, 2% glucose, 
2% Bacto agar and 0.02% drop-out mix) was used for selection of plasmids based on the use 
of auxotrophic mutant strains which cannot grow in the absence of a specific medium 
component. Only yeast strains containing plasmid(s) with the gene required for growth in 
the absence of the specific component enables the transformants to grow on medium 
lacking that required component. 
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Table 3.1: Strains used in this study 
Strain designation Genotype Description Reference/ 
Source 
Yeast    
AH109  HIS3, ADE2, lacZ, MEL1 containing reporter 
strain for screening protein interactions, 
MATa, trp1-901, leu2-3, 112, ura3-52, his3-
200, gal4Δ, gal80Δ, LYS2::GAL1UAS-
GAL1TATA-HIS3, MEL1 GAL2UAS-GAL2TATA-
ADE2, URA3::MEL1UAS-MEL1TATA-lacZ 
Clontech 
Msm    
WT mc2155 High-frequency transformation mutant of 
Msm mc26; ATCC 706 
(Snapper et al., 
1990) 
ZD 1 dnaE1D49A mc2155 mutant with the aspartate to alanine 
substitution at position 49 in DnaE1 
This study 
ZD 2 dnaE1E133A mc2155 mutant with a glutamate to alanine 
substitution at position 133 in DnaE1 
This study 
ZD 3 dnaE1 
::p2NILdnaE1D228N 
Merodiploid mutant of mc2155 containing 
both WT and the mutant allele with an 
aspartate to asparagine substitution at 
position 228 in DnaE1 at the native dnaE1 
chromosomal locus 
This study 
ZD 4 dnaE1E133A::dnaE1 dnaE1E133A mutant of mc2155 complemented 
with wild-type (WT) dnaE1 
This study 
ZD 5 ΔdnaQ 
(MSMEG_6275) 
dnaQ knockout mutant of mc2155 This study 
ZD 6 ΔdnaQ dnaE1E133A ΔdnaQ dnaE1E133A double mutant of mc2155 This study 
ΔdnaQ-uvrC ΔMSMEG_4259 mc2155 deletion mutant of the second dnaQ 
homolog which comprises the N-terminal 3’-
(Ford, 2012) 
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5’ exonuclease domain and the C-terminal 
UvrC-like endonuclease domain 
ΔdnaQ ΔdnaQ-uvrC ΔMSMEG_6275 
ΔMSMEG_4259 
Double dnaQ and dnaQ-uvrC  knockout 
mutant of mc2155 
(Ford, 2012) 
ΔdnaE2 ΔdnaE2::aph dnaE2 knockout mutant of mc2155; KmR (Boshoff et al., 
2003) 
ZD 7 ΔdnaE2::aph 
attB::dnaE2 
ΔdnaE2::aph complemented with dnaE2 
integrated at attB site; KmR 
This study 
ZD 8 ΔdnaE2::aph 
attB::dnaE2ΔSRDFR 
ΔdnaE2 mutant complemented at attB site 
with a mutant form of dnaE2 in which the C-
terminal pentapeptide motif, SRDFR, is 
truncated; KmR 
This study 
ZD 9 ΔdnaE2::aph 
attB::dnaE2N38 
ΔdnaE2 mutant complemented at attB site 
with a mutant form of dnaE2 in which the 38 
N-terminal amino acids are truncated; KmR 
This study 
ΔL ΔdinB1 ΔdinB2 
ΔdinB2::hyg ΔdinB3 
ΔdnaE2 
Quintuple gene deletion mutant of mc2155 in 
which both dinB2 alleles, dinB3, dinB1 and 
dnaE2 are inactivated; HygR 
D. Warner, 
unpublished 
ZD 10 ΔL dnaE1D49A dnaE1D49A mutant of mc2155 in the ΔL 
background; HygR 
This study 
ZD 11 ΔL dnaE1E133A dnaE1E133A mutant of mc2155 in the ΔL 
background; HygR 
This study 
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Table 3.2 Plasmids used in this study 
Plasmids Description Source 
p2NIL E. coli cloning vector, KmR (Parish and Stoker, 
2000) 
pMC1r  Derivative of pMC1s (Ehrt et al., 2005) with 
NotI fragment containing tet repressor 
removed, KmR 
(Warner et al., 2010) 
pGOAL17  Plasmid carrying lacZ and sacB genes as a PacI 
cassette; ApR 
(Parish and Stoker, 
2000) 
pGOAL19  Plasmid carrying hyg, lacZ and sacB genes as a 
PacI cassette; ApR 
(Parish and Stoker, 
2000) 
pMC1rE1 pMC1r carrying full length dnaE1 at the 
bacterial att locus; KmR 
This study 
p2NILE1 p2NIL carrying full length dnaE1 containing 
PacI cassette from pGOAL19; KmR, HygR, SucS 
This study 
p2NILE1D49A p2NIL carrying full length dnaE1 with the D49A 
substitution and PacI cassette from pGOAL19; 
KmR, HygR, SucS 
This study 
p2NILE1E133A p2NIL carrying full length dnaE1 with the 
E133A substitution and PacI cassette from 
pGOAL19; KmR, HygR, SucS 
This study 
p2NILE1D228N p2NIL carrying full length dnaE1 with the 
D228N substitution and PacI cassette from 
pGOAL19; KmR, HygR, SucS 
This study 
p2NILΔdnaQ p2NIL carrying ΔdnaQ allele containing PacI 
cassette from pGOAL19; KmR, HygR, SucS 
This study 
   
pOmsmE2 Multicopy E. coli–Mycobacterium integrating 
shuttle vector carrying full length dnaE2; HygR 
(Boshoff et al., 2003) 
pMC1rdnaE2 Msm dnaE2 complementation vector - pMC1r 
carrying full length dnaE2; KmR 
This study 
pMC1rdnaE2ΔSRDFR pMC1r carrying dnaE2 with the C-terminal 
pentapeptide sequence SRDFR truncated; KmR 
This study 
pMC1rdnaE2N38 pMC1r carrying dnaE2 with the 38 N-terminal 
amino acids truncated; KmR 
This study 
pGADT7  Yeast-two-hybrid (Y2H) vector to produce 
activation domain (AD) fusions, GAL4 (768-881) 
AD, LEU2, HA epitope tag; ApR 
Clontech 
pGBKT7  
 
Y2H vector to produce binding domain (BD) 
fusions, GAL4 (1-147) DNA-BD, TRP1, c-MYC 
epitope tag; KmR 
Clontech  
pGBDDnaE1  pGBKT7 containing Mtb DnaE1 ORF fused to 
GAL4 BD 
(Kana et al., 2010) 
pGBDDnaE2  pGBKT7 containing Mtb DnaE2 ORF fused to 
GAL4 BD 
(Kana et al., 2010) 
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pGADImuB  pGADT7 containing Mtb ImuB ORF fused to 
GAL4 AD 
(Kana et al., 2010) 
pGBDDnaE2 pGBKT7 containing Msm DnaE2 ORF fused to 
GAL4 BD 
This study 
pGBDDnaE2ΔSRDFR pGBKT7 containing Msm DnaE2 ORF, with the 
C-terminal pentapeptide sequence SRDFR 
truncated, fused to GAL4 BD 
This study 
pGBDDnaE2N38 pGBKT7 containing Msm DnaE2 ORF, with the 
38 N-terminal amino acids truncated, fused to 
GAL4 BD 
This study 
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Table 3.3 Primers used in this study 
Name Sequence (5’-3’) Restriction 
site 
Application Region targeted/ location in 
the gene 
dnaE1WTF tcagcgtgtgttagcggaattcggagggcgtcg
tttgccacagcagatagttatcgatgcaatagct
atgccata 
EcoRI and ClaI Forward primer used to amplify full 
length dnaE1 
4475 bp amplicon, primer 
located 810 bp upstream of the 
dnaE1 gene 
dnaE1WTR tccgctgcgcgagaagct  Reverse primer used to amplify full 
length dnaE1 
4475 bp amplicon, primer 
located 107 bp downstream of 
the dnaE1 gene 
dnaQKOFP1 tgtcaccgcgcggccgtat  Forward primer used to amplify a 
region downstream the dnaQ gene 
2019 bp amplicon downstream 
full length dnaQ 
dnaQKORP1 accgctggtgcgtgacgacgagatcttgcgtct
gctcgaccat 
BglII Reverse primer used to amplify a 
region downstream dnaQ 
2019 bp amplicon downstream 
full length dnaQ 
dnaQKOFP2 aggatggcacgcagatctgacaagccgggtcg
gcacgcca 
BglII Forward primer used to amplify a 
region upstream the dnaQ gene 
1965 bp amplicon upstream full 
length dnaQ 
dnaQKORP2 ttcgacctcgggaagcttgagcgggggcagat HindIII Reverse primer used to amplify a 
region upstream dnaQ 
1965 bp amplicon upstream full 
length dnaQ 
attBS1 acgtggcggtccctaccg  Reverse primer used to confirm site-
specific recombination at the bacterial 
attachment (attB) site 
Hybrid primer which amplifies 
both the vector and phage 
attachment sites. 
attBS2 acaggatttgaacctgcggc  Forward primer used to confirm site-
specific recombination at the attB site 
Hybrid primer which amplifies 
both the vector and phage 
attachment sites. 
attL2 cttggatcctcccgctgcgc  Forward primer used to confirm site-
specific recombination at the attB site 
Hybrid primer which amplifies 
both the vector and phage 
attachment sites. 
attL4 aattcttgcagacccctgga  Reverse primer used to confirm site-
specific recombination at the attB site 
Hybrid primer which amplifies 
both the vector and phage 
attachment sites. 
43 
 
dnaQF gcttgtcggagccgcgtgccat  Forward primer used to amplify full 
length dnaQ 
1140 bp amplicon, primer 
located 30 bp upstream dnaQ  
dnaQR ccaggagatcgccgacgccaa  Reverse primer used to amplify full 
length dnaQ 
1140 bp amplicon, primer 
located 97 bp downstream 
dnaQ 
dnaQ-uvrCF cgggcagcctctgctgcatt  Forward primer used to amplify full 
length dnaQ-uvrC 
2130 bp amplicon, primer 
located 141 bp upstream dnaQ 
dnaQ-uvrCR ccgtgccgtgctcggcggtgccaa  Reverse primer used to amplify full 
length dnaQ-uvrC 
2130 bp amplicon, primer 
located 85 bp downstream 
dnaQ 
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3.2 DNA manipulations  
 
3.2.1 Plasmid and genomic DNA extraction 
 
3.2.1.1 E. coli small scale plasmid isolation 
A single colony was inoculated into 3 ml of LB containing the appropriate antibiotic, in a 5 ml 
tube, which was incubated either overnight at 37°C with shaking or standing at 30°C for 48 
h, to avoid plasmid rearrangement. Cells were harvested by centrifugation at 15700 × g 
using the Eppendorf 5415 D centrifuge (Merck) for 1 min. The pellet was re-suspended in 
100 μl of Solution I (50 mM glucose, 25 mM Tris-hydrochloride, 10 mM 
ethylenediaminetetraacetic acid (EDTA), pH 8.0) followed by 200 μl of Solution II (0.2 M 
sodium hydroxide, 1% sodium dodecyl sulphate (SDS)) and mixed by gentle inversion of the 
tube. This was followed by addition of 150 μl of Solution III (5M potassium acetate, 11.5% 
glacial acetic acid) into the cell suspension, vigorous shaking and centrifugation at 15700 × g 
for 10 min to remove cellular debris. The supernatant was collected into a fresh sterile 1.5 
ml Eppendorf tube and 350 μl of isopropanol was added to precipitate the DNA. The DNA 
was harvested by centrifugation at 15700 × g for 10 min at room temperature. The DNA 
pellet was washed with 200 μl of 100% ethanol and vacuum-dried for 20 min in the vacuum-
dryer (GeneVac, Thermo Scientific). The DNA pellet was then re-suspended in 20 μl of sterile 
RNase-free water (Qiagen).  
 
3.2.1.2 E. coli large scale plasmid isolation 
A single colony was inoculated into 100 ml of LB broth supplemented with the appropriate 
antibiotic in a 250 ml Erlenmeyer flask. Cells were grown with gentle shaking at 37°C 
overnight or standing at 30°C for 48 h. Cells were then transferred into two 50 ml Falcon 
tubes and harvested by centrifugation at 3901 × g (Beckman Coutler Allegra X-22R 4250 
rotor) for 10 min. Pellets were re-suspended in 1 ml of Solution I, followed by 2 ml of 
Solution II and inverted gently for mixing. This was followed by addition of 1.5 ml of Solution 
III and vigorous shaking. The suspension was aliquoted into 1.5 ml Eppendorf tubes and 
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centrifuged for 10 min at 15700 × g. The supernatant was transferred into a fresh 1.5 ml 
Eppendorf tube and 3 μl RNaseA (10 mg/ml stock) was added to each tube, followed by 
incubation at 37°C for 1 h. Following incubation, 700 μl of isopropanol was added to each 
tube to precipitate the DNA and centrifuged for 10 min at 15700 × g. The DNA pellet was 
washed with 500 μl of cold 70% ethanol and dried in the vacuum-dryer to remove excess 
ethanol. The DNA pellet from each tube was re-suspended in 100 μl of sterile autoclaved 
water (dH2O) and pooled to a volume of 500 μl. Following this, 50 μl of 3M sodium acetate 
(pH 5.2) and 700 μl of phenol:chloroform (1:1) was added to the DNA mixture. The mixture 
was vortexed and centrifuged at 15700 × g for 10 min. The aqueous layer was transferred 
into a clean 1.5 ml Eppendorf tube, 350 μl of chloroform:isoamyl alcohol (24:1) was added 
to the aqueous solution and the mixture was vortexed and centrifuged at 15700 × g for 10 
min. Following this, the aqueous layer was transferred into a clean 1.5 ml Eppendorf tube 
and 1 ml of cold 100% ethanol was added to the mixture. To precipitate the DNA, the tube 
containing the mixture was gently inverted several times and stored at -20°C for 1 h before 
centrifugation at room temperature for 25 min. The DNA pellet was washed with 70% cold 
ethanol, vacuum-dried and re-suspended 50-100 μl of sterile RNase free water. The DNA 
was quantified using a NanoDrop 2000c Spectrophotometer (Thermo Scientific) according to 
the manufacturer’s instructions. 
 
3.2.1.3 Genomic DNA extraction from Msm 
Mycobacterial genomic DNA was extracted using the modified cetyltrimethylammonium 
bromide (CTAB, ICN Biomedicals, Aurora, Ohio) method described by Larsen (Larsen, 2000). 
Briefly, mycobacterial cells were harvested and re-suspended in 500 μl of TE buffer (10 mM 
Tris-hydrochloride and 0.1 mM EDTA, pH 8.0). Cells were heat-killed at 65°C for 20 min, 
followed by centrifugation at 15700 × g for 5 min. Cells were re-suspended in 500 μl of TE 
buffer and 50 μl lysozyme (10 mg/ml) was added and this mixture was incubated at 37°C 
overnight. This was followed by addition of 70 μl 10% SDS and 6 μl of proteinase K (10 
mg/ml) and the mixture incubated at 65°C, shaking at 400 rpm in a Eppendorf thermomixer 
(Merck) for 2 h. Whilst the mixture was still at 65°C, 100 μl of pre-warmed 5 M NaCl and 
CTAB/NaCl mix (10% CTAB in 0.5 M NaCl chloride) was added to the mixture and incubated 
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for 15 min. Following incubation, the mixture was stored at -80°C for 15 min, allowed to 
thaw first before re-incubation at 65°C for a further 15 min. The mixture was allowed to cool 
first before addition of 700 μl chloroform:isoamyl alcohol (24:1) and inverted several times 
until formation of a homogeneous white solution. Samples were centrifuged at 15700 × g 
for 10 min, followed by the removal of the aqueous phase containing the DNA into fresh 
microcentrifuge tubes. The DNA pellet was precipitated by addition of 700 μl of isopropanol 
and incubation at 4°C overnight. This was followed by centrifugation at 4°C for 10 min and 
the DNA pellet washed with 70% cold ethanol. The DNA pellet was vacuum-dried and re-
suspended in 50 μl of sterile RNase free water.  
 
3.2.2 Polymerase Chain Reaction (PCR)  
For amplification of genes to be used for cloning purposes, a high-fidelity polymerase, 
Phusion® (Finnzymes, NEB) was used, whereas a low-fidelity polymerase, Faststart Taq 
(Roche Applied Science), was used for preliminary PCRs and screening purposes. Reactions 
were performed according to manufacturers’ instructions. For reactions using the NEB 
Phusion kit, the standard 50 μl PCR reaction consisted of 1× HF buffer, 200 μM of each dNTP 
[dATP, dCTP, dGTP and dTTP (Roche Applied Science)], 1× GC rich buffer (Roche Applied 
Science), 0.5 μM of each primer (IDT, Whitehead Scientific (Pty) Ltd), 1.5 μl DMSO and 2.5 U 
of the DNA polymerase. DNA amplification conditions were as follows: initial denaturation 
at 98°C for 5 min followed by 30 cycles of denaturation at 98°C for 1 min, annealing at 60°C 
for 1 min, extension at 72°C for 30 s/kbp and final extension at 72°C for 7 min. For the Roche 
Faststart Taq kit, the standard 50 μl PCR reaction consisted of 1× FastStart PCR buffer with 
MgCl2 (Roche Applied Science), 200 μM of each dNTP, 1× GC rich buffer, 0.5 μM of each 
primer, 1.5 μl DMSO, 2.5 U of the DNA polymerase and 2 μl of the template DNA. DNA 
amplification conditions were as follows: initial denaturation at 95°C for 3 min followed by 
30 cycles of denaturation at 95°C for 30s min, annealing at 60°C for 1 min, extension at 72°C 
for 1 min/kbp and final extension at 72°C for 7 min. The PCR reaction mixture without the 
template DNA and dH2O were used as negative controls to test for contaminating 
chromosomal DNA and non-specific fragments. All the PCRs were performed using 
MyCycler™ or C1000™ Thermal cyclers (Bio-Rad).  
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3.2.3 Agarose gel electrophoresis  
Standard gel electrophoretic techniques were used for separation of DNA fragments 
(Sambrook et al., 1989). High molecular weight (500 bp–12 kbp) DNA fragments were 
separated in 0.8-1% agarose gels and low molecular weight DNA fragments of ≤500 bp were 
separated in 2-4% agarose gels. Agarose gels were prepared in 1×TAE buffer (1 mM EDTA, 
40 mM Tris-acetic acid, pH 8.0) and contained 0.5 μg/ml ethidium bromide for detection. 
DNA samples were loaded with a loading dye (0.025% bromophenol blue in 30% glycerol) 
for visual tracking of DNA migration during electrophoresis. DNA molecular weight markers 
(III, IV and V; Roche Applied Science) were used to determine DNA fragment sizes. Agarose 
gels were electrophoresed between 80–100V in a Mini-Sub® or Sub-Cell® GT Cell horizontal 
electrophoresis system (Bio-Rad). Fragments to be cloned were visualized using the blue-
light Dark Reader DR88M transilluminator (Inqaba) to avoid UV–induced DNA damage; 
otherwise gels were visualized using the Wealtec Keta UV transilluminator (Inqaba). 
 
3.2.4 Purification of DNA from agarose gels and PCR reactions  
The DNA fragment of interest was excised from the gel and purified using the Nucleospin kit 
(Macherey-Nagel) as per manufacturer’s instructions. Briefly, the excised agarose gel 
containing the fragment of interest was incubated at 60°C in a 2 ml Eppendorf tube 
containing the DNA-binding buffer (Nucleospin, Macherey-Nagel). After all the agarose gel 
had solubilized, the sample was loaded onto a Nucleospin column (Macherey-Nagel) to bind 
the DNA. For purification of PCR products, 1× volume of the PCR mixture was mixed with 2× 
volume of the DNA-binding buffer and the sample loaded onto a Nucleospin column to bind 
the DNA. The column containing the DNA was washed twice with the wash buffer 
(Nucleospin, Macherey-Nagel) to remove excess salts. The DNA was then eluted using pre-
warmed sterile RNase-free water. The DNA was quantified either on agarose gels or using 
the NanoDrop.  
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3.2.5 DNA sequencing 
DNA was sequenced at the Central Analytical Facilities (CAF) DNA Sequencing Unit at 
Stellenbosch University. Sequencing data were visualized and analysed using the CLC DNA 
Workbench 6 software (http://www.clcbio.com/products/clc-main-workbench).  
 
3.2.6 DNA manipulation for cloning  
 
3.2.6.1 Digestion of DNA with restriction enzyme(s) 
Enzymes were obtained from Fermentas, New England Biolabs (NEB), Amersham or Roche 
Applied Science and used as per manufacturer’s instructions. Up to 5 μg plasmid DNA and 1 
μg PCR product was digested in a 20 μl reaction volume for 4-24 h. Digested samples were 
incubated at the recommended temperature for maximal enzyme activity for at least 4 h. 
For double digestions, an appropriate buffer in which both restriction enzymes had maximal 
activity was selected; otherwise, the digestions were performed sequentially. DNA 
fragments were then separated and analysed on agarose gels by electrophoresis (section 
3.2.3). 
 
3.2.6.2 DNA phosphorylation  
Phosphorylation of blunt-ended PCR products to enable ligation with de-phosphorylated 
vector was performed for 30 min at 37°C using polynucleotide kinase (Roche Applied 
Science), as per the manufacturer’s instruction. Reactions were stopped by inactivation at 
65°C and the DNA was purified using the PCR clean-up protocol (section 3.2.4). 
 
3.2.6.3 DNA dephosphorylation  
Following digestion from plasmid DNA, the vector was treated with Antarctic Alkaline 
Phosphatase (NEB) to remove the 5’-phosphate group from the linearized vector DNA to 
prevent vector re-ligation. Dephosphorylation reactions were carried out at 37°C for 1h 
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followed by inactivation at 65°C for 20 min. The DNA was purified using the PCR clean-up 
protocol (section 3.2.4) as per manufacturer’s instructions.  
 
3.2.6.4 DNA ligation  
DNA ligations were performed using either the Fast-Link™ ligation kit (Epicentre® 
Biotechnologies) or T4 DNA Ligase (Roche Applied Science), as per manufacturer’s 
instructions. Blunt-end ligations were performed at 4°C and sticky-end ligations were 
performed at room temperature.  
 
3.2.7 Transformation of bacterial cells  
 
3.2.7.1 Chemical transformation of E. coli cells 
Rubidium chloride-treated E. coli DH5α cells were used for transformation of plasmid DNA 
into E. coli cells. Cells were treated with rubidium chloride as follows: One millilitre from the 
stationary phase culture was used to inoculate 100 ml of LB broth and grown at 37°C to an 
OD600 = 0.48. Cells were kept on ice for 15 min and harvested by centrifugation at 3901 × g 
for 5 min at 4°C. Pellets were re-suspended in 20 ml of transformation buffer (Tfb) I solution 
(30 mM potassium acetate; 100 mM rubidium chloride; 10 mM calcium chloride; 50 mM 
manganese chloride; 15% v/v glycerol; pH 5.8) and stored on ice for a further 15 min. Cells 
were harvested by centrifugation at 3901 × g for 5 min at 4°C and re-suspended in 2 ml Tfb 
II solution (10 mM MOPS; 75 mM calcium chloride; 10 mM rubidium chloride; 15% glycerol; 
pH 6.5). Following this, 500 μl aliquots of cells were stored on ice for 15 min and either used 
immediately or quick-frozen in ethanol dry ice at -80°C, prior to storage at -80°C until 
further use. For transformation, chemically competent DH5α cells were thawed on ice and 
100 μl was used per transformation. Up to 1 μg of plasmid DNA or 10 μl of the ligation 
mixture was incubated with the cells on ice for 30 min. Following incubation, cells were heat 
shocked at 42°C for 90s and incubated on ice for 1 min to facilitate the uptake of plasmid 
DNA. The transformation mixture was rescued in 400 μl of 2×TY (0.16% tryptone, 0.10% 
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yeast extract and 0.05% sodium chloride) broth and incubated at 37°C for 1 h. Following 
incubation, cells were plated on LA media containing the appropriate antibiotic and 
incubated overnight at 37°C or at 30°C for 48 h.  
 
3.2.7.2 Electroporation into Msm 
Msm electroporations were carried out as described by Larsen (Larsen, 2000). Briefly, a 
single colony of Msm was used to inoculate a pre-culture of 5 ml 7H9 OADC and grown 
overnight at 37°C. A volume of 1 ml of the pre-culture was inoculated into 100 ml 7H9 OADC 
and grown at 37°C until mid-log phase (OD600 of 0.6-1.0). Cells were harvested by 
centrifugation at 2600 × g for 10 min at 4°C and the pellet washed three times by gentle re-
suspension in 40, 30 and 20 ml of ice-cold 10% glycerol, respectively. Cells were harvested 
by centrifugation at 2600 × g for 10 min at 4°C. The pellet was re-suspended in 1 ml of ice-
cold 10% glycerol. Up to 4 μg of plasmid DNA was added to 400 μl of Msm competent cells. 
The mixture was transferred into a 0.2 cm pre-chilled electroporation cuvette and pulsed 
using the GenePulser Xcell™ (Bio-Rad) at the following settings: 2.5 kV, 1000 Ω resistance, 
25 μF capacitance and 2 mm path length. Cells were rescued immediately with 800 μl of 
2×TY for 4 h, shaking at 37°C before plating on 7H10 OADC media supplemented with 
appropriate antibiotics. Plates were incubated for 7 days at 37°C before scoring for growth 
of potential recombinants. 
 
3.2.7.3 Lithium acetate-mediated yeast transformation 
A single colony from the YPDA plate was inoculated into 5 ml YPD broth and vigorously 
vortexed to disperse the clumps, followed by incubation at 30°C with shaking for 48 h. A 
volume of 2 ml of the pre-culture was used to inoculate 100 ml YPD broth and incubated at 
30°C for 16–18 h with shaking at 250 rpm until the culture reached stationary phase (OD600 
>1.5). This culture was diluted 1:10 to an OD600 =0.2-0.3 and grown for two generations until 
an OD600 =0.6-0.8 was reached. Cells were harvested at 2600 × g for 5 min at room 
temperature. Pellets were re-suspended in 10 ml sterile RNase-free water and pooled into a 
50 ml tube. Cells were then harvested at 2600 × g for 5 min at room temperature. The pellet 
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was re-suspended in 1.5 ml freshly made 1×TE/1×LiAc solution (10 mM Tris-hydrochloride, 1 
mM EDTA, pH 8.0 plus 0.1 M lithium acetate, pH 7.5). The mixture was incubated for 1 h at 
30°C with gentle agitation. Plasmid DNA (0.1 μg) and 0.1 mg of herring sperm carrier DNA 
(Invitrogen) were added to a fresh 1.5 ml tube and mixed thoroughly by passing them up 
and down through a needle. Following incubation, 100 μl of the yeast suspension was added 
to the tube containing the transforming and carrier DNA. This was incubated at 30°C for 30 
min. This was followed by addition of 600 μl of sterile PEG/LiAc solution (40% polyethylene 
glycol, 10 mM Tris-hydrochloride, 1 mM EDTA, pH 8.0 plus 0.1 M lithium acetate, pH 7.5) 
and further incubation at 30°C for 30 min with gentle agitation. The yeast-DNA mixture was 
heat-shocked at 42°C for 15 min then chilled on ice for 1 min. Cells were harvested for 5 s at 
15700 × g and re-suspended in 500 μl TE buffer. This step was repeated twice followed by 
final re-suspension in 200 μl TE buffer. The suspension was plated on SD agar to select for 
the desired transformants and the plates incubated at 30°C for 3-5 days. 
 
3.3 Generation of dnaE1 constructs for complement switching 
The essentiality of dnaE1 complicates genetic approaches to elucidate structure-function-
relationships in the encoded protein. A set of dnaE1 constructs that could be used for both 
allelic exchange and complement switching methods were generated. Complement 
switching involves the deletion of a chromosomal copy of an essential gene in the presence 
of a second copy of the gene (complementing allele) integrated at the mycobacterial attB 
locus. Integration of a cassette expressing the protein of interest and containing a particular 
antibiotic resistance gene into the attB site creates a merodiploid strain. The native copy of 
the gene is knocked out by allelic exchange resulting in one copy of the gene integrated at 
the attB locus. Mutant alleles are introduced on alternative vectors containing different 
antibiotic markers (Williams et al., 2011).  
Fragments containing WT dnaE1 and targeted dnaE1 point mutations were initially cloned 
into pMC1r, respectively to generate constructs for the complement switching method 
(details shown below). In parallel to this, the same fragments were excised from 
representative pMC1r constructs and subsequently cloned into the suicide vector, p2NIL, for 
the allelic exchange method (Figure 3.1) (Parish and Stoker, 2000), which enabled for 
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generation of the dnaE1 point mutants quicker and was then used throughout to generate 
all the dnaE1 mutants (Figure 3.1) and the dnaQ knock-out mutant (details shown below).  
pMC1rE1: The sequence of the WT Msm dnaE1 gene was obtained by BLAST homology 
search (Altschul et al., 1990) of the preliminary Msm genome sequence database at The 
Institute for Genomic Research (TIGR; http://www.tigr.org) using its respective Mtb gene 
sequence (TubercuList; http://www.pasteur.fr/Bio/TubercuList) as a probe. The primers, 
dnaE1WTF and dnaE1WTR (Table 3.3), were designed to amplify the full length dnaE1 from 
WT Msm mc2155 genomic DNA with 800 bp upstream and 107 bp downstream of dnaE1. 
The forward primer contained an engineered EcoRI restriction site which enabled cloning 
into the integrative mycobacterial shuttle vector, pMC1r. Both vector and full length dnaE1 
PCR product were digested with EcoRI and ligated to generate pMC1rE1. This construct was 
used as the site-directed mutagenesis (SDM) template to generate the dnaE1 mutants.  
pMC1rE1D49A: The synthesized suicide vector pIDTdnaE1D49A, containing the aspartate to 
alanine mutation at position 49 in DnaE1, was digested with EcoRI and MfeI to release the 
700 bp fragment containing the targeted mutation. This fragment was swapped into 
pMC1rE1 using the same restriction sites. The D49A mutation introduced an additional NcoI 
site in dnaE1 and this was used to distinguish WT dnaE1 from dnaE1D49A.  
pMC1rE1E133A: A similar strategy was used to generate the pMC1rE1E133A construct. A 1500 
bp fragment containing the glutamate to alanine mutation at position 133 in DnaE1, from 
the synthesized suicide vector pIDTdnaE1E133A, was swapped into pMC1rE1 using the native 
EcoRV and MfeI sites in dnaE1. The E133A mutation introduced an additional MscI site in 
dnaE1 which was used to distinguish WT dnaE1 from dnaE1E133A. 
pMC1rE1D228N: A 1500 bp fragment containing the aspartate to asparagine mutation at 
position 228 in DnaE1, from the synthesized suicide vector pIDTdnaE1D228N, was swapped 
into pMC1rE1 using the native EcoRV and PvuII sites in dnaE1. The D228N mutation 
introduced an additional HindIII site in dnaE1 which was used to distinguish WT dnaE1 from 
dnaE1D228N.  
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Figure 3.1: Generation of the dnaE1 alleles. dnaE1 constructs that could be used for both allelic exchange and complement switching methods 
were generated in pMC1r and then sequentially cloned into p2NIL for the allelic exchange method which was used throughout to generate all 
the dnaE1 mutants.  
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3.4 Construction of unmarked suicide delivery plasmids for use in allelic exchange 
mutagenesis  
p2NILE1, p2NILE1D49A, p2NILE1E133A and p2NILE1D228N: The 4470 bp fragments containing 
WT dnaE1, dnaE1D49A, dnaE1E133A and dnaE1D228N were excised as an EcoRI fragment from 
pMC1rE1, pMC1rE1D49A, pMC1rE1E133A and pMC1rE1D228N and cloned separately into p2NIL 
using the same restriction site. The 7939 bp PacI cassette from pGOAL19 - containing a Hyg 
resistance gene (hyg), as well as the lacZ and sacB genes to enable blue/white and sucrose 
counterselection, respectively (Parish and Stoker, 2000), was cloned into each construct 
generating unmarked p2NILE1, p2NILE1D49A, p2NILE1E133A and p2NILE1D228N, respectively .  
p2NILE1E133AKI: A 1500 bp fragment containing WT dnaE1 was swapped into pMC1rE1E133A 
using the native EcoRV and MfeI sites in dnaE1. This regenerated the WT dnaE1 sequence in 
this background. The MscI site was used for screening between p2NILE1E133A and 
p2NILE1E133AKI to verify loss of this site in the knock-in construct. The PacI cassette from 
pGOAL 19 (hyg, lacZ and sacB) (Parish and Stoker, 2000) was cloned into this construct, 
generating unmarked p2NILE1E133AKI. 
All the p2NILE1 constructs containing mutations in dnaE1, including the knock-in construct, 
were verified by restriction enzyme analysis and sequencing at CAF, University of 
Stellenbosch. 
p2NILΔdnaQ: The sequence of the WT Msm dnaQ (MSMEG_6275) gene was obtained by 
BLAST homology search (Altschul et al., 1990) of the preliminary Msm genome sequence 
database at The Institute for Genomic Research (TIGR; http://www.tigr.org) using its 
respective Mtb gene sequence (TubercuList; http://www.pasteur.fr/Bio/TubercuList) as a 
probe. Two primer sets dnaQKOFP1/dnaQKORP1 and dnaQKOFP2/dnaQKORP2 were used 
to amplify sequences upstream and downstream of the Msm dnaQ gene. The two PCR 
products were ligated and this resulted in the elimination of 990 bp dnaQ gene. The ligated 
PCR product was then cloned into p2NIL. The PacI cassette from pGOAL 19 (hyg, lacZ and 
sacB) (Parish and Stoker, 2000), was cloned into this construct, generating the unmarked 
p2NILΔdnaQ construct, respectively. 
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3.5 Construction of unmarked dnaE1 and dnaQ mutants using allelic exchange  
The allelic exchange method was used throughout to generate the dnaE1 and dnaQ mutants 
in Msm (Parish and Stoker, 2000) (Figure 3.1). Briefly, WT mc2155 was electroporated with 
p2NILE1, p2NILE1D49A, p2NILE1E133A, p2NILE1D228N and p2NILΔdnaQ separately and plated on 
7H10 OADC containing Km, Hyg, and X-gal. Five putative single cross-over (SCO) 
recombinants per construct that were KmR, HygR and blue in colour were selected and 
grown in liquid 7H9 OADC containing no antibiotic, to allow for the second cross-over event 
to occur. Serial dilutions of each culture were plated on 7H10 medium containing 2% 
sucrose and X-gal to enable phenotypic selection of putative double-cross over (DCO) 
recombinant mutants (Parish and Stoker, 2000). White, sucrose-resistant colonies were 
screened by PCR using dnaE1 internal primers to confirm the genotype. Genomic DNA was 
extracted using the crude method of boiling the colony at 65°C to lyse the mycobacterial 
wall, followed by precipitation of DNA using chloroform. The genomic DNA obtained was 
used as a template for PCR. An internal fragment in dnaE1 of ~2000 bp covering the region 
where the point mutations were introduced was amplified and screened by restriction 
enzyme analysis to verify the mutants relative to WT.  
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3.6 Construction of dnaE2 constructs  
pMC1rdnaE2: The multicopy E. coli–Mycobacterium shuttle vector carrying full length 
dnaE2, pOmsmE2 (Boshoff et al., 2003) was digested with EcoRI to release the full length 
WT dnaE2. This fragment was cloned into pMC1r using the same restriction site, to generate 
pMC1rdnaE2. This construct was verified by restriction enzyme analysis and PCR 
amplification of the bacterial att locus to confirm integration (see Appendix B). This 
construct was also used as a template for generating the dnaE2ΔSRDFR and dnaE2N38 
constructs and for complementation.  
pMC1rdnaE2ΔSRDFR: The synthesized suicide vector, pIDTdnaE2ΔSRDFR, containing Msm dnaE2 
with the C-terminal SRDFR motif truncated, was digested with SrfI and HindIII to release a 
fragment containing the targeted truncation and an additional BglII silent mutation, for 
screening purposes. This fragment was swapped into pMC1rdnaE2 using the same 
restriction sites and confirmed by restriction enzyme analysis.  
pMC1rdnaE2N38: The synthesized suicide vector, pIDTdnaE2N38, containing Msm dnaE2 with 
38 N-terminal amino acids truncated, was digested with AcvI and SrfI to release a fragment 
containing the targeted truncation and an additional SpeI silent mutation for screening 
purposes. This fragment was swapped into pMC1rdnaE2 using the same restriction sites and 
confirmed by restriction enzyme analysis.  
 
3.7 Construction of dnaE2 mutants  
Following verification, WT mc2155 was separately electroporated with pMC1rdnaE2, 
pMC1rdnaE2ΔSRDFR and pMC1rdnaE2N38 and plated into 7H10 OADC containing 20μg/ml Km. 
This resulted into integration at the attB site which was verified by the PCR strategy shown 
in Appendix B. The attB primers amplify the bacterial attachment site which is 276 bp long 
and the attL primers amplify the phage attachment site (vector sequence) which is 326 bp 
long. Site specific recombination of attB and attP creates the flanking attL and attR sites. 
These sites contain hybrid portions originating from attB and attP which are used as a 
marker for the recombination event. Following homologous recombination, screening with 
a combination of either primer set (attBS2 and attL4 or attL2 and attBS1) results in a 320 bp 
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or a 282 bp fragment as shown in Appendix B. If recombination is not successful neither 
combination will give a product.  
 
3.8 Construction of vectors for Y2H assays 
Full length WT dnaE2, dnaE2ΔSRDFR and dnaE2N38 fragments were digested from 
pMC1rdnaE2, pMC1rdnaE2ΔSRDFR and pMC1rdnaE2N38 using EcoRI and cloned in-fusion with 
the GAL4 BD of the GAL4 transcription regulator in pGBKT7, using the same restriction site, 
to generate pGBDDnaE2, pGBDDnaE2ΔSRDFR and pGBDDnaE2N38 respectively. Correct clones 
were confirmed by restriction enzyme analysis. pGADImuB and pGBDDnaE1 were generated 
as described (Kana et al., 2010, Warner et al., 2010).  
 
3.9 Microbiological characterization of the dnaE1, dnaQ and dnaE2 strains 
Assays used were common across the dnaE1, dnaQ and dnaE2 strains. However, the Luria-
Delbruck assay was not performed for dnaE2 mutants relative to the WT strain. Details of 
the methods are shown below. 
 
3.9.1 Mutation rate (μ) assessment using the Luria-Delbrück fluctuation assay 
Rates of spontaneous mutations to rifampicin were assessed for dnaE1 and dnaQ strains 
relative to WT mc2155 using the Luria-Delbrück fluctuation assay and analysed according to 
Rosche and Foster (Rosche and Foster, 2000). Briefly, a single colony of each Msm strain was 
used to inoculate a pre-culture of 7H9 OADC, which was grown till mid-log phase (OD600= 
0.6-1.0). This culture was used to inoculate 7H9 OADC at a concentration of ~100 colony 
forming units per millilitre (CFU/ml). Aliquots were plated on standard 7H10 OADC plates 
for enumeration of CFU in the initial culture (N0) as well as on 7H10 OADC plates containing 
200 μg/ml Rif (Sigma, R3501) to detect any pre-existing Rif-resistant mutants in the starting 
culture. Approximately 3 ml of the starting culture was aliquoted into 20 parallel 15 ml 
culture tubes for each strain. The tubes were incubated for 3 days at 37°C shaking until mid-
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log phase (OD600= 0.6-1). Cultures were serially diluted in un-supplemented 7H9 media 
containing 0.5% Tween 80, vortexed and plated on standard 7H10 OADC to determine the 
final number of cells per culture (Nt). Undiluted cultures were plated on 7H10 OADC plates 
containing 200 μg/ml Rif to determine the number of Rif-resistant mutants. The mutation 
rate and 95% confidence intervals were calculated using the software developed in the 
MMRU by Z. Martin and J. Kent (unpublished), optimized from the MSS method as 
described by Rosche and Foster (Rosche and Foster, 2000).  
  
3.9.2 DNA damage assays 
To determine damage tolerance of the dnaE1, dnaQ and dnaE2 mutants, mitomycin C 
(MMC) sensitivity and UV-induced mutagenesis assays were performed as described by 
Boshoff et al. (Boshoff et al., 2003). Briefly, mycobacterial cultures were grown until mid-log 
phase (OD600 = 0.6-1.0). Log10-fold dilutions (10
-1 – 10-7) of each culture were spotted on 
7H10 OADC solid media without and with varying concentrations (0.02 and 0.04 μg/ml) of 
MMC. A volume of 1 ml culture for each strain was serially diluted and used for CFU 
enumeration to ensure that the total number of cells per culture was comparable across all 
strains. The remaining cultures were used to set up UV-induced mutagenesis assays as 
described below.  
 
Briefly, 1 ml of each culture was serially diluted and used for CFU enumeration before UV 
treatment. The remaining cells were harvested and re-suspended in 5 ml aliquots. Cultures 
were then transferred into open petri dishes and irradiated at 25 mJ/cm2 (Spectrolinker XL-
1000, Spectroline). After irradiation, cells were rescued in fresh 45 ml 7H9 OADC media at 
37°C for 4 h. After incubation, 1 ml of the irradiated culture was plated on 7H10 OADC solid 
media without antibiotic for CFU enumeration and 1 ml was plated on 7H10 OADC plates 
containing 200 μg/ml rifampicin (Rif)200 for determination of Rif-resistant mutants. The 
frequency of Rif-resistant mutants was determined as described (Boshoff et al., 2003). 
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3.10 Y2H assays 
Y2H assays were used to determine the role for the N-terminal extension and C-terminal 
motif in DnaE2 in mediating protein-protein interactions during function of the mutasome. 
Protein-protein interactions were assessed using the Clontech Matchmaker® Y2H system, as 
per the manufacturer’s instructions. Genes encoding proteins of interest were cloned in-
frame with the GAL4 AD and BD of a GAL4 transcription factor, and then co-transformed 
into the yeast strain, AH109. Fusion of ImuB to the BD of a GAL4 transcription factor has 
been shown to result in auto-activation, therefore giving a false positive signal (Warner et 
al., 2010). ImuB was therefore cloned as a fusion protein to the GAL4 AD of the transcription 
factor to determine the interactions between ImuB and the DnaE2 mutants. WT DnaE1 and 
DnaE2 as well as DnaE2 mutants were cloned in as BD fusion proteins. Yeast strains carrying 
plasmid to be assessed were grown in SD-LT broth to an OD600 of 0.20 and then spotted 
onto different media with increasing stringency to identify interacting partners (Warner et 
al., 2010). 
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CHAPTER 4: RESULTS 
 
4.1 Investigating the role of conserved PHP domain residues in replication fidelity in 
mycobacteria 
4.1.1 The PHP domain of mycobacterial DnaE1 contains a complete set of metal co-
ordinating residues  
The role of the PHP domain in bacterial DNA PolIIIα subunits remains unclear. The PHP 
domains of Thermus thermophilus and T. aquaticus PolIIIα subunits, which have complete 
sets of metal co-ordinating residues [H H D/H H E H C/H D/N H], possess exonuclease 
proofreading activity (Stano et al., 2006, Wing et al., 2008). The presence of an intrinsic 
exonuclease in these dnaE-type polymerases resembles similar observations for the PHP 
domains of PolX from both B. subtilis (Banos et al., 2008) and T. thermophilus (Nakane et al., 
2009). In contrast, no exonuclease activity could be detected for the PHP domain of G. 
kaustophilus PolC (Evans et al., 2008) in which an asparagine residue substitutes for the 
metal-binding aspartate at position 8 (Barros et al., 2013). This implies that a complete set 
of metal co-ordinating residues is required for exonuclease proofreading activity. In E. coli, 
the PHP domain of the sole DnaE-type PolIIIα subunit lacks most of the conserved metal co-
ordinating residues, and does not exhibit exonuclease activity in enzyme assays in vitro 
(Barros et al., 2013). It is notable, though, that introduction of the complete set of residues 
into E. coli DnaE does not enable exonuclease function in vitro, suggesting that an additional 
factor is required (Barros et al., 2013). Instead, it appears that the E. coli PHP domain might 
be required to stabilize the structure of the PolIII core. 
 
To determine whether the dnaE-encoded α subunit in Mtb contains an intact PHP domain, 
protein sequences from representative mycobacterial DnaE subunits were aligned against 
the sequences of PolIIIα subunits from E. coli (Barros et al., 2013, Lamers et al., 2006) and T. 
aquaticus (Bailey et al., 2006) (Figure 4.1). As reported previously (Barros et al., 2013), E. 
coli PolIII contains a variant PHP domain in which five of the metal co-ordinating residues 
are replaced by residues incompatible for this function (H14R, H48F, E73D, C158G and 
H228G). Mtb DnaE1 contains a complete set of metal co-ordinating residues [H14, H16, D23, 
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H48, E73, H107, C158, D226 and H228]. In contrast, an aspartate to glycine substitution 
(D228G) in DnaE2 (Figures 4.1 and S1) suggests that this α subunit is unlikely to possess 
intrinsic exonuclease function. Analysis of sequenced mycobacterial DnaE2 polymerases 
suggests that conservation of eight of the nine canonical metal co-ordinating residues is a 
characteristic of all mycobacteria (Figure S1), as suggested (Timinskas et al., 2014). Both M. 
leprae and Msm DnaE1 homologs also possess the full nine residues (Figure S1), which was 
important for two reasons: (i) it confirmed the applicability of Msm as mycobacterial model 
for these assays and (ii) it reinforced the inferred likelihood that strong selection has 
maintained the DnaE1 PHP domain given the massive reductive evolution that characterises 
the M. leprae genome (Monot et al., 2009).  
 
4.1.2 Identification of PHP domain residues which might contribute to the differential 
fidelities of mycobacterial DnaE1 and DnaE2  
Based on the sequence alignments, it was decided that this study should focus on the role of 
residues which are conserved in the PHP domain of the essential dnaE1-encoded DnaE-type 
polymerase in Msm but are absent in the corresponding domain of the non-essential DnaE2 
(Figures 4.1 and S1), specifically: 
 
i. The glutamate at position 133 (E133) in Msm DnaE1, which was predicted to be 
required for exonuclease function based on observations with other intrinsic 
exonucleases (Barros et al., 2013, Nakane et al., 2009, Wieczorek and McHenry, 
2006)  
ii. The aspartate at position 228 (D228), which was selected based on studies of 
exonuclease function (Barros et al., 2013, Nakane et al., 2009, Wieczorek and 
McHenry, 2006) and, subsequently, was implicated in metal binding (Barros et al., 
2013) 
In addition, given the key role of DnaQ in replisome function in model systems such as E. 
coli, as well as evidence implicating the PHP domain aspartate at position 49 (D49) in the 
DnaQ-DnaE1 protein-protein interaction (Wieczorek and McHenry, 2006), this residue was 
also investigated despite its conservation in both DnaE1 and DnaE2.  
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Conservation:                                                                                 
T._aquaticus_DnaE          1  MG-------------------------------------------------------SKL--KFAHLHQH   13 
MLep_DnaE                  1  MN----------------------------------------------------QS------SFVHLHNH   12 
Mtb_DnaE1_                 1  MS----------------------------------------------------GSSAGS--SFVHLHNH   16 
MSMEG_DnaE1_               1  MS----------------------------------------------------GTDGRSSGSFVHLHNH   18 
E.coli_DnaE                1  M--------------------------------------------------------SEP--RFVHLRVH   12 
MSMEG_DnaE2                1  MGWHNGPPSWSEMERVLTSKPRRSGLPLESPGDGGDSPAWSRKRGAYEPPDQARMPASAL--PYAELHAH   68 
Mtb_DnaE2                  1  ------------MERVLNGKPRHAGVP--AFDADGDVPR-SRKRGAYQPPGRERV-GSSV--AYAELHAH   52 
 
 
 
Conservation:                  
T._aquaticus_DnaE         14  TQFSLLDGAAKLQDLLKWVKETTPEDPALAMTDHGNLFGAVEFYKKATAMGVKPIIGYEAYVAAESRFDR   83 
MLep_DnaE                 13  TEYSMLDGAAKITPMFAEVERLQ--MPAVGMTDHGNMFGASEFYNTAIKAGIKPIIGVEAYIAPGSRFDT   80 
Mtb_DnaE1_                17  TEYSMLDGAAKITPMLAEVERLG--MPAVGMTDHGNMFGASEFYNSATKAGIKPIIGVEAYIAPGSRFDT   84 
MSMEG_DnaE1_              19  TEYSMLDGAAKITPMLAEAQRLE--MPAIGMTDHGNMFGASEFYNSATKAGIKPIIGIEAYIAPGSRFDT   86 
E.coli_DnaE               13  SDYSMIDGLAKTAPLVKKAAALG--MPALAITDFTNLCGLVKFYGAGHGAGIKPIVGADFNVQCDLLG--   78 
MSMEG_DnaE2               69  SAYSFLDGASTPEELVEEAARLN--LRAIALTDHDGLYGVVRFAEAARELDVATVFGAELSLSNVARTED  136 
Mtb_DnaE2                 53  SAYSFLDGASTPEELVEEAARLG--LCALALTDHDGLYGAVRFAEAAAELDVRTVFGAELSLGATARTER  120 
 
 
 
 
Conservation:                                        
T._aquaticus_DnaE         84  KRGK-----------GLDGGYFHLTLLAKDFTGYQNLVRLASRAYLEGFY-EKPRIDREILREHAQG-LI  140 
MLep_DnaE                 81  RRITWGDPSQKADDVSAGGAYTHLTMVAENAAGLRNLFKLSSLASFEGQLSKWSRMDAELIGEYAEG-II  149 
Mtb_DnaE1_                85  RRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQLSKWSRMDAELIAEHAEG-II  153 
MSMEG_DnaE1_              87  KRVTWGDPGQKGDDVSGSGAYTHMTMVAENATGLRNLFKLSSLASFEGQLGKWSRMDAEIIAEHAEG-II  155 
E.coli_DnaE               79  ------------------DELTHLTVLAANNTGYQNLTLLISKAYQRGYGAAGPIIDRDWLIELNEG-LI  129 
MSMEG_DnaE2              137  ----------------PDPPGPHLLVLARGPEGYRRLSREIAKAHLAGGEKGRPRYDFDQLTEAAGGHWH  190 
Mtb_DnaE2                121  ----------------PDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGGEKGKPRYDFDALTEAAGGHWH  174 
 
 
 
PHP 
PHP 
PHP 
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Conservation:                   
T._aquaticus_DnaE        141  ALSGCLGAEIPQFILQDRLDLAEARLNEDLSIF-GDRFFIEIQNHGLPEQKKVNQVLKEFARKYGLGMVA  209 
MLep_DnaE                150  VTTGCPSGEVQTRLRLGHDREALESAAKWREIVGPDNYFLELMDHGLSIEQRVREGLLNIGRKLNIPPLA  219 
Mtb_DnaE1_               154  ITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIERRVRDGLLEIGRALNIPPLA  223 
MSMEG_DnaE1_             156  ATTGCPSGEVQTRLRLGHEREALEAAAKWREIFGPENFFLELMDHGLDIERRVREGLLEIGRKLGIPPLA  225 
E.coli_DnaE              130  LLSGGRMGDVGRSLLRGNSALVDECVAFYEEHF-PDRYFLELIRTGRPDEESYLHAAVELAEARGLPVVA  198 
MSMEG_DnaE2              191  ILTGCRKGHVRQALSDGGPDAAAAALADLVDRFGADRVSIELTHHGHPCDDERNAALAELAPRFGLGVVA  260 
Mtb_DnaE2                175  ILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDDERNAALAGLAPRFGVGIVA  244 
 
 
Conservation:                  
T._aquaticus_DnaE        210  TNDGHYVRKEDARAHEVLLAIQSKTTLDDPERWRFPCDEFYVKTPEEMRAMLPEAEWGDEPFDNTVEIAR  279 
MLep_DnaE                220  TNDCHYVTRDAVHNHEALLCVQTGKTLSDPNRFKFHGDGYYLKSAAEMRQLWDDE--VPGACDSTLLIAE  287 
Mtb_DnaE1_               224  TNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQIWDDE--VPGACDSTLLIAE  291 
MSMEG_DnaE1_             226  TNDCHYVTREAARNHEALLCVQTGKTLSDPTRFKFDGDGYFLKSAEEMRALWDSQ--VPGACDSTLLIGE  293 
E.coli_DnaE              199  TNDVRFIDSSDFDAHEIRVAIHDGFTLDDPKRPRNYSPQQYMRSEEEMCELFAD---IPEALANTVEIAK  265 
MSMEG_DnaE2              261  TTAAHFATPSRGRLAMAMAAIRARNSIDTAAGWLAPLGGVHLRSGEEMARLFD-----PEFVAAAADLGE  325 
Mtb_DnaE2                245  TTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARLFAWC---PEAVTAAAELGE  311 
 
 
Conservation:                  
T._aquaticus_DnaE        280  MCDVDLPIGDKMVYRIPRFPLPEGRTEAQYLRELTFLGLLRRYPDRITEAFYREVLRLLGTMPPHGDERA  349 
MLep_DnaE                288  RVQSYADVWEP-RNRMPVFPVPVGHDQASWLRHEVDAGLKRRFPDG------------------------  332 
Mtb_DnaE1_               292  RVQSYADVWTP-RDRMPVFPVPDGHDQASWLRHEVDAGLRRRFPAG------------------------  336 
MSMEG_DnaE1_             294  RVQSYADVWEP-RDRMPVFPVPEGHDQASWLTHEVKAGLERRFRGG------------------------  338 
E.coli_DnaE              266  RCNVTVRLGE---YFLPQFPTGD-MSTEDYLVKRAKEGLEERLAFLFPDEEERL----------------  315 
MSMEG_DnaE2              326  QCAFGLALIA---PQLPPFDVPDGHTEDSWLRHLAMAGAARRYGPP------------------------  368 
Mtb_DnaE2                312  RCAFGLQLIA---PRLPPFDVPDGHTEDSWLRSLVMAGARERYGPP------------------------  354 
 
 
 
PHP 
PHP 
Palm 
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Figure 4.1: Multiple sequence alignment of the PHP domains of representative bacterial 
DnaE homologs. DnaE-type sequences from T. aquaticus (AAD44403), M. leprae (ML1207), 
Mtb [DnaE1 (Rv1547) and DnaE2 (Rv3370c)], Msm [DnaE1 (MSMEG_3718) and DnaE2 
(MSMEG_1633)], and E. coli DnaE (AP_000844) were aligned using the PROMALS3D multiple 
sequence and structure alignment server 
(http://prodata.swmed.edu/promals3d/promals3d.php). (1) Bold red residues shaded in 
green are the conserved metal co-ordinating residues [H H D/H H E H C/H D/N H] (Barros et 
al., 2013), (2) residues shaded in grey are predicted to bind DnaQ in E. coli (Vandewiele et 
al., 1998, Borden et al., 2002), (3) Bold blue residues inside boxes are conserved in essential 
DnaE-type polymerases and absent in non-essential DnaE-type polymerases, with the 
exception of D49. The annotation of the polymerase domains is derived from crystal 
structures of E. coli (Lamers et al., 2006) and T. aquaticus (Bailey et al., 2006) PolIIIα 
subunits. 
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4.1.3 Construction of site-directed dnaE1 mutants 
To investigate the contribution of the conserved PHP domain residues to the fidelity of the 
dnaE1-encoded α subunit, mutant Msm strains containing targeted substitutions (D49A, 
E133A and D228N) in DnaE1 were generated by allelic exchange (Figure 3.1) (Parish and 
Stoker, 2000). The genotype (Figure 4.2A) of each mutant was verified by restriction enzyme 
analysis of a 2075 bp PCR amplicon spanning the region containing the targeted dnaE1 point 
mutations (Figure 4.2B). This result was confirmed by Sanger sequencing of the PCR 
product. Attempts to generate a dnaE1D228N DCO were not successful: a total of 180 
potential DCOs were screened by restriction enzyme analysis and PCR sequencing, however, 
all contained the WT genotype. Although formal proof is required, this result suggested that 
the D228N mutation is not compatible with optimal growth in vitro. Therefore, the 
merodiploid SCO mutant (ZD 3) containing both WT and dnaE1D228N mutant alleles at the 
native dnaE1 chromosomal locus was utilized in all subsequent experiments.  
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Figure 4.2: Genotypic confirmation of site-directed dnaE1 mutants. (A) Schematic diagram 
detailing the allelic exchange method used to generate the dnaE1 mutants containing 
targeted point mutations in selected PHP domain residues. The asterisks denote mutations 
in specific residues in the dnaE1 locus. The black cross depicts deletion of the dnaQ gene (B) 
Chromosomal DNA was amplified by PCR from putative dnaE1 mutants (ZD 1, ZD 2 and ZD 3) 
containing site-directed mutations in PHP domain residues, and PCR products digested with 
NcoI (ZD 1, lane 4), MscI (ZD 2, lane 6) and HindIII (ZD 3, lane 8), and analysed on a 2% 
agarose gel (B). There is no natural NcoI site in WT dnaE1, therefore amplification of mc2155 
genomic DNA yields a 2075 bp PCR product that is not subject to NcoI restriction (lane 3); 
the engineered D49A mutation introduces an NcoI site in the dnaE1D49A allele which results 
in 1831 bp and 244 bp fragments after digestion of the PCR product (lane 4). Digestion of 
the PCR product from WT mc2155 with MscI results in 807 bp, 766 bp and 494 bp fragments, 
whereas the engineered E133A mutation introduces an additional MscI site in the 
dnaE1E133A allele which results in 766 bp, 498 bp and 268 bp fragments after digestion of the 
PCR product, respectively (lanes 5 and 6). There is no natural HindIII site in WT dnaE1, 
therefore digestion of the PCR product from the ZD 3 containing both WT and mutant allele 
results in 2067 bp (from WT) and 1455 bp and 620 bp fragments from the engineered 
D228N allele which introduces an additional HindIII site (lanes 7 and 8). The PCR product 
amplified from WT mc2155 was included as a control (lanes 3, 5 and 7). Lane 1, molecular 
weight marker IV (Roche); lane 3, WT mc2155 digested with NcoI; lane 4, ZD 1 digested with 
NcoI; lane 5, WT mc2155 digested with MscI; lane 6, ZD 2 digested with MscI; lane 7, WT 
mc2155 digested with HindIII; lane 8, ZD 3 digested with HindIII; and lane 10, molecular 
weight marker V (Roche). 
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4.1.4 Conserved PHP domain residues are required for replication fidelity 
To determine whether conserved residues in the PHP domain in DnaE1 are required for 
replication fidelity, spontaneous mutation rates (μ) were assessed for the ZD 1, ZD 2 and ZD 
3 mutants by fluctuation assay (Rosche and Foster, 2000) using Rif-resistance as the 
readout. A total of 20 cultures was used to set up each fluctuation assay, and spontaneous 
Rif-resistant mutants enumerated on solid medium containing 200 μg/ml Rif. There was no 
difference in the mutation rates of the ZD 1 mutant versus WT (p>0.05) (Figure 4.3A). In 
contrast, mean 3-fold and 10-fold (p<0.05) increases, respectively, were observed in the 
spontaneous mutation rates of the ZD 2 and ZD 3 mutants. To confirm that the apparent loss 
in replication fidelity was attributable to the dnaE1E133A mutation alone, the wild-type dnaE1 
allele was restored in the ZD 2 background by allelic exchange. The mutation rate of the 
resulting “knock-in” strain (ZD 4) was the same as WT (Figure 4.3A), thereby establishing 
that the mutator phenotype of ZD 2 arose as a consequence of the E133A substitution in the 
DnaE1 PHP domain.  
In performing the fluctuation assays, it became apparent that slightly different mutation 
rates were observed for the same strain each time the experiment was performed (i.e., 
intra-strain variation). This variation in experimentally determined mutation rates is an 
intrinsic feature of fluctuation analyses (Rosche and Foster, 2000) and, while not significant 
in magnitude, it can complicate attempts to determine the reproducibility of observed 
mutation rate differences between strains in serial independent experiments. To address 
this concern, the fold-change relative to WT was calculated for each experiment according 
to the formula: 
 
                                      
                                  ⁄  
 
Notably, by plotting fold-difference in the mutation rates of each allelic exchange mutant 
relative to the wild-type parental strain in independent experiments, the reproducibility of 
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inferred mutation rate changes in the different mutant strains was confirmed (Figure 4.3B). 
That is, replacement of the wild-type PolIIIα subunit in Msm with a DnaE1E133A mutant 
resulted in a 3-fold increase in the spontaneous mutation rate. This was a significant result, 
since it provided the first evidence of a small mutator effect consequent on impaired DnaE1 
function in mycobacteria. Similarly, the presence in the merodiploid ZD3 mutant of both 
wild-type and dnaE1D228N alleles was associated with a 10-fold increase in the mutation rate. 
Given that the error-prone DnaE2 subunit contains a natural substitution (D228G) at this 
site, this result reinforced the possibility that the differential intrinsic fidelities of the 
mycobacterial PolIIIα subunits might be explained, in part, by the elimination of 
proofreading exonuclease function in DnaE2.  
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Figure 4.3: Mutation of conserved residues in the PHP domain in DnaE1 results in increased spontaneous mutation rates. Fluctuation assays 
were used to measure spontaneous rates of acquiring Rif-resistance in mutant strains carrying targeted amino acid substitutions in the 
putative DnaQ-binding residue, D49A (ZD 1), and residues that are conserved in essential DnaE-type polymerases, E133A (ZD 2) and D228N (ZD 
3). Data represent mutation rates (µ) (A) and fold differences (B) for six independent experiments. Error bars represent the 95% confidence 
interval. Significance was determined by comparing strain pairs using the Mann-Whitney U test. **p<0.01; ***p<0.001 
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4.1.5 The mycobacterial proofreading DnaQ subunit does not contribute to DNA 
replication fidelity 
The observation that mutation of the D49 residue in DnaE1 did not impact the mutation rate 
(Figure 4.3) could be interpreted as suggesting that this residue was not required to mediate 
the interaction with DnaQ. However, the role of DnaQ in mycobacterial replication fidelity 
had not been investigated at the time of this study. Therefore, while strong mutator 
phenotypes have been reported in E. coli strains deficient in DnaQ-mediated proofreading 
function (Fijalkowska and Schaaper, 1995, Horiuchi et al., 1978, Degnen and Cox, 1974, 
Fijalkowska and Schaaper, 1996), the impact of impaired DnaQ-dependent proofreading 
function on replication fidelity in mycobacteria was unknown. To investigate the role of the 
mycobacterial proofreading DnaQ subunit homolog, allelic exchange mutagenesis was used 
to construct a targeted Msm ΔdnaQ mutant by in-frame elimination of the gene encoding 
the Msm DnaQ homolog, MSMEG_6275. In addition, evidence from homology modelling 
had suggested that the DnaE1 PHP domain residue was located in the DnaQ-binding region 
(Česlovas Venclovas, personal communication). Therefore, a second Msm mutant was 
constructed in parallel in which dnaQ was deleted in the ZD 2 (dnaE1E133A) background, 
yielding the ΔdnaQ dnaE1E133A double mutant (ZD 6). The genotypes of both mutants were 
confirmed by PCR and restriction enzyme analysis.  
To determine the impact of abrogated DnaQ function on mycobacterial replication fidelity, 
spontaneous mutation rates were assessed in both ΔdnaQ and ΔdnaQ dnaE1E133A (ZD 6) 
relative to WT. As before, a total of 20 cultures was used to set up each fluctuation assay, 
and Rif-resistant mutants were isolated on medium containing 200 μg/ml Rif. A very small 
(1.4-fold; p<0.05), but reproducible, increase in mutation rate was calculated for ΔdnaQ 
(Figure 4.4), indicating that the mycobacterial dnaQ homolog does not contribute 
significantly to replication fidelity in vitro. This observation was surprising, and contrasted 
sharply with the very well-characterised models of replisome organization and function in 
other bacteria. In addition, a mean 4.3-fold increase in mutation rate was observed for the 
ΔdnaQ dnaE1E133A double mutant (ZD 6) compared with WT (Figure 4.4). This value 
appeared to be an additive effect of the mutation rates observed for the ΔdnaQ (1.4-fold) 
and dnaE1E133A (3-fold) alleles, and suggested that the roles (albeit small) of the intrinsic PHP 
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domain and the extrinsic DnaQ subunit in maintaining replication fidelity were non-
redundant.  
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Figure 4.4: DnaQ is not required for proofreading in mycobacteria. Fluctuation assays were used to measure rates of acquiring Rif-resistance 
in ΔdnaQ and ZD 6 strains. Data represent mutation rates (µ) (A) and fold differences (B) for six replicates. A total of 20 cultures was used to 
set up each fluctuation assay. Rif was used at a concentration of 200 μg/ml. Error bars represent the 95% confidence interval. Significance was 
determined by comparing strain pairs using the Mann-Whitney U test. **p<0.01 
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4.1.6 The conserved DnaE1 PHP domain residues are not required for UV-induced 
mutagenesis  
In E. coli, disruptions of DnaQ-dependent proofreading activity enable PolIII-mediated TLS in 
the absence of specialist Y-family polymerases (Borden et al., 2002, Vandewiele et al., 
1998). Moreover, in S. pyogenes, the essential DnaE subunit that catalyses TLS does not bind 
DnaQ (Bruck et al., 2003). To determine whether substitution of conserved DnaE1 residues 
impacts replication fidelity following exposure to genotoxic stress, the mutation frequencies 
to Rif-resistance were measured following UV treatment of ZD 1 and ZD 2 mutants. WT 
Msm, ΔdnaE2 and the dnaE2 complementation mutant were used as controls since the 
dominant role of DnaE2 in UV-induced mutagenesis has been established (Boshoff et al., 
2003). Treatment of WT Msm with UV has been previously shown to increase the mutation 
frequency to Rif-resistance, whereas the dnaE2 knockout mutant is expected to eliminate 
UV-induced mutagenesis. This UV-induced phenotype is reversed by complementation with 
the WT copy of dnaE2 at the attB locus (Boshoff et al., 2003). Consistent with previous 
findings (Boshoff et al., 2003), deletion of dnaE2 eliminated UV-induced mutagenesis and 
this phenotype was restored by integration of the WT copy of dnaE2 at the attB locus. In 
contrast, no phenotype was observed in the ZD 1 and ZD 2 PHP domain mutants, which 
phenocopied the WT strain (Figure S2). Since the dominant role of DnaE2 in damage-
induced mutagenesis (Boshoff et al., 2003) may have masked the impact of mutations in the 
PHP domain of DnaE1, the ZD 1 and ZD 2 mutations were therefore transferred into a 
genetic background in which all dinB homologs and dnaE2 had been deleted from the Msm 
mc2155 genome (ΔL mutant; D. Warner, unpublished), to generate strains ZD 10 and ZD 11 
(Table 3.1). However, even in this genetic background, which is depleted of genes encoding 
specialist DNA polymerases, a DNA damage phenotype was not associated with either 
dnaE1D49A or dnaE1E133A alleles (Figure S2).  
  
4.1.7 Contribution of conserved DnaE1 PHP domain residues to damage tolerance 
Prior work (Warner et al., 2010) has established that deletion of dnaE2 renders 
mycobacteria hypersensitive to treatment with MMC, a genotoxic agent that forms 
crosslinks between the complementary strands of DNA preventing their separation and 
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inhibiting DNA replication (Tomasz, 1995). To determine the impact on DNA damage 
tolerance of the targeted DnaE1 PHP domain mutations, ZD 1 and ZD 2 mutants were plated 
in 7H10 OADC without and with varying concentrations of MMC. Again, the total number of 
CFU per culture was calculated to ensure comparable starting values across all the strains 
tested. Consistent with previous observations (Boshoff et al., 2003, Warner et al., 2010), the 
dnaE2 mutant was hypersensitive to MMC treatment and this phenotype was reversed by 
complementation. In contrast, no DNA damage phenotype was observed for the ZD 1 and 
ZD 2 mutants, which phenocopied the WT strain (Figure S3). In addition, no DNA damage 
phenotype was observed for the ZD 10 and ZD 11 mutants following exposure to MMC 
(Figure S3), eliminating the possibility that any contribution, albeit small, of the PHP 
residues was obscured by the presence in Msm of multiple specialist TLS polymerases.  
 
4.1.8 Investigating the role of DnaQ: compiling an expanded panel of dnaQ mutants 
During the course of this study, a report emerged (Ford, 2012) describing the results of an 
independent analysis of the contributions to Msm replication fidelity of the canonical Msm 
dnaQ homolog (MSMEG_6275) and a second, dnaQ-like homolog comprising DnaQ and 
UvrC domains on a single peptide, MSMEG_4259 (dnaQ-uvrC). The panel of Msm dnaQ 
mutants (Table 3.1) comprising ΔdnaQ, ΔdnaQ-uvrC and ΔdnaQ ΔdnaQ-uvrC (Ford, 2012) 
was obtained from the author of that study for inclusion in DNA damage sensitivity and UV-
induced mutagenesis assays. Prior to commencing the work, the genotypes of all mutants 
were confirmed by PCR utilizing primers designed to amplify full length dnaQ 
(MSMEG_6275) and dnaQ-uvrC (MSMEG_4259) (Table 3.3). Amplification of the WT mc2155 
and ΔdnaQ-uvrC mutants using the dnaQ-specific primer set resulted in a PCR product of 
1140 bp for both strains, whereas the ΔdnaQ and ΔdnaQ ΔdnaQ-uvrC strains yield a PCR 
product of 152 bp (Figure 4.5). Amplification of the WT mc2155 and ΔdnaQ with dnaQ-uvrC 
specific primers resulted in a PCR product of 2130 bp respectively, whereas the ΔdnaQ-uvrC 
and ΔdnaQ ΔdnaQ-uvrC strains yield a PCR product of 196 bp. In combination, these 
analyses confirmed that the strain designations reflected the underlying genotypes. 
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Since a separate dnaQ mutant had been generated independently in the current study, it 
was considered useful to compare both ΔdnaQ mutant strains in parallel in fluctuation 
analyses (to determine spontaneous mutation rates) and DNA damage assays (to elucidate a 
role, if any, in DNA damage tolerance and induced mutagenesis). The dnaQ mutants 
phenocopied each other in the fluctuation experiments (the dnaQ mutants were associated 
with a 1.4-fold loss in fidelity) as well as in preliminary DNA damage assays (details below, 
section 4.1.9). Therefore, for all remaining assays, the ΔdnaQ mutant generated in this study 
was used as experimental strain.   
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Figure 4.5: Genotypic confirmation of dnaQ, dnaQ-uvrC and dnaQ dnaQ-uvrC deletion 
mutants by PCR. WT (lanes 3 and 4), ΔdnaQ (lanes 6-8), ΔdnaQ-uvrC (lanes 10-12) and 
ΔdnaQ ΔdnaQ-uvrC (lanes 13- 16) strains were amplified using primer sets targeting the full-
length dnaQ (A) and dnaQ-uvrC (B) alleles to verify deletion of these genes. Three colonies 
per strain were screened for the dnaQ mutants and two colonies were screened for the WT 
mc2155 strain which was used as a positive control. Lane 1, molecular weight marker IV 
(Roche); lane 18, molecular weight marker V (Roche).  
B 
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4.1.9 The role of the mycobacterial dnaQ homologs in UV-induced mutagenesis 
To determine whether inactivation of dnaQ in Msm enhances UV-induced mutagenesis, as 
has been reported in E. coli (Borden et al., 2002, Vandewiele et al., 1998), the ΔdnaQ, 
ΔdnaQ-uvrC and ΔdnaQ ΔdnaQ-uvrC mutants were applied in UV-induced mutagenesis 
assays. Again, ΔdnaE2 and the complemented dnaE2 derivative were included as controls, 
and the total number of cells per culture was calculated to ensure comparable starting CFU 
across all strains tested. Consistent with previous observations (Boshoff et al., 2003), a 50-
100-fold decrease in mutation frequency was observed for the ΔdnaE2 mutant relative to 
WT. The mutation frequencies to Rif-resistance for the ΔdnaQ and ΔdnaQ-uvrC mutants, as 
well as the ΔdnaQ ΔdnaQ-uvrC double knockout, were similar to that of WT Msm (p>0.05) 
suggesting that neither gene is required for UV-induced mutagenesis (Figure 4.6).  
 
4.1.10 DnaQ-UvrC is required for DNA damage sensitivity 
Finally, to assess the potential contribution of the DnaQ homologs to DNA damage 
tolerance, the panel of mutants was applied in MMC assays, again using the dnaE2 deletion 
mutant as a negative control. Deletion of dnaQ did not increase damage sensitivity relative 
to WT. In contrast, the dnaQ-uvrC deletion mutant was hypersensitive to MMC treatment, 
as indicated by the 2-log10 reduction in CFU compared with WT (Figure 4.7). Surprisingly, the 
MMC-hypersensitivity phenotype was even more profound than that which was observed 
for the ΔdnaE2 control. Moreover, damage hypersensitivity was not evident in the dnaQ 
dnaQ-uvrC double deletion mutant (Figure 4.7). In order to confirm that the single dnaQ-
uvrC and double dnaQ dnaQ-uvrC mutants had not been inadvertently switched, the 
gentoypes of both strains were re-confirmed by PCR analysis. This result established that 
loss of DnaQ-UvrC renders Msm hypersusceptible to MMC-mediated DNA damage, and that 
this effect is reversed by deletion of dnaQ in the same background.  
  
79 
 
 
 
 
 
 
 
 
 
 
Figure 4.6: Msm dnaQ homologs are not required for UV-induced mutagenesis. UV-
induced mutation frequencies of WT, ΔdnaE2, ΔdnaQ, ΔdnaQ-uvrC and ΔdnaQ ΔdnaQ-uvrC 
following UV-irradiation. Mycobacterial cultures of WT mc2155 and mutant strains were 
grown until log phase harvested, re-suspended and UV irradiated at 25 mJ/cm2. After 
irradiation, cells were rescued at 37°C for 4 h and plated on 7H10 OADC containing 200 
μg/ml Rif. Error bars represent the 95% confidence interval. Significance was determined by 
comparing strain pairs using the Mann-Whitney U test. ***p<0.001 
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Figure 4.7: dnaQ-uvrC is required for DNA damage tolerance. Log10-fold dilutions (10
-1–10-6) 
of WT, ΔdnaE2, ΔdnaQ, ΔdnaQ-uvrC and ΔdnaQ ΔdnaQ-uvrC were spotted on standard 
7H10 media without (first row for each strain) and with 0.02 μg/ml MMC (middle row for 
each strain) or 0.04 μg/ml MMC (last row for each strain). CFU determinations confirmed 
that all strains were spotted at equivalent cell numbers (not shown). Data are from a 
representative experiment performed in triplicate. 
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4.2 Determination of functional interactions that are essential for DnaE2-dependent 
induced mutagenesis in Mtb 
The central role of DnaE2 in DNA damage survival and induced mutagenesis (Boshoff et al., 
2003) identified the mycobacterial PolIIIα subunit as the founder member of a novel family 
of DnaE-type family C polymerases from Gram-positive bacteria that catalyse TLS (Tippin et 
al., 2004). Subsequent work then elaborated a model in which DnaE2 functions together 
with at least two accessory proteins, ImuA’ and ImuB, both of which are upregulated 
together with DnaE2 in the mycobacterial SOS response (Warner et al., 2010). The C-
terminal domain of ImuB has been shown to be critical for the separate ImuB’-DnaE2 and 
ImuB-ImuA’ protein-protein interactions which are thought to enable DnaE2 to access the 
damage lesion during TLS (Warner et al., 2010). The specific domains in DnaE2 that are 
critical for this function remain unknown, however. As noted above (Table 1.2), DnaE2 lacks 
the C-terminal τ domain but instead contains a highly conserved C-terminal pentapeptide 
motif, SRDFR and an N-terminal extension of ~40 amino acid residues that is only found in 
Actinobacteria (Figure S1) (Timinskas et al., 2014, Warner et al., 2010). Owing to their high 
conservation and lack of a defined structure, it was hypothesized that these DnaE2 domains 
are required for mediating protein–protein interactions during mutasome function.  
 
4.2.1 Construction of N- and C-terminally truncated dnaE2 mutants 
To test this hypothesis, mutant Msm strains were generated containing defined truncations 
of the N-terminal extension and, separately, the C-terminal pentapeptide motif in DnaE2. To 
this end, two alleles were engineered: (i) a dnaE2 mutant allele in which the C-terminal 
pentapeptide-encoding motif was truncated (dnaE2ΔSRDFR) and (ii) a second dnaE2 allele in 
which 38 N-terminal residues were eliminated, resulting in an N-terminally truncated DnaE2 
(dnaE2N38). The alleles were subcloned into the integrating vector, pMC1s (Warner et al., 
2010), to generate mutant complementation vectors that were subsequently electroporated 
into the ΔdnaE2 mutant background. As such, this strategy investigated the ability of the N- 
and C-terminally truncated DnaE2 proteins to complement a dnaE2 null mutant, analogous 
to the approach that was used previously to elucidate the structure-function relationships of 
the other mutasome components, ImuA’ and ImuB (Warner et al., 2010).  
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The dnaE2ΔSRDFR and dnaE2N38 fragments contained engineered BglII and SpeI restriction 
sites, respectively, to enable differentiation of WT and mutant alleles. Digestion of 
pMC1rdnaE2 with SpeI results in a linear fragment of 9946 bp (Figure 4.8A, lane 6). The 
additional SpeI site in pMC1rdnaE2N38 cleaves the 9946 bp fragment resulting in 1344 bp 
and 8590 bp, respectively (Figure 4.8A, lane 11). Digestion of pMC1rdnaE2 with BglII results 
in 2751 bp, 18 bp, 1464 bp and 5713 bp fragments (Figure 4.8A, lane 5). The additional BglII 
site in pMC1rdnaE2ΔSRDFR cleaves the 5713 bp in WT dnaE2 resulting in 2751 bp, 18 bp, 1464 
bp, 1548 bp and 4169 bp fragments, respectively (Figure 4.8A, lane 15).  
The Msm ΔdnaE2 mutant was then transformed with vectors carrying the WT dnaE2 allele 
(yielding strain ZD 7) and the dnaE2ΔSRDFR (ZD 8) and dnaE2N38 (ZD 9) alleles. In each case, the 
complementation vector integrated into the att locus in the ΔdnaE2 chromosome; this was 
confirmed using the PCR strategy shown in Appendix B. Amplification of the WT dnaE2 
complementation mutant and dnaE2 mutant strains using attL2 and attBS1 primers resulted 
in a PCR product of the expected size (282 bp) for each strain (Figure 4.8). Mutant strains of 
Msm with a validated dnaE2 genotype were assessed for DNA damage tolerance and UV-
induced mutagenesis (section 4.2.2). In addition, the same alleles were used as templates to 
generate a panel of “bait” and “prey” vectors for Y2H analyses designed to assess the 
impact of deletion of these terminal sequences on protein-protein interactions involving 
DnaE2 (section 4.2.4). 
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Figure 4.8: Genotypic confirmation of dnaE2 constructs and mutants. (A) pMC1rdnaE2 
(lanes 4-6), pMC1rdnaE2N38 (lanes 9-7) and pMC1rdnaE2ΔSRDFR (lanes 14-16) were digested 
with BamHI, BglII, and SpeI, and analysed on a 1% agarose gel. Undigested controls were 
included for each construct (lanes 3, 8 and 13). Lane 1, molecular weight marker III (Roche); 
lane 3, undigested pMC1rdnaE2; lane 4, pMC1rdnaE2 digested with BamHI; lane 5, 
pMC1rdnaE2 digested with BglII; lane 6, pMC1rdnaE2 digested with SpeI; lane 8, undigested 
pMC1rdnaE2N38; lane 9, pMC1rdnaE2N38 digested with BamHI; lane 10, pMC1rdnaE2N38 
digested with BglII; lane 11, pMC1rdnaE2N38 digested with SpeI; lane 13, undigested 
pMC1rdnaE2ΔSRDFR; lane 14, pMC1rdnaE2ΔSRDFR digested with BamHI; lane 15, 
pMC1rdnaE2ΔSRDFR digested with BglII; lane 16, pMC1rdnaE2ΔSRDFR digested with SpeI and 
lane 18, molecular weight marker IV (Roche) (B) Integration of the WT and dnaE2 mutant 
alleles at the bacterial att locus was verified using primers that amplify hybrid portions 
originating from attB and attP. The attB primer set amplified the attB site which is 276 bp 
long (lanes 2-5) and the attL primers amplify a portion of the vector sequence which is 326 
bp long (lanes 7 and 8). Genomic DNA was screened using attB primers and the vector 
(pMC1r) was screened using attL primers. Three colonies from ZD 9 and two from ZD 7 and 
ZD 8 were screened using attL2 and attBS1 primers which yielded PCR products of 282 bp. 
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4.2.2 The N-terminal extension and C-terminal pentapetide motif are not required for 
DnaE2-dependent damage tolerance and UV-induced mutagenesis 
To determine whether deletion of either the N-terminal extension or the C-terminal motif in 
DnaE2 impacted polymerase function, the ZD 8 (dnaE2ΔSRDFR) and ZD 9 (dnaE2N38) mutants 
were assessed in DNA damage-induced mutagenesis. It was expected that, if either terminal 
sequence was essential for DnaE2 polymerase function, a ΔdnaE2 mutant carrying the 
respective dnaE2ΔSRDFR and dnaE2N38 allele should phenocopy the ΔdnaE2 deletion mutant. 
That is, the mutant alleles should not reverse the deficiency in UV-induced mutagenesis to 
Rif that is characteristic of the ΔdnaE2 strain (Boshoff et al., 2003, Warner et al., 2010).  
As observed previously (Boshoff et al., 2003, Warner et al., 2010), the ΔdnaE2 mutant was 
associated with a low frequency of UV-induced Rif-resistance; moreover, complementation 
with the WT dnaE2 allele (ZD 7) reversed this phenotype, although it did not fully restore 
the Rif-resistance mutation frequencies to WT (Figure 4.9A). In contrast, no DNA-damage 
phenotype was observed for both ZD 8 and ZD 9 dnaE2 mutants following UV damage, as 
evidenced by the fact that no differences in mutation frequencies to Rif were observed for 
both mutants relative to WT (p>0.05) (Figure 4.9A).  
In addition to DNA damage-induced mutagenesis, the dnaE2 deletion mutant was previously 
shown to be hypersensitive to MMC treatment; again, this effect could be reversed by 
integration of the WT copy of dnaE2 at the attB locus (Boshoff et al., 2003, Warner et al., 
2010). Here, log10-fold dilutions of each strain were plated on MMC at two concentrations 
known to elicit a damage tolerance phenotype (Warner et al., 2010). As observed 
previously, the ΔdnaE2 was hypersusceptible to MMC at both concentrations, and this 
phenotype was reversed by complementation with the WT dnaE2 allele in the ZD 7 strain. In 
contrast, neither dnaE2ΔSRDFR nor dnaE2N38 mutant allele resulted in a damage sensitivity 
phenotype following exposure to MMC, with both ZD 8 and ZD 9 mutants phenocopying the 
WT strain (Figure 4.9B). In summary, these observations indicated that elimination of either 
N-terminal extension or C-terminal pentapeptide motif did not disrupt DnaE2 function in 
DNA damage tolerance and mutagenesis assays in vitro.  
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Figure 4.9: The N-terminal extension and C-terminal motif in DnaE2 are not required for 
induced mutagenesis and DNA damage tolerance. (A) UV mutation frequencies of WT, 
dnaE2 complementation strain (ZD 7), ZD 8, ZD 9 and ΔdnaE2 following UV-irradiation. (B) 
Log10-fold dilutions of the mycobacterial cultures (10
-1-10-5) were spotted on 7H10 OADC 
media without MMC (top row for each strain), with 0.02 μg/ml MMC (second row for each 
strain); and 0.04 μg/ml MMC (third row for each strain. ***p<0.001 
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4.2.3 Identification of protein-protein interactions between putative mutasome 
components. 
To determine whether the C-terminal pentapeptide motif and/or the N-terminal extension 
in DnaE2 was required for mediating protein-protein interactions during mutasome 
function, “bait” and “prey” constructs containing the targeted DnaE2 mutations 
(DnaE2ΔSRDFR and DnaE2N38) were generated and assessed in Y2H assays. Protein-protein 
interactions were previously detected between Mtb ImuB and DnaE1, and both proteins 
were also shown to interact separately with the dnaN-encoded β2 clamp processivity factor, 
consistent with the presence in DnaE1 and ImuB of β2 clamp-binding motifs (Kana et al., 
2010, Warner et al., 2010). In addition, DnaE2 was shown to interact with ImuB (Warner et 
al., 2010). Therefore, for the current analyses, Msm WT DnaE2, WT DnaE1 and ImuB genes 
were cloned into pGADT7 (ImuB) or pGBKDT7 (DnaE1 and DnaE2) and these constructs were 
used as positive controls (Table 3.2). For negative controls, pGADT7 was co-transformed 
with the empty plasmid pGBKT7, pGBDDnaE2 or pGBDDnaE2N38 (Table 3.2) constructs, 
respectively.  
 
Consistent with previous findings (Warner et al., 2010), an interaction was detected 
between DnaE2 and ImuB, although cellular growth was poor even on low stringency (LTH) 
medium. This contrasted with DnaE1 and ImuB, for which a strong interaction was observed 
even on high stringency medium (LTHA-3AT) (Figure 4.10). As expected, no interaction was 
observed for the pGADT7-pGBKT7, pGADT7-pGBDDnaE2 and pGADT7-pGBDDnaE2N38 
negative controls. Both DnaE2 mutants co-transformed with ImuB failed to grow on high 
stringency medium (LTH-3AT) compared with WT DnaE2-ImuB (Figure 4.10). In combination, 
these results suggested that the N-terminal extension and C-terminal motif in DnaE2 are 
necessary for mediating the imuA’-imuB/dnaE2 interaction during TLS. However, the 
observation that the corresponding alleles did not impact DnaE2 function in Msm (section 
4.2.2) indicates that inferences about protein-protein interactions must be made with 
caution. 
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Figure 4.10: The N- and C-terminal domains in DnaE2 are not required for interaction with 
ImuA’ and ImuB. Protein interactions were detected on synthetic drop-out (SD) medium 
lacking leucine and tryptophan (LT); leucine, tryptophan and histidine (LTH); and leucine, 
tryptophan, histidine and adenine (LTHA). 3-amino triazole (3-AT) was added to medium 
and high stringency media in order to reduce HIS3 expression required for growth on 
histidine-deficient media. pGADT7-pGBKT7, pGADT7-pGBDDnaE2 and pGADT7-
pGBDDnaE2N38 were used as negative controls, whereas pGADImuB and pGBDDnaE1 were 
used as a positive controls. Data are from a single representative experiment performed in 
triplicate.   
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CHAPTER 5: DISCUSSION 
 
5.1 Replication fidelity in mycobacteria 
In most prokaryotes, replication fidelity is determined by a combination of three separate 
but inter-related processes: 1) base selection by the replicative polymerase 2) exonuclease 
proofreading and 3) post-replicative MMR (Fijalkowska et al., 2012). Mycobacteria lack the 
MMR system (Mizrahi and Andersen, 1998), suggesting that base selection and proofreading 
are sufficient to ensure overall replication fidelity, or that alternative mechanisms exist for 
the correction of replication errors. To elucidate the molecular mechanisms governing 
replication fidelity in mycobacteria, the contributions of two subunits of the mycobacterial 
PolIII enzyme were investigated: DnaE1, the essential α subunit which contains a PHP 
domain with putative proofreading activity, and the dnaQ-encoded ε subunit which, in E. 
coli, encodes the major proofreading function. Given that the Mtb genome encodes a 
second, error-prone α subunit, DnaE2, the differential fidelity of the two α subunits (DnaE1 
and DnaE2) was also investigated to determine whether 1) it was a direct function of their 
respective intrinsic biochemical properties (PHP-mediated exonuclease proofreading) or 2) 
whether this property was instead determined by differential interactions with other 
cellular components via specific structural domains. Therefore, the second part of this study 
adopted a genetic approach to investigate the requirement for specific N- and C-terminal 
domains of DnaE2 in damage-induced mutagenesis.  
 
5.1.1 The PHP domain in DnaE1 contains a complete set of metal co-ordinating residues 
The PHP domains of PolIIIs from some Gram-positive bacteria have been shown to contain a 
complete set of metal-binding residues that are important for 3’-5’ exonuclease activity 
(Banos et al., 2008, Nakane et al., 2009, Stano et al., 2006, Wing et al., 2008). In contrast, no 
exonuclease activity could be detected for the PHP domain of G. kaustophilus PolC (Evans et 
al., 2008) which contains an almost intact active site – suggesting that a complete set of the 
catalytic metal co-ordinating residues is required to constitute an “active” PHP domain; that 
is, a PHP domain with exonuclease activity. In this study, the essential PolIIIα subunit in 
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mycobacteria, DnaE1, was demonstrated to contain a complete set of the conserved metal 
co-ordinating residues in its PHP domain, suggesting that it might possess 3’-5’ exonuclease 
activity. Interestingly, DnaE2 was also found to contain an almost intact 3’-5’ exonuclease 
active site in its PHP domain, with eight out of nine residues conserved, the only difference 
being the D228A substitution in Msm or D228G substitution in Mtb instead. This was 
reported elsewhere (Timinskas et al., 2014) and raises an important question as to whether 
the PHP domain in DnaE2 is active or not, given the observation that conservation of the 
same eight residues is not sufficient for exonuclease function in G. kaustophilus PolC. In this 
regard, the conservation in a subgroup of Actinobacterial DnaE2s of an almost intact PHP 
active site (Figure S1) (Timinskas et al., 2014) might indicate a role in the maintenance of 
structural fidelity rather than proofreading since the results of this study (discussed below) 
indicate that proofreading can be eliminated by a single deviation (dnaE1D228N) from the 
highly conserved nine-residue PHP exonuclease active site. 
 
Even though the third DnaE-type C-family polymerase, DnaE3, strongly resembles DnaE1 in 
terms of domain architecture, the PHP domain in DnaE3-type polymerases is smaller, as it 
lacks several structural elements (Timinskas et al., 2014). In contrast to DnaE2 which 
contains eight of the nine conserved metal co-ordinating residues, the PHP domain in 
DnaE3-type polymerases are very diverse and exhibit limited identity with the 
corresponding DnaE1 and DnaE2 PHP domains, suggesting that DnaE3 proteins are 
completely deficient in exonuclease proofreading activity (Timinskas et al., 2014). Similarly, 
the PHP domain in E. coli has been shown to lack five of the nine metal co-ordinating results 
and therefore possesses no proofreading activity. However, re-introduction of the catalytic 
residues did not restore the proofreading function but instead stabilized the PolIII core, 
suggesting that the PHP domain in E. coli is critical for maintenance of the structural 
integrity of the PolIII HE, instead of genome maintenance (Barros et al., 2013).  
 
5.1.2 The conserved PHP domain residues in DnaE1 are required for genome maintenance 
In addition to the metal co-ordinating residues, the PHP domain in DnaE1 was also shown to 
contain conserved residues that are predicted to be required for maintaining replication 
fidelity in mycobacteria (E133). It is worth noting that these residues are absent in the PHP 
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domain of DnaE2 and other non-essential DnaE-type polymerases (Figure S1) (Warner et al., 
2010), possibly correlating with the inability of the alternative DnaEs to carry-out high 
fidelity DNA synthesis. Mutation of the Glu-133 residue in DnaE1 resulted in loss of intrinsic 
replication fidelity, suggesting that additional residues not directly involved in metal co-
ordination are also necessary for robust exonuclease activity (Barros et al., 2013). 
 
In addition to metal co-ordination, the Asp-228 residue was also found to be conserved in 
DnaE1 and absent in DnaE2. Efforts to generate an Msm DCO mutant containing only the 
dnaE1D228N allele proved unsuccessful despite numerous attempts. It was striking, therefore, 
that a merodiploid strain (ZD 3) carrying both WT dnaE1 and the dnaE1D228N allele was 
associated with a 10-fold increase in spontaneous mutation rate. This study did not 
investigate gene expression from the different alleles; however, if it is assumed that the 
alleles are expressed equally, the mutator effect observed in ZD 3 implies that any 
disruption to intrinsic proofreading function in the active replisome can impact replicative 
fidelity significantly. It is tempting to speculate, therefore, that upregulation in the 
mycobacterial SOS response of dnaE2, a “natural” D228N mutant, might impact fidelity – a 
notion that is consistent with the elevated mutagenesis observed following DNA damage.  
 
Failure to generate the isogenic dnaE1D228N mutant suggests that there is a high selection 
pressure against this mutation. Mutation of this residue could possibly result in “error 
catastrophe” which will have an impact on genome maintenance as the fidelity of the 
replication machinery decreases. In support of this notion, a mutator phenotype was 
observed for the merodiploid strain carrying both WT and dnaE1D228N alleles at the native 
dnaE1 chromosomal locus, suggesting the importance of this specific residue in genome 
maintenance. Previous studies measured mutation rates for the ΔdnaE2 mutant and 
demonstrated no differences between this mutant relative to WT (Boshoff et al., 2003). 
Given the strong mutator phenotype observed in this study associated with the DnaE1D228N 
mutation and observations that this residue is required to complete the set of metal co-
ordinating residues in DnaE2, further studies are required to test whether introduction of 
this PHP domain residue in DnaE2 would enhance replication fidelity (but decrease damage 
tolerance) following exposure to genotoxic stress. 
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5.1.3 DnaQ is not required for maintaining replication fidelity in mycobacteria 
 
The presence of a dnaQ homolog in mycobacteria suggests that the mycobacterial PolIII HE 
might use DnaQ for proofreading, as in the case of E. coli (Fijalkowska and Schaaper, 1995, 
Horiuchi et al., 1978, Degnen and Cox, 1974, Fijalkowska and Schaaper, 1996). In the E. coli 
 subunit, the counterpart of the Asp-49 residue has been shown by structural analysis to 
bind the DnaQ proofreading subunit (Wieczorek and McHenry, 2006). In contrast to the 
model organism, mutation of the Asp-49 residue in DnaE1 did not impact the mutation rate 
of Msm, suggesting that this residue is not required for binding DnaQ. Moreover, a 4.3-fold 
increase in mutation rate was observed for the ZD 6 (ΔdnaQ dnaE1E133) mutant, which 
appeared to be an additive effect of the ΔdnaQ (1.4-fold) and dnaE1E133 (3-fold) mutations. 
This suggests that DnaQ and Glu-133 residue in DnaE1 perform non redundant functions 
and that the Glu-133 residue in DnaE1 does not bind DnaQ during DNA replication.  
 
Barros and colleagues demonstrated a correlation between a variant PHP domain – a PHP 
domain lacking one or more conserved catalytic metal co-ordinating residues – with the 
presence of a separate proofreading subunit, DnaQ in E. coli (Barros et al., 2013). This raises 
questions in the context of mycobacteria which contain both the intact PHP domain and two 
dnaQ homologs. That is, is the inferred correlation between the presence of an intact PHP 
domain and the possession of a separate DnaQ subunit of any relevance to this organism, 
given that both mycobacterial dnaQ homologs have been demonstrated to be dispensable 
for replication fidelity?  
 
5.1.4 Mycobacteria use non canonical mechanisms of proofreading to maintain genome 
integrity. 
Deletion of dnaQ in mycobacteria has been shown to have a very modest effect on mutation 
rate (1.4-fold increase). During the course of this work, Ford reported the results of an 
independent analysis of the function of the canonical dnaQ gene and the second dnaQ-type 
homolog (MSMEG_4259) on replication fidelity in Msm and Mtb, whereby deletion of 
MSMEG_4259 was found to have no impact on the mutation rate. Moreover, consistent 
with findings presented here, deletion of the canonical dnaQ gene was found to result in a 
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1.4-fold loss in fidelity (Ford, 2012). That study also showed that deletion of both dnaQ 
homologs did not further increase the mutation rate (Ford, 2012). The findings were 
intriguing since E. coli strains with inactivating mutations in dnaQ were reported to have 
100-1000 fold increase in mutation rate (Fijalkowska and Schaaper, 1995, Horiuchi et al., 
1978, Degnen and Cox, 1974, Fijalkowska and Schaaper, 1996), suggesting that 
mycobacteria use alternative mechanisms of proofreading to maintain genome integrity. 
 
Furthermore, in contrast to E. coli (Gerdes et al., 2003) and other organisms (Akerley et al., 
2002, van Opijnen et al., 2009), dnaQ homologs in mycobacteria were found to be 
dispensable for viability (Griffin et al., 2011, Sassetti et al., 2001, Sassetti and Rubin, 2003). 
Again, this observation raises the question: why does Mtb contain two homologs of dnaQ? 
M. leprae, which lacks both dnaQ homologs, may have provided some insight about the 
dispensability of the dnaQ homologs in genome maintenance in mycobacteria. It is worth 
noting that this organism, which is undergoing genomic decay (Cole et al., 2001), contains a 
complete set of the metal co-ordinating residues in the PHP domain of its replicative 
polymerase, suggesting the crucial role for the PHP domain in genome maintenance in 
mycobacteria. In addition, in a comprehensive genome-wide screen for genes under 
selection in clinical drug-resistant Mtb isolates performed by Farhat and colleagues, dnaQ 
(Rv3711) was among those genes which were found to be associated with drug resistance 
(Farhat et al., 2013). Does this mean that DnaQ is serving in another pathway that may not 
involve replicative fidelity directly? The identification of genes that are conditionally 
essential in the absence of the dnaQ homologs may provide some insight into proteins that 
serve in the same pathway as the dnaQ homologs, and hence their possible function. Most 
importantly, based on findings presented here, an important question arises: is the fidelity 
in mycobacteria solely determined by the intrinsic 3’-5’ exonuclease activity in the PHP 
domain in DnaE1?  
 
Springer and colleagues demonstrated that the key NER helicase, UvrD1, fulfils a critical role 
in limiting recombination-associated mismatches, therefore providing evidence that other 
repair components have enabled Mtb to mitigate the lack of the MMR system (Guthlein et 
al., 2009). It is also possible that other replication-associated factors contribute to 
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replication fidelity in mycobacteria such as the interplay between replisome components 
and dNTP levels at the replication fork. There is no direct evidence for this mechanism in 
mycobacteria, however, in E. coli, increased dNTP levels were shown to modify the balance 
of PolIII activity by increasing the polymerase activity and reducing the proofreading 
function (Gon et al., 2011). The same study demonstrated that spontaneous mutagenesis 
increased proportionally to dNTP pool levels, therefore defining a unique “dNTP 
spontaneous mutator” phenotype (Gon et al., 2011). Another factor that contributes to 
replication fidelity is the co-ordination between the replication machinery and the pathways 
that function in chromosomal segregation and cell division (Aldridge et al., 2012, Arjes et al., 
2014, Joyce et al., 2012, Kester and Fortune, 2014, Kieser and Rubin, 2014, Kysela et al., 
2013). Further work focused on the relationship between dNTP pools and the replication 
rate of Mtb at different stages of infection is required to enable accurate estimates of the 
intracellular dNTP concentration during different phases of the mycobacterial cell cycle. In 
addition to this, even though there are insights into proteins that are involved in DNA 
replication, further studies focusing on identification of mycobacterial replisome 
components and their organization may assist in understanding how genome integrity is 
maintained in Mtb.  
 
5.1.5 A role for mutator strains in Mtb  
Considering that Mtb does not exhibit an elevated mutation rate relative to other bacteria 
(Ford et al., 2011), how do mutator strains arise and is there any evidence to support a role 
for mutators in this organism? For many bacterial pathogens, the absence of key DNA repair 
functions might facilitate adaptation during specific stages of the life cycle; however, the 
loss of repair machinery can impact long-term colonization and transmission. To some 
extent, the benefits of a mutator phenotype for the development of drug resistance are 
likely to be outweighed by negative effects on virulence and the susceptibility of mutators 
to extinction as a result of evolutionary bottlenecks (Warner et al., 2013). However, recent 
studies using WGS demonstrated strain-specific differences in mutation rates, whereby Mtb 
strains from lineage 2 which include the Beijing family, were shown to acquire drug 
resistance in vitro more rapidly compared with strains from lineage 4 (Euro-American 
lineage). This higher rate was attributed to a higher basal mutation rate in lineage 2 strains, 
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although the exact mechanism is unknown (Ford et al., 2013). Therefore, even though small 
changes in mutation rate for the ZD 2 and ZD 3 PHP mutants (3-fold and 10-fold, 
respectively) were observed, small changes can profoundly affect the rate at which strains 
from different lineages acquire drug resistance, as demonstrated by Ford et al. (Ford et al., 
2013). The findings reported in this study suggest that polymorphisms in the PHP domain of 
DnaE1 may confer strain-specific alterations in replicative fidelity. Moreover, since none of 
PHP domain polymorphisms have been found among clinical strains of Mtb that have been 
sequenced so far, this implies that there is a high selection pressure in this domain. 
 
This study has limitations, including the fact that the choice of amino acid residues selected 
for mutation in the PHP domain of Msm DnaE1 was guided by insights gained from 
homology modelling as the structure of DnaE1 has not been determined. Secondly, a 
genetic approach was used to understand the contribution of the conserved PHP domain 
residues in DnaE1 function. Biochemical studies were not performed to validate the 
exonuclease activity of the PHP domain in DnaE1 and to understand and contextualise the 
effects (or lack thereof) of the PHP domain mutations in maintaining genome integrity 
which is one of the limitations of this study. These studies would have also provided insights 
into the potential catalytic activity of the PHP domain in DnaE2. Moreover, the impact of the 
PHP domain point mutations on the overall structural integrity of DnaE1 was not 
investigated. This could be addressed using structural studies which were also not 
performed in this study. Based on recent observation in E. coli which demonstrated that 
mutations in PHP domain of PolIII affected the overall stability of the protein (Barros et al., 
2013), this warrants further investigation.  
 
In conclusion, in contrast to model organisms where high fidelity DNA replication is 
dependent on the DnaQ proofreading subunit, this study demonstrated that the 
corresponding subunit is dispensable in Msm. Instead, conserved residues in the PHP 
domain in DnaE1 are required for genome maintenance, therefore updating the current 
view of the mycobacterial replisome (Figure 5.1) and demonstrating that mycobacteria use 
non-canonical mechanisms of proofreading to maintain genome integrity. This conclusion is 
supported by very recent evidence from the laboratory of Sarah Fortune (Harvard 
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University), which was published during the examination of this thesis. In their very elegant 
study, a combination of genetic, biochemical, and comparative genomic analyses 
established the essential role of the PHP-dependent 5’-3’exonuclease activity in maintaining 
the mycobacterial mutation rate (Rock et al., 2015).  
 
 
 
Figure 5.1: A model for DNA replication fidelity in E. coli versus Mtb. In E. coli, DNA 
replication fidelity is accomplished using three primary mechanisms - base selection by the 
replicative polymerase, 3’-5’exonuclease proofreading by the separate DnaQ subunit, and 
postreplicative MMR - which contribute to the overall error rate of 10-10 mutations per base 
pair per generation. The error rate for each process is shown in the figure. Mtb lacks the 
MMR system and this work, as well as a recent study (Rock et al., 2015), has established that 
the dnaQ homologs are dispensable for proofreading in mycobacteria. Instead, conserved 
residues in the PHP domain in DnaE1 are required to maintain overall mycobacterial 
replication fidelity. In Mtb, the contribution of each mechanism to the overall error rate of 
10-10 mutations per base pair per generation is still unknown. 
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5.2 The mycobacterial SOS and damage-induced response  
5.2.1 The role of the N- and C-terminal domains in DnaE2 in mediating protein-protein 
interactions during mutasome function  
The dominant role for DnaE2 in DNA damage-induced mutagenesis in Mtb is well 
established (Boshoff et al., 2003). Moreover, DnaE2 has been shown to function in 
association with other DNA damage response proteins, ImuA’ and ImuB during TLS, thereby 
implicating differential protein interactions in specialist polymerase function (Warner et al., 
2010). The C-terminal region of ImuB has been shown to mediate interactions with other 
mutasome components suggesting that ImuB may act as a hub/adaptor protein that 
interacts with both DnaE2 and ImuA’ in mediating TLS (Warner et al., 2010). Y2H data 
demonstrated that the DnaE2N38 and DnaE2ΔSRDFR mutants failed to interact with ImuB, thus 
potentially implicating interactions between ImuB and both the N-terminal extension and C-
terminal motif in DnaE2 mutasome function. Consistent with previous studies (Warner et 
al., 2010), an interaction was detected between WT DnaE2 and ImuB, however it was 
associated with very poor colony growth. This complicated comparison of very small 
changes between ImuB and the DnaE2 mutants relative to WT DnaE2. Based on this notion, 
it might be concluded that the deletion of the N-terminal extension and C-terminal motif in 
DnaE2 mutations did not impact the interaction with ImuB significantly.  
It should be noted, however, that even though Y2H assays are still one of the most widely 
used methods for determining protein-protein/DNA interactions in vivo, there are important 
limitations to the technique: for example, the interacting proteins must be localized to the 
nucleus, since proteins which are less likely to be present in the nucleus are excluded due 
their inability to activate reporter genes. In addition, many true interactions may not be 
traced using Y2H assays, therefore leading to false negative results. Proteins which need 
posttranslational modifications to carry out their function are unlikely to behave or interact 
normally in a Y2H experiment. Most importantly, the proteins are not in their natural 
physiological environment and, therefore, may not fold properly to interact, also leading to 
false negative results (Rao et al., 2014). Moreover, proteins form part of complexes or 
networks in vivo; in the case of the Y2H system, the proteins are not in the host cell, where 
other proteins which may form part of the functional interactome are present. If other 
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proteins compensate for the loss of function of another protein in the host cell, this effect 
will not be observed in the Y2H system which only determines interaction between protein 
pairs, therefore resulting in false negative results (Rao et al., 2014). In addition, since the 
inferred interactions occur in a heterologous system: yeast versus Msm, under non-DNA-
damaging conditions, it is not clear whether these interactions are relevant, in any way, 
during TLS.   
 
Research has advanced such that techniques based on live cell imaging are now being used 
to address some of the limitations of Y2H assays and these can be included in future work 
involving determination of protein-protein interactions in mycobacteria. One such example 
is fluorescence resonance energy transfer (FRET) microscopy, which uses time-correlated 
single-photon counting to predict protein interactions (Lleres et al., 2007). FRET is more 
advantageous in that it allows for retrieving information on molecular proximity, spatial 
organization, orientation and conformation of molecules on the nanometre scale and 
interactions between molecules can be quantified from living cells (Pietraszewska-Bogiel 
and Gadella, 2011), therefore increasing the sensitivity of this technique.  
 
5.2.2 The N-terminal extension and C-terminal motif in DnaE2 are not required for DnaE2 
function 
Prior work in the Warner and Mizrahi laboratory characterised mutants of Msm and Mtb 
that are impaired in mutasome function (e.g. dnaE2, imuA’ and imuB deletion mutants), 
showing specifically that these strains exhibit: an increase in sensitivity to certain DNA 
damaging agents (e.g. UV and MMC) and an inability to display UV-induced mutation to Rif-
resistance (Boshoff et al., 2003; Warner et al., 2010). The same assays were therefore used 
to assess the impact of the DnaE2 mutations investigated in this study. The dnaE2ΔSRDFR and 
dnaE2N38 mutants were indistinguishable from the parental WT strain in both assays, thus 
ruling out a significant role for the N-terminal extension and C-terminal pentapeptide motif 
in DnaE2 function during TLS.  
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One possible reason for the contrasting conclusions from these phenotypic assays versus 
the Y2H analysis, is that the phenotypic assays were conducted under damage-inducing 
conditions, where there is elevated expression of DnaE2, which may mask any effect that 
deletion of one domain may potentially have on polymerase function. In support of this, 
DnaE2 levels were shown to be 50-times greater than physiological conditions following UV-
damage (Warner et al., 2010). However, based on the sensitivity the phenotypic assays 
employed in this study, it is reasonable to conclude that the N-terminal extension and C-
terminal motif are not critical for DnaE2 function. 
 
5.2.3 The conserved PHP domain residues in DnaE1 are dispensable for damage tolerance 
and induced mutagenesis. 
In addition to dnaE2, the mycobacterial damage response includes DnaE1 (Boshoff et al., 
2003, Warner et al., 2010) instead of the Y-family polymerases, in contrast to most model 
organisms (Brooks et al., 2001). No damage-induced phenotype was observed for the DnaE1 
PHP mutants with defects in proofreading function, suggesting that the conserved PHP 
domain residues in DnaE1 are dispensable for damage tolerance and/or induced 
mutagenesis.  
 
5.2.4 Mycobacterial dnaQ-uvrC is not required for UV-induced mutagenesis  
Lack of a DNA damage phenotype for the ΔdnaQ and ΔdnaQ-uvrC following UV treatment 
suggests that neither mycobacterial dnaQ homolog is required for UV-induced mutagenesis. 
This finding contrasts observations from E. coli, whereby inactivation of the proofreading 
subunit, DnaQ, enabled PolIII-mediated TLS in the absence of specialist DNA repair 
polymerases IV and V (Borden et al., 2002). Even though the present study demonstrated 
that both mycobacterial dnaQ homologs are dispensable for proofreading in mycobacteria, 
which may explain the absence of a phenotype following UV treatment, it is quite intriguing 
that this phenotype was still not observed for the DnaE1 PHP domain mutants with defects 
in proofreading function, even in a genetic background that is severely depleted of genes 
encoding specialist DNA polymerases (all dinB homologs and dnaE2). This implies that 
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molecular mechanisms used by mycobacteria to adapt to genotoxic stresses are different 
compared with model organisms.  
UvrC is part of the UvrABC endonuclease, multi-enzymatic complex which carries out DNA 
repair in a sequential manner. Genes encoding the UvrABC complex have been identified in 
Mtb (Dos Vultos et al., 2009, Mizrahi and Andersen, 1998). The uvrB deletion mutant of 
Msm (Kurthkoti et al., 2008) and Mtb (Darwin and Nathan, 2005, Guthlein et al., 2009) was 
shown to be hypersensitive to UV treatment and other DNA damaging agents (Kurthkoti et 
al., 2008). The uvrA and uvrB genes were also shown to be induced following treatment by 
MMC (Rand et al., 2003), as well as upon infecting human macrophages (Graham and Clark-
Curtiss, 1999). The absence of a UV-induced damage phenotype in the dnaQ-uvrC mutant is 
quite intriguing since previous studies have demonstrated a role for the canonical Mtb UvrC 
protein in DNA repair following UV damage (Prammananan et al., 2012). The dnaQ-uvrC 
gene is SOS-inducible and the encoded protein contains an additional GIY-YIG catalytic 
domain that is found in the N-terminus of UvrC-like nucleases – suggesting a potential role 
in NER. It is possible, therefore, that this GIY-YIG domain is not required for DNA repair 
following UV-induced damage, which may explain observations of the lack of phenotype for 
the ΔdnaQ-uvrC mutant. Further studies focused at individual contribution of different 
domains in DnaQ-UvrC to DNA damage following treatment with different DNA-damaging 
agents are required to further address these observations. In support of this notion, Davis 
and colleagues demonstrated differential requirements for different domains in UvrD2, 
which also functions in NER (Williams et al., 2011). In this study they demonstrated that the 
C-terminal domain in UvrD2 is required for the helicase activity, whereas the N-terminal 
domain was demonstrated to be required for the ATPase activity (Williams et al., 2011).   
 
5.2.5 DnaQ-UvrC is required for MMC tolerance  
Lack of a DNA damage sensitivity phenotype in the ΔdnaQ mutant following MMC 
treatment suggests that DnaQ is not required for tolerance of DNA damaging agents. In 
contrast the ΔdnaQ-uvrC mutant was profoundly hypersensitive to MMC treatment, even 
more than the ΔdnaE2 mutant (Boshoff et al., 2003). However, this phenotype was reversed 
in the ΔdnaQ ΔdnaQ-uvrC double knock-out mutant. The presence of a damage sensitivity 
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phenotype for the ΔdnaQ-uvrC mutant following MMC treatment, but absence of a 
phenotype following UV treatment, suggests that the regulation of mycobacterial damage 
response pathways might be lesion-specific (Boshoff et al., 2003). Kesavan and colleagues 
demonstrated that the dnaQ-uvrC homolog in Mtb (Rv2191) is critical for persistence in the 
granuloma during chronic infection, where bacillary DNA damage requiring repair may be 
more likely (Kesavan et al., 2009). These studies however, looked at the differential 
expression of this gene in vivo, which does not necessarily translate into functional 
importance. To the author’s knowledge, the present work and that of Ford’s (Ford, 2012) 
are the only studies, to date, which have attempted to determine the functional role of this 
protein. 
 
Future work should then investigate whether deletion of dnaE2 in the ΔdnaQ-uvrC 
background will further increase hypersensitivity to MMC, in order to assess whether these 
genes act in the same pathway or not. In addition, in order to assess whether the observed 
phenotype is due to the UvrC-like domain in DnaQ-UvrC, a strain with the entire UvrC-like 
domain truncated should be generated and assessed in similar assays. Deletion of ΔdnaQ in 
the ΔdnaQ-uvrC background resulted in the loss of the MMC-hypersensitive phenotype. 
Implication (s) of these observations also warrants further investigation.  
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APPENDIX A: GROWTH MEDIA 
All media was made up to a final volume of 1 litre with deionised water, and sterilised by 
autoclaving at 121°C for 20 minutes, unless otherwise stated. 
 
2TY broth 
16 g tryptone powder; 10 g yeast extract; 5 g sodium chloride. 
 
Luria-Bertani broth (LB) 
10 g tryptone powder; 5 g yeast extract; 10 g sodium chloride. 
 
Luria-Bertani agar (LA) 
10 g tryptone powder; 5 g yeast extract; 10 g sodium chloride; 15 g DIFCO™ agar powder. 
 
Middlebrook-OADC (7H9-OADC) 
4.7 g Middlebrook 7H9 broth base; 2 ml glycerol. 
100ml ADC supplement added after autoclaving. 
 
Middlebrook-OADC plates (7H10-OADC) 
19 g Middlebrook 7H10 agar powder; 5 ml glycerol.  
100 ml OADC supplement added after autoclaving. 
 
YPD broth 
1.0 g yeast extract, 2.0 g peptone and 2.0 g glucose 
 
YPDA 
YPD plus 0.15% agar both supplemented with 0.003% adenine. 
 
Synthetic Drop out medium (SD) 
6.7g yeast nitrogen base without amino acids, 0.2 g glucose, 20 g Bacto agar and 0.2 g 
dropout mix 
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APPENDIX B: PCR strategy for attB screening 
 
 
 
Schematic representation of the PCR strategy that was used to confirm successful 
integration at the bacterial attB locus. The attB primers amplify the bacterial attachment 
site and the attL primers amplify the phage attachment site. Site specific recombination of 
attB and attP creates the flanking attL and attBS sites.  
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APPENDIX C: LIST OF ABBREVIATIONS  
 
3-AT      3-Amino-1,2,4-triazole  
A     Adenine 
AD      Activation domain 
ADE2      Gene encoding phosphoribosylaminoimidazole  
carboxylase 
Ap      Ampicillin 
aph      Gene encoding aminoglycoside phosphotransferase 
attB      bacterial tRNAGly attachment site 
BD      Binding domain 
bp      base pair(s) 
CFU      Colony forming unit 
DCO      Double cross over 
DMSO      Dimethylsulphoxide 
DNA      Deoxyribonucleic acid 
dNTP      Deoxyribonucleotide triphosphate 
g     gravitational force  
H      Histidine 
h      hour 
HIS3      Gene encoding imidazoleglycerol- 
     phosphate-dehydratase 
HIV      Human immunodeficiency virus 
hyg      Gene conferring resistance to hygromycinB 
Hyg      Hygromycin B 
kbp      kilo base pair(s) 
Km      Kanamycin 
L     Leucine 
LA      Luria-Bertani agar 
lacZ      Gene encoding β-galactosidase 
LB      Luria-Bertani broth 
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Ml     millilitre 
MMR      Mismatch repair 
Mtb      Mycobacterium tuberculosis 
OADC      Oleic acid- albumin-dextrose catalase supplement for  
Middlebrook 7H9 and 7H10 
OB      Oligonucleotide/oligosaccharide binding 
OD600      Optical density at 600 nanometre wavelength 
PCR      Polymerase chain reaction 
PHP      Polymerase and histidinol phosphatase 
R      Resistant/resistance 
Rif      Rifampicin 
RNA      Ribonucleic acid 
rpm      Revolutions per minute 
sacB      Gene encoding levansucrase 
SCO      Single cross over 
SD      synthetic drop-out 
SDS      Sodium dodecylsulphate 
SSB      Single-stranded DNA-binding 
Suc      Sucrose 
T      Tryptophan 
TB      Tuberculosis 
Tris      Tris(hydroxymethyl)aminomethane 
Tween     Polyoxyethylene sorbitan monooleate 
U      Units 
v/v      Volume per volume 
WHO      World Health Organization 
X-gal      5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside- 
Y2H     Yeast-two-hybrid 
μg      microgram 
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SUPPLEMENTARY INFORMATION 
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Conservation:                                                                                     
Mavium_MaviaA2_DnaE2      1  -------MGWFNGPPSWAEMERVLDSKPRRAGESPAPEP------DGP-LSRGRATYRP-PDEGRAAR--   53 
Maviumparatub_MAP3476c    1  -------MGWFNGPPSWAEMERVLDSKPRRAGESAAPEP------DGP-LSRGRATYRP-PDEGRAAR--   53 
Mavium_104_MAV4335        1  -------MGWFNGPPSWAEMERVLDSKPRRAGESPAPEP------DGP-LSRGRATYRP-PDEGRAAR--   53 
CDC1551_MT3480            1  MFDILWNVGWSNGPPSWAEMERVLNGKPRHAGV---PAFDA--DGDVP-RSRKRGAYQP-PGRERVG---   60 
MTB_DnaE2_Rv3370c         1  M-------------------ERVLNGKPRHAGV---PAFDA--DGDVP-RSRKRGAYQP-PGRERVG---   41 
Mbovis_Mb3405c            1  M-------GWSNGPPSWAEMERVLNGKPRHAGV---PAFDA--DGDVP-RSRKRGAYQP-PGRERVG---   53 
BCG_Pasteur_BCG3442c      1  M-------------------ERVLNGKPRHAGV---PAFDA--DGDVP-RSRKRGAYQP-PGRERVG---   41 
Mcanettii_DnaE2           1  M-------------------ERVLDGKPRHAGV---PAFDA--DGDVP-RSRKRGAYQL-PGRERVG---   41 
MintA_DnaE2               1  -------MGWFNGPPSWAEMERVLDSKPRRAGEPAGLPE------DAP-LSRKRATYRP-PGDGRAPRPS   55 
Mkansasii_MkanA1_DnaE2    1  -------MGWGNGPPSWAEMERVLDGKPRHAGAPVAAEPADDAGLEGP-WSRQRGTYQP-PENARVR---   58 
Mmarinum_MMAR1158         1  -------MGWGNGPPSWAEMERVLDGKPRHAGVPDAAGPTAEAGWDGP-LSRKRETYAPKPDANRVD---   59 
Mulcerans_MUL0923         1  -------------------MERVLDGKPRHAGVPDAAGPTAEAGWDGP-LSRKRETYAPKPDANRVD---   47 
Myco_sp_Mmcs_1183         1  -------MGFSNG-PTWPEIERVLNGKPRRAGESLREPPGD--GGDSPAWSRKRGAYQA-PQLPRSG---   56 
Myco_sp_Mjls_1210         1  -------MGFSNG-PTWPEIERVLNGKPRRAGESLREPPGD--GGDSPAWSRKRGAYQA-PQLPRSG---   56 
Mvanbaalenii_Mvan1530     1  -------MGWHTGPPSWTEMERVLSGKPRRAGWPIDQQIGD--GGDSPAWSRKRGEYHA-PEGPGAQE--   58 
Mgilvum_Mflv4893          1  -------------------MRRVLEGKPRRAGWPIDAQVGD--GGDSPAWSSKRGQYRA-PESRGPAT--   46 
MSMEG_DnaE2_MSMEG_1633    1  -------------------MERVLTSKPRRSGLPLES-PGD--GGDSPAWSRKRGAYEP-PDQARMPA--   45 
Mabscessus_MAB3703c       1  ----------------------MLDGR-----LNPHAPPGD--GGDGPAWSRKRQPYEP-PPRERGR---   37 
Maviumparatub_MAP1257     1  ----------------------------------------------------------------MNHS--    4 
Mavium_104_MAV3224        1  ----------------------------------------------------------------MNHS--    4 
MintA_DnaE1               1  ----------------------------------------------------------------MNHS--    4 
Mabscessus_MAB2696c       1  ----------------------------------------------------------------MSSS--    4 
Myco_sp_Mmcs_3087         1  ----------------------------------------------------------------MSGSD-    5 
Myco_sp_Mjls_3107         1  ----------------------------------------------------------------MSGSD-    5 
Mgilvum_Mflv3636          1  ----------------------------------------------------------------MSG---    3 
Mvanbaalenii_Mvan2777     1  ----------------------------------------------------------------MSG---    3 
MSM_MSMEG3178             1  ----------------------------------------------------------------MSGTD-    5 
Mmarinum_MMAR2369         1  ----------------------------------------------------------------MSGS--    4 
Mulcerans_MUL1545         1  ----------------------------------------------------------------MSGS--    4 
ML_ML1207                 1  ----------------------------------------------------------------MNQS--    4 
Mkansasii_MkanA1_DnaE1    1  ----------------------------------------------------------------MSGS--    4 
MTB_DnaE1_Rv1547          1  ----------------------------------------------------------------MSGS--    4 
Mbovis_Mb1574             1  ----------------------------------------------------------------MSGS--    4 
BCG_Pasteur_BCG1600       1  ----------------------------------------------------------------MSGS--    4 
Mcanettii_DnaE1           1  ----------------------------------------------------------------MSGS--    4 
CDC1551_MT1598            1  ----------------------------------------------------------------MSGS--    4 
PHP 
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Conservation:                    
Mavium_MaviaA2_DnaE2     54  --SS-VPYAELHAHSAFSFLDGVSTPEEMVEEAARLDLRALALTDHDGLYGAVRFAEAAAELDVRTVFGA  120 
Maviumparatub_MAP3476c   54  --SS-VPYAELHAHSAFSFLDGASTPEEMVEEAARLDLRALALTDHDGLYGAVRFAEAAAELDVRTVFGA  120 
Mavium_104_MAV4335       54  --SS-VPYAELHAHSAFSFLDGASTPEEMVEEAARLDLRALALTDHDGLYGAVRFAEAAAELDVRTVFGA  120 
CDC1551_MT3480           61  --SS-VAYAELHAHSAYSFLDGASTPEELVEEAARLGLCALALTDHDGLYGAVRFAEAAAELDVRTVFGA  127 
MTB_DnaE2_Rv3370c        42  --SS-VAYAELHAHSAYSFLDGASTPEELVEEAARLGLCALALTDHDGLYGAVRFAEAAAELDVRTVFGA  108 
Mbovis_Mb3405c           54  --SS-VAYAELHAHSAYSFLDGASTPEELVEEAARLGLCALALTDHDGLYGAVRFAEAAAELDVRTVFGA  120 
BCG_Pasteur_BCG3442c     42  --SS-VAYAELHAHSAYSFLDGASTPEELVEEAARLGLCALALTDHDGLYGAVRFAEAAAELDVRTVFGA  108 
Mcanettii_DnaE2          42  --SS-VAYAELHAHSAYSFLDGASTPEELVTEAARLGLRALALTDHDGLYGAVRFAEAAAEVDVRTVFGA  108 
MintA_DnaE2              56  AARS-VPYAELHAHSAFSFLDGASTPEELVEEAARLGLRALALTDHDGLYGAVRFAEAAAELDMRTVFGA  124 
Mkansasii_MkanA1_DnaE2   59  --SS-AAYAELHAHTAYSFLDGASTPEELVEEAARLDLCALALTDHNGLYGAVRFAEAAAELDMRTVFGA  125 
Mmarinum_MMAR1158        60  --SS-IAYAELHAHSAYSFLDGASTPEELVEEAARLDLRALALTDHNGLYGAVRFAEAASGLGVRTVFGA  126 
Mulcerans_MUL0923        48  --SS-IAYAELHAHSAYSFLDGASTPEELVEEAARLDLRALALTDHNGLYGAVRFAEAASGLGVRTVFGA  114 
Myco_sp_Mmcs_1183        57  --GA-VPYAELHAHSAYSFLDGAGTPEELVEEAARLDLRAIALTDHDGLYGVVRFAEAARELDMRTVFGA  123 
Myco_sp_Mjls_1210        57  --GA-VPYAELHAHSAYSFLDGAGTPEELVEEAARLDLRAIALTDHDGLYGVVRFAEAARELDMRTVFGA  123 
Mvanbaalenii_Mvan1530    59  --SS-TPYAELHAHSAYSFLDGASTPEELVEEAARLNLRAIALTDHDGLYGVVRFAEAARELDVATVFGA  125 
Mgilvum_Mflv4893         47  -GRS-MPYAELHAHSAYSFLDGASTPEELVEEASRLGLRALALTDHDGLYGVVRFAEAAKELDVDTVFGA  114 
MSMEG_DnaE2_MSMEG_1633   46  --SA-LPYAELHAHSAYSFLDGASTPEELVEEAARLNLRAIALTDHDGLYGVVRFAEAARELDVATVFGA  112 
Mabscessus_MAB3703c      38  --SV-VPYAELHAHSAFSFLDGASLPEEMVQEAARLDLKALAITDHDGFYGVVRFAEAAKELGLPTVFGA  104 
Maviumparatub_MAP1257     5  ------SFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNAATKAGIKPIIGV   68 
Mavium_104_MAV3224        5  ------SFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNAATKAGIKPIIGV   68 
MintA_DnaE1               5  ------SFVHLHNHTEYSMLDGAAKIAPMLAEVDRLQMPAVGMTDHGNMFGASEFYNAATKAGIKPIIGV   68 
Mabscessus_MAB2696c       5  --NS--SFVHLHNHTEYSMLDGAAKIKPMLAEVERLGMSAVGMTDHGNMYGASEFYNVAAATGVKPIIGI   70 
Myco_sp_Mmcs_3087         6  GRSS-GSFVHLHNHTEYSMLDGAAKVKPMLAEAQRLEMPAIGMTDHGNMFGASEFYNAATDAGIKPIIGI   74 
Myco_sp_Mjls_3107         6  GRSS-GSFVHLHNHTEYSMLDGAAKVKPMLAEAQRLEMPAIGMTDHGNMFGASEFYNAATDAGIKPIIGI   74 
Mgilvum_Mflv3636          4  ------SFVHLHNHTEYSMLDGAAKVKPMLAEAQRLEMPAIGMTDHGNMFGASEFYNAATDAGIKPIIGI   67 
Mvanbaalenii_Mvan2777     4  ------SFVHLHNHTEYSMLDGAAKVKPMLAEAQRLEMPAIGMTDHGNMFGASEFYNAATDAGIKPIIGI   67 
MSM_MSMEG3178             6  GRSS-GSFVHLHNHTEYSMLDGAAKITPMLAEAQRLEMPAIGMTDHGNMFGASEFYNSATKAGIKPIIGI   74 
Mmarinum_MMAR2369         5  --SS-RSFVHLHNHTEYSMLDGAAKITPMLAEVERLDMPAIGMTDHGNMFGASEFYNSATKAGVKPIIGV   71 
Mulcerans_MUL1545         5  --SS-RSFVHLHNHTEYSMLDGAAKITPMLAEVERLDMPAIGMTDHGNMFGASEFYNSATKAGVKPIIGV   71 
ML_ML1207                 5  ------SFVHLHNHTEYSMLDGAAKITPMFAEVERLQMPAVGMTDHGNMFGASEFYNTAIKAGIKPIIGV   68 
Mkansasii_MkanA1_DnaE1    5  --SS-RSFVHLHNHTEYSMLDGAAKINPMLAEVERLQMPAIGMTDHGNMFGASEFYNSATQAGIKPIIGV   71 
MTB_DnaE1_Rv1547          5  --SAGSSFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNSATKAGIKPIIGV   72 
Mbovis_Mb1574             5  --SAGSSFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNSATKAGIKPIIGV   72 
BCG_Pasteur_BCG1600       5  --SAGSSFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNSATKAGIKPIIGV   72 
Mcanettii_DnaE1           5  --SAGSSFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNSATKAGIKPIIGV   72 
CDC1551_MT1598            5  --SAGSSFVHLHNHTEYSMLDGAAKITPMLAEVERLGMPAVGMTDHGNMFGASEFYNSATKAGIKPIIGV   72 
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Conservation:                 
Mavium_MaviaA2_DnaE2    121  ELSLGPS---ART----------------EAPDPPGPHLLVLARGAEGYRRLSRQLAVAHLAGG----EK  167 
Maviumparatub_MAP3476c  121  ELSLGPS---ART----------------EAPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  167 
Mavium_104_MAV4335      121  ELSLGPS---ART----------------EAPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  167 
CDC1551_MT3480          128  ELSLGAT---ART----------------ERPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  174 
MTB_DnaE2_Rv3370c       109  ELSLGAT---ART----------------ERPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  155 
Mbovis_Mb3405c          121  ELSLGAT---ART----------------ERPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  167 
BCG_Pasteur_BCG3442c    109  ELSLGAT---ART----------------ERPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  155 
Mcanettii_DnaE2         109  ELSLGASVSAART----------------ERPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  158 
MintA_DnaE2             125  ELSLGGE---ART----------------ERPDPAGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  171 
Mkansasii_MkanA1_DnaE2  126  ELSLGSE---ART----------------EQPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  172 
Mmarinum_MMAR1158       127  ELSLGPE---ART----------------EQPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  173 
Mulcerans_MUL0923       115  ELSLGPE---ART----------------EQPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  161 
Myco_sp_Mmcs_1183       124  ELSLGMG---ARSARN-------------EVPDPPGPHLLVLARGPEGYRRLSREIAKAHLAGG----EK  173 
Myco_sp_Mjls_1210       124  ELSLGMG---ARSARN-------------EVPDPPGPHLLVLARGPEGYRRLSREIAKAHLAGG----EK  173 
Mvanbaalenii_Mvan1530   126  ELSLGGG---TRT----------------DVPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  172 
Mgilvum_Mflv4893        115  ELSLGGG---TRT----------------DVPDPPGPHLLVLARGPEGYRRLSRQLAAAHLAGG----EK  161 
MSMEG_DnaE2_MSMEG_1633  113  ELSLSNV---ART----------------EDPDPPGPHLLVLARGPEGYRRLSREIAKAHLAGG----EK  159 
Mabscessus_MAB3703c     105  ELSLGGQ---GNT--------------------EDSVHLLVLARGQEGYRRLSRQMAGAHLSGGTPKDRK  151 
Maviumparatub_MAP1257    69  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMVAENAAGLRNLFKLSSLASFEGQ----LG  131 
Mavium_104_MAV3224       69  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMVAENAAGLRNLFKLSSLASFEGQ----LG  131 
MintA_DnaE1              69  EAYIAPA---SRFDTRRILWGDPGQKSDDVSGSGSYTHMTMVAETPTGLRNLFKLSSLASFEGQ----LG  131 
Mabscessus_MAB2696c      71  EAYIAPA---SRFDTKRVFWGDPGQKSDDVSGSGSYTHMTMVAENATGLRNLFKLSSLASFEGQ----LG  133 
Myco_sp_Mmcs_3087        75  EAYIAPA---SRFETKRVLWGDPSQKSDDVSGSGSYTHMTMVAENATGLRNLFKLSSLASFEGQ----LG  137 
Myco_sp_Mjls_3107        75  EAYIAPA---SRFETKRVLWGDPSQKSDDVSGSGSYTHMTMVAENATGLRNLFKLSSLASFEGQ----LG  137 
Mgilvum_Mflv3636         68  EAYIAPA---SRFDTKRVLWGDPGQKSDDVSGSGSYTHMTMVAENATGLRNLFKLSSLASFEGQ----LG  130 
Mvanbaalenii_Mvan2777    68  EAYIAPA---SRFETKRVLWGDPSQKSDDVSGGGSYTHMTMVAENATGLRNLFKLSSLASFEGQ----LG  130 
MSM_MSMEG3178            75  EAYIAPG---SRFDTKRVTWGDPGQKGDDVSGSGAYTHMTMVAENATGLRNLFKLSSLASFEGQ----LG  137 
Mmarinum_MMAR2369        72  EAYVAPG---SRFDTRRITWGDPSQKGDDVSGSGSYTHLTMVAENATGLRNLFKLSSLASFEGQ----LG  134 
Mulcerans_MUL1545        72  EAYVAPG---SRFDTRRITWGDPSQKGDDVSGSGSYTHLTMVAENATGLRNLFKLSSLASFEGQ----LG  134 
ML_ML1207                69  EAYIAPG---SRFDTRRITWGDPSQKADDVSAGGAYTHLTMVAENAAGLRNLFKLSSLASFEGQ----LS  131 
Mkansasii_MkanA1_DnaE1   72  EAYIAPA---SRFDTRRIFWGDPSQKADDISGSGSYTHLTMMAENATGLRNLFKLSSLASFEGQ----LS  134 
MTB_DnaE1_Rv1547         73  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQ----LS  135 
Mbovis_Mb1574            73  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQ----LS  135 
BCG_Pasteur_BCG1600      73  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQ----LS  135 
Mcanettii_DnaE1          73  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQ----LS  135 
CDC1551_MT1598           73  EAYIAPG---SRFDTRRILWGDPSQKADDVSGSGSYTHLTMMAENATGLRNLFKLSSHASFEGQ----LS  135 
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Conservation:                 
Mavium_MaviaA2_DnaE2    168  GKPRYDLDALTEAAGGHWHILTGCRKGHVRQALSDGGPDAAARALADLVDRFGAARVSIELTRHGQPLDD  237 
Maviumparatub_MAP3476c  168  GKPRYDLDALTEAAGGHWHILTGCRKGHVRQALSDGGPDAAARALADLVDRFGAARVSIELTRHGQPLDD  237 
Mavium_104_MAV4335      168  GKPRYDLDALTEAAGGHWHILTGCRKGHVRQALSEGGPDEAARALADLVDRFGAARVSIELTRHGQPLDD  237 
CDC1551_MT3480          175  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDD  244 
MTB_DnaE2_Rv3370c       156  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDD  225 
Mbovis_Mb3405c          168  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDD  237 
BCG_Pasteur_BCG3442c    156  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDD  225 
Mcanettii_DnaE2         159  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSQGGPAAAQRALADLVDRFTPSRVSIELTHHGHPLDD  228 
MintA_DnaE2             172  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSDGGPDAAERALADLVDRFGAQSVSVELTHHGQPLDD  241 
Mkansasii_MkanA1_DnaE2  173  GKPRYDFDALTEAAGGHWHILTGCRKGHVRQALSEGGPDAAQRALADLVDRFGAYRVSIELTHHGHPLDD  242 
Mmarinum_MMAR1158       174  GKPRYDFDSLTEAAGGHWHILTGCRKGHVRQALRQGGPDAAERALADLVDRFTAGRVSVELTHHGHPLDD  243 
Mulcerans_MUL0923       162  GKPRYDFDSLTEAAGGHWHILTGCRKGHVRQALRQGGPDAAERVLADLVDRFTAGRVSVELTHHGHPLDD  231 
Myco_sp_Mmcs_1183       174  GKPRYDYDTLTEAAGGHWHILTGCRKGHVRQALSEGGPAAAEKALADLVDRFGRDRVSVELTHHGHPLDD  243 
Myco_sp_Mjls_1210       174  GKPRYDYDALTEAAGGHWHILTGCRKGHVRQALSEGGPAAAEKALADLVDRFGRDRVSVELTHHGHPLDD  243 
Mvanbaalenii_Mvan1530   173  GVLRYDFDALTEAAGGHWQILTGCRKGHVRQALSTGGPEAAEAALADLVDRFGPDRVTVELTHHGHPLDD  242 
Mgilvum_Mflv4893        162  GVLRYDFDALTEAAGGHWQILTGCRKGHVRQALLRGGDSAAEAALADLVDRFGRERVTVELTHHGHPLDD  231 
MSMEG_DnaE2_MSMEG_1633  160  GRPRYDFDQLTEAAGGHWHILTGCRKGHVRQALSDGGPDAAAAALADLVDRFGADRVSIELTHHGHPCDD  229 
Mabscessus_MAB3703c     152  GKPRYDLDALTEAAGGHWHILTGCRKGHVRRALAGGGPVAAERALANLVDRFGADRVSIELNRHGHPGED  221 
Maviumparatub_MAP1257   132  KWSRMDAELIAEHADG-IIATTGCPSGEVQTRLRLGQDREALESAAKWREIFGADNFFLELMDHGLSIEQ  200 
Mavium_104_MAV3224      132  KWSRMDAELIAEHADG-IIATTGCPSGEVQTRLRLGQDREALESAAKWREIFGADNFFLELMDHGLSIEQ  200 
MintA_DnaE1             132  KWSRMDAEIIAEHAEG-IIATTGCPSGEVQTRLRLGHDREALESAAKWREIFGADNYFLELMDHGLSIEQ  200 
Mabscessus_MAB2696c     134  KWARMDADLIAEHASG-IIATTGCPSGEVQTRLRLGQESEALAAAAKWQDIFGKDNFFLELMDHGLSIER  202 
Myco_sp_Mmcs_3087       138  KWSRMDAEIIAEHAEG-IIATTGCPSGEVQTRLRLGHQREALEAAAKWREIFGPQNFFLELMDHGLDIER  206 
Myco_sp_Mjls_3107       138  KWSRMDAEIIAEHAEG-IIATTGCPSGEVQTRLRLGHQREALEAAAKWREIFGPQNFFLELMDHGLDIER  206 
Mgilvum_Mflv3636        131  KWSRMDAEIIAEHAEG-IIATTGCPSGEVQTRLRLGHDREALEAAARWREIFGPENFFLELMDHGLDIER  199 
Mvanbaalenii_Mvan2777   131  KWARMDAEIIAEHAEG-IIATTGCPSGEVQTRLRLGHDREALEAAARWREIFGPENFFLELMDHGLDIER  199 
MSM_MSMEG3178           138  KWSRMDAEIIAEHAEG-IIATTGCPSGEVQTRLRLGHEREALEAAAKWREIFGPENFFLELMDHGLDIER  206 
Mmarinum_MMAR2369       135  KWSRMDAELVAEHAEG-IIATTGCPSGEVQTRLRLGHDREALESAAKWREIFGADNYFLELMDHGLSIER  203 
Mulcerans_MUL1545       135  KWSRMDAELVAEHAEG-IIATTGCPSGEVQTRLRLGHDREALESAAKWREIFGADNYFLELMDHGLSIER  203 
ML_ML1207               132  KWSRMDAELIGEYAEG-IIVTTGCPSGEVQTRLRLGHDREALESAAKWREIVGPDNYFLELMDHGLSIEQ  200 
Mkansasii_MkanA1_DnaE1  135  KWSRMDAELIAEHAEG-IIITTGCPSGEVQTRLRLGQEREALEAAARWREIVGPENYFLELMDHGLTIER  203 
MTB_DnaE1_Rv1547        136  KWSRMDAELIAEHAEG-IIITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIER  204 
Mbovis_Mb1574           136  KWSRMDAELIAEHAEG-IIITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIER  204 
BCG_Pasteur_BCG1600     136  KWSRMDAELIAEHAEG-IIITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIER  204 
Mcanettii_DnaE1         136  KWSRMDAELIAEHAEG-IIITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIER  204 
CDC1551_MT1598          136  KWSRMDAELIAEHAEG-IIITTGCPSGEVQTRLRLGQDREALEAAAKWREIVGPDNYFLELMDHGLTIER  204 
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Conservation:                 
Mavium_MaviaA2_DnaE2    238  ERNAALAALAPRFGVGVVATTGAHFAGPSRRRLAMAVGAIRARESLDSAAGWLAPLGGSHLRSGEEMARL  307 
Maviumparatub_MAP3476c  238  ERNAALAALAPRFGVGVVATTGAHFAGPSRRRLAMAMGAIRARESLDSAAGWLAPLGGSHLRSGAEMARL  307 
Mavium_104_MAV4335      238  ERNAALAALAPRFGVGVVATTGAHFAGPSRRRLAMAVGAIRARESLDSAAGWLAPLGGSHLRSGEEMARL  307 
CDC1551_MT3480          245  ERNAALAGLAPRFGVGIVATTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARL  314 
MTB_DnaE2_Rv3370c       226  ERNAALAGLAPRFGVGIVATTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARL  295 
Mbovis_Mb3405c          238  ERNAALAGLAPRFGVGIVATTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARL  307 
BCG_Pasteur_BCG3442c    226  ERNAALAGLAPRFGVGIVATTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARL  295 
Mcanettii_DnaE2         229  ERNAALAGLAPRFGVGIVATTGAHFADPSRGRLAMAMAAIRARRSLDSAAGWLAPLGGAHLRSGEEMARL  298 
MintA_DnaE2             242  ERNAVLAALAPRFGVGVVATTGAHFAGPSRRRLAMAMGAIRARESLDSAAGWLAPLGGSHLRSGAEMARL  311 
Mkansasii_MkanA1_DnaE2  243  ERNATLAGLAPRFGVGVVATTGAHFAHPSRSRLAMAMGAIRARQSLDSAAGWLAPLGGSHLRSGDEMARM  312 
Mmarinum_MMAR1158       244  ENNAMLAGLAPRFGVGVVATTGAHFAHPARSRLAMAMGAIRARQSLDSAAGWLAPLGGSHLRSGAEMARL  313 
Mulcerans_MUL0923       232  ENNAMLAGLAPRFGVGVVATTGAHFAHPARSRLAMAMGAIRARQSLDSAAGWLAPLGGSHLRSGAEMARL  301 
Myco_sp_Mmcs_1183       244  ERNAALAELAPRFGLTVVATTAAHFAEPSRGRLAMAMGAIRARHSIDEAAGYLAPLGGSHLRSGEEMARL  313 
Myco_sp_Mjls_1210       244  ERNAALAELAPRFGLTVVATTAAHFAEPSRGRLAMAMGAIRARHSIDEAAGYLAPLGGSHLRSGEEMARL  313 
Mvanbaalenii_Mvan1530   243  ERNAALAALAPRFGLGVVATTAAHFAEPARGRLAMAMGAIRARNSIDEAAGYLAPLGGSHLRSGDEMARM  312 
Mgilvum_Mflv4893        232  ERNAALAALAPRFGLTVIATTAAHFAEPSRGRLAMAMGAIRARNSIDEAAGYLAPLGGSHLRSGEEMARV  301 
MSMEG_DnaE2_MSMEG_1633  230  ERNAALAELAPRFGLGVVATTAAHFATPSRGRLAMAMAAIRARNSIDTAAGWLAPLGGVHLRSGEEMARL  299 
Mabscessus_MAB3703c     222  ERNAELAALARGFGVGVIATTAAHFATPESGRLAMAMAAVRARKSLDDAAGWLDPVGGAHLRSGDEMARL  291 
Maviumparatub_MAP1257   201  RVRDGLLEIGRKLNIPPLATNDCHYITRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  270 
Mavium_104_MAV3224      201  RVRGGLLEIGRKLNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  270 
MintA_DnaE1             201  RVRDGLLEIGRKLGIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRRI  270 
Mabscessus_MAB2696c     203  RVREGLLEVGKKLGIPPLATNDCHYVTKDHAHNHEALLCVQTGKTLSDPTRFKFDGDGYYLKPASEMRDL  272 
Myco_sp_Mmcs_3087       207  RVREGLLEIGQKLGIPPLATNDCHYVTRDASQNHEALLCIQTGKTLSDPTRFKFDGDGYYLKSAAEMRAL  276 
Myco_sp_Mjls_3107       207  RVREGLLEIGQKLGIPPLATNDCHYVTRDASQNHEALLCIQTGKTLSDPTRFKFDGDGYYLKSAAEMRAL  276 
Mgilvum_Mflv3636        200  RVREGLLEIGQKLGIPPLATNDCHYVTRDASQNHEALLCIQTGKTLSDPNRFKFDGDGYYLKSAAEMRAL  269 
Mvanbaalenii_Mvan2777   200  RVREGLLDIGQKLGIPPLATNDCHYVTRDAAQNHEALLCIQTGKTLSDPNRFKFDGDGYFLKSAAEMRAL  269 
MSM_MSMEG3178           207  RVREGLLEIGRKLGIPPLATNDCHYVTREAARNHEALLCVQTGKTLSDPTRFKFDGDGYFLKSAEEMRAL  276 
Mmarinum_MMAR2369       204  RVREGLIEIGRKLDIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQL  273 
Mulcerans_MUL1545       204  RVREGLIEIGRKLDIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQL  273 
ML_ML1207               201  RVREGLLNIGRKLNIPPLATNDCHYVTRDAVHNHEALLCVQTGKTLSDPNRFKFHGDGYYLKSAAEMRQL  270 
Mkansasii_MkanA1_DnaE1  204  RVREGLLHIGRTLNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  273 
MTB_DnaE1_Rv1547        205  RVRDGLLEIGRALNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  274 
Mbovis_Mb1574           205  RVRDGLLEIGRALNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  274 
BCG_Pasteur_BCG1600     205  RVRDGLLEIGRALNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  274 
Mcanettii_DnaE1         205  RVRDGLLEIGRALNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  274 
CDC1551_MT1598          205  RVRDGLLEIGRALNIPPLATNDCHYVTRDAAHNHEALLCVQTGKTLSDPNRFKFDGDGYYLKSAAEMRQI  274 
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Conservation:                 
Mavium_MaviaA2_DnaE2    308  FA-WCPEAVTAAAELGEQCAFGLALI--APRLPPFDVPDGHTEDSWLRQLTMTGA-RDRYG---SPERAP  370 
Maviumparatub_MAP3476c  308  FA-WRPQAVTAAAELGEQCAFGLALI--APRLPPFDVPDGHTEDSWLRQLTMTGA-RDRYG---SPEHAP  370 
Mavium_104_MAV4335      308  FA-WCPEAVTAAAELGEQCAFGLALI--APRLPPFDVPDGHTEDSWLRQLTMTGA-RDRYG---SPEHAP  370 
CDC1551_MT3480          315  FA-WCPEAVTAAAELGERCAFGLQLI--APRLPPFDVPDGHTEDSWLRSLVMAGA-RERYG---PPKSAP  377 
MTB_DnaE2_Rv3370c       296  FA-WCPEAVTAAAELGERCAFGLQLI--APRLPPFDVPDGHTEDSWLRSLVMAGA-RERYG---PPKSAP  358 
Mbovis_Mb3405c          308  FA-WCPEAVTAAAELGERCAFGLQLI--APRLPPFDVPDGHTEDSWLRSLVMAGA-RERYG---PPKSAP  370 
BCG_Pasteur_BCG3442c    296  FA-WCPEAVTAAAELGERCAFGLQLI--APRLPPFDVPDGHTEDSWLRSLVMAGA-RERYG---PPKSAP  358 
Mcanettii_DnaE2         299  FA-WCPEAVTAAAELGERCAFGLQLI--APRLPPFDVPDGHTEDSWLRSLVLAGA-RERYG---PPESAP  361 
MintA_DnaE2             312  FA-GGPDVVTAAAELGEQCAFGLALI--APQLPPFDVPDGHTEDSWLRQLTMAGA-RDRYG---P--NAP  372 
Mkansasii_MkanA1_DnaE2  313  FA-WRPEAVTAAAELGGQCAFELALI--APQLPPFDVPGGHTEDSWLRQLVMAGA-RHRYG---PPDGAP  375 
Mmarinum_MMAR1158       314  FA-QRPDVVTAAAELGEQCAFGLALI--APRLPPFDVPDGHTEDSWLRSLVMSGA-RERYG---STERSP  376 
Mulcerans_MUL0923       302  FA-QRPDVVTAAAELGEQCAFGLALI--APRLPPFDVPDGHTEDSWLRSLVMSGA-RERYG---STERSP  364 
Myco_sp_Mmcs_1183       314  FA-HCPQVVTAAADLGEQCAFGLALI--APKLPPFDVPAGHTEDSWLRHLVMLGA-RNRYG---PPERAP  376 
Myco_sp_Mjls_1210       314  FA-HCPQVVTAAADLGEQCAFGLALI--APKLPPFDVPAGHTEDSWLRHLVMLGA-RNRYG---PPERAP  376 
Mvanbaalenii_Mvan1530   313  FA-HCPEVVTAAAELGEQCAFGLALI--APQLPPFDVPDGHTESSWLRHLVMQGA-RERYG---PPERAS  375 
Mgilvum_Mflv4893        302  FA-HCPEVVTAAADLGEQCAFGLALI--APQLPPFEVPAGHTENSWLRHLVMQGA-RERYG---PPERAS  364 
MSMEG_DnaE2_MSMEG_1633  300  FD---PEFVAAAADLGEQCAFGLALI--APQLPPFDVPDGHTEDSWLRHLAMAGA-ARRYG---PPERAP  360 
Mabscessus_MAB3703c     292  FS-HYPEVVTAAAELGEECAFDLRLI--APQLPPFDVPSGHTEDSWLRHLALEGA-ARRYG---PRAGAQ  354 
Maviumparatub_MAP1257   271  WDAEVPGACDSTLLIAERVQSYAEVWTPRDRMPVFPVPEGHDQASWLHHEVMAGL-RRRFP----DGVGQ  335 
Mavium_104_MAV3224      271  WDAEVPGACDSTLLIAERVQSYAEVWTPRDRMPVFPVPEGHDQASWLHHEVMAGL-RRRFP----DGVGQ  335 
MintA_DnaE1             271  WDDEVPGACDSTLLIAERVQPYDEVWAPRDRMPIFPVPEGHDQASWLHHEVMAGL-ARRFP----SGVGQ  335 
Mabscessus_MAB2696c     273  WDDAVPGACDNTLLIAERVQSYEDVWNFKDRMPIFPVPEGEDQDSWLRKEVDRGL-ERRFEG-VPGGVPD  340 
Myco_sp_Mmcs_3087       277  WDSQVPGACDSTLLIAERVQSYADVWAPRDRMPIFPVPEGHDQASWLHHEVMAGL-KRRFSAVSGGVVPN  345 
Myco_sp_Mjls_3107       277  WDSQVPGACDSTLLIAERVQSYADVWAPRDRMPIFPVPEGHDQASWLHHEVMAGL-KRRFSAVSGGVVPN  345 
Mgilvum_Mflv3636        270  WDGQVPGACDSTLLIAERVQPYTDVWAPKDRMPVFPVPEGHDQGSWLTHEVMAGL-ERRFSAAAGGQVPP  338 
Mvanbaalenii_Mvan2777   270  WDGQVPGACDSTLLIAERVQSYADVWTPKDRMPIFPVPEGHDQGSWLTHEVMTGLQERRFH---GAPVPQ  336 
MSM_MSMEG3178           277  WDSQVPGACDSTLLIGERVQSYADVWEPRDRMPVFPVPEGHDQASWLTHEVKAGL-ERRFR---GGPVPE  342 
Mmarinum_MMAR2369       274  WDDDIPGACDSTLLIAERVQSYADVWTPRDRMPIFPVPEGHDPASWLHHEVMAGL-RRRFP----SGLGQ  338 
Mulcerans_MUL1545       274  WDDDIPGACDSTLLIAERVQSYADVWTPRDRMPIFPVPEGHDPASWLHHEVMAGL-RRRFP----SGLGQ  338 
ML_ML1207               271  WDDEVPGACDSTLLIAERVQSYADVWEPRNRMPVFPVPVGHDQASWLRHEVDAGL-KRRFP----DGPPN  335 
Mkansasii_MkanA1_DnaE1  274  WDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDPASWLRHEVAAGL-RRRFP----DGPPA  338 
MTB_DnaE1_Rv1547        275  WDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDQASWLRHEVDAGL-RRRFP----AGPPD  339 
Mbovis_Mb1574           275  WDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDQASWLRHEVDAGL-RRRFP----AGPPD  339 
BCG_Pasteur_BCG1600     275  WDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDQASWLRHEVDAGL-RRRFP----AGPPD  339 
Mcanettii_DnaE1         275  WDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDQASWLRHEVDAGL-RRRFP----AGPPD  339 
CDC1551_MT1598          275  WDDEVPGACDSTLLIAERVQSYADVWTPRDRMPVFPVPDGHDQASWLRHEVDAGL-RRRFP----AGPPD  339 
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Conservation:                     
Mavium_MaviaA2_DnaE2    371  R---AYAQIEHELKVIAQLQFPGYFLVVHDIARFCRENNI-LCQGRGSAANSAVCYALGVTAVDPVANEL  436 
Maviumparatub_MAP3476c  371  R---AYAQIEHELKVIAQLQFPGYFLVVHDIARFCRENNI-LCQGRGSAANSAVCYALGVTAVDPVANEL  436 
Mavium_104_MAV4335      371  R---AYAQIEHELKVIAQLQFPGYFLVVHDIARFCRENNI-LCQGRGSAANSAVCYALGVTAVDPVANEL  436 
CDC1551_MT3480          378  R---AYSQIEHELKVIAQLRFPGYFLVVHDITRFCRDNDI-LCQGRGSAANSAVCYALGVTAVDPVANEL  443 
MTB_DnaE2_Rv3370c       359  R---AYSQIEHELKVIAQLRFPGYFLVVHDITRFCRDNDI-LCQGRGSAANSAVCYALGVTAVDPVANEL  424 
Mbovis_Mb3405c          371  R---AYSQIEHELKVIAQLRFPGYFLVVHDITRFCRDNDI-LCQGRGSAANSAVCYALGVTAVDPVANEL  436 
BCG_Pasteur_BCG3442c    359  R---AYSQIEHELKVIAQLRFPGYFLVVHDITRFCRDNDI-LCQGRGSAANSAVCYALGVTAVDPVANEL  424 
Mcanettii_DnaE2         362  R---AYSQIEHELKVIAQLRFPGYFLVVHDITRFCRDNDI-LCQGRGSAANSAVCYALGVTAVDPVANEL  427 
MintA_DnaE2             373  R---AYAQIEHELKVIAQLQFPGYFLVVHDIARFCRDNNI-LCQGRGSAANSAVCYALGVTAVDPVANEL  438 
Mkansasii_MkanA1_DnaE2  376  R---AYAQIGHELKVIAQLKFPGYFLVVHDITQFCRRNNI-LCQGRGSAANSAVCYALGITAVDPVANEL  441 
Mmarinum_MMAR1158       377  RARKAYTQIEHELKVIAQLSFPGYFLVVHDITQFCRRNDI-LCQGRGSAANSAVCYALGVTAVDPIANEL  445 
Mulcerans_MUL0923       365  RARKAYAQIEHELKVIAQLSFPGYFLVVHDITQFCRRNDI-LCQGRGSAANSAVCYALGVTAVDPIANEL  433 
Myco_sp_Mmcs_1183       377  Q---AYAQIEHELRVIEKLSFPGYFLVVHDITRFCKENGI-LAQGRGSAANSAVCYALGVTNVDPVANEL  442 
Myco_sp_Mjls_1210       377  Q---AYAQIEHELRVIEKLSFPGYFLVVHDITRFCKENGI-LAQGRGSAANSAVCYALGVTNVDPVANEL  442 
Mvanbaalenii_Mvan1530   376  R---AYAQIEHELAVIEQLNFPGYFLVVHDITRFCRDNNI-LSQGRGSAANSAVCYALKVTNVDPIANDL  441 
Mgilvum_Mflv4893        365  R---AYAQIEHELRVIEQLNFPGYFLVVHDITRFCRENAI-LSQGRGSAANSAVCYALKVTNVDPIANGL  430 
MSMEG_DnaE2_MSMEG_1633  361  K---AYAQIEHELRIIEQLRFPGYFLVVHDITQFCRDNNI-LCQGRGSAANSAVCYALGVTNVDPIANDL  426 
Mabscessus_MAB3703c     355  K---AYAQIERELEIIAQLNFPGYFLVVHDITQFCRRSDI-LCQGRGSAANSAVCYALGVTNVDPVDNGL  420 
Maviumparatub_MAP1257   336  D---YIDRAEYEIKVICDKGFPSYFLIVADLINYARSVDIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  402 
Mavium_104_MAV3224      336  D---YIDRAEYEIKVICDKGFPSYFLIVADLINYARSVDIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  402 
MintA_DnaE1             336  D---YIDRAEYEIKVICDKGFPSYFLIVADLINYARSVDIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  402 
Mabscessus_MAB2696c     341  E---YFTRAHYELDVIKQKGFPAYFLVVGDLVSHAKEVGIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  407 
Myco_sp_Mmcs_3087       346  D---YIERAEYEIKVICDKGFPSYFLIVADLINYAKSVDIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  412 
Myco_sp_Mjls_3107       346  D---YIERAEYEIKVICDKGFPSYFLIVADLINYAKSVDIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  412 
Mgilvum_Mflv3636        339  E---YIERADYEIKVICDKGFPAYFLIVADLINYAKSVGIRVGPGRGSAAGSLVAYAMGITNIDPIPHGL  405 
Mvanbaalenii_Mvan2777   337  E---YIDRAQYEIKVICDKGFPAYFLIVADLINYARSVGIRVGPGRGSAAGSLVAYAMGITNIDPIPHGL  403 
MSM_MSMEG3178           343  E---YTTRAEYEIKVICDKGFPSYFLIVADLINYARSVGIRVGPGRGSAAGSLVAYALGITNIDPIPHGL  409 
Mmarinum_MMAR2369       339  D---YIDRAEYEIKVICDKGFPSYFLIVADLINYARSVDIRVGPGRGSAAGSLVAYAMGITNIDPIPHGL  405 
Mulcerans_MUL1545       339  D---YIDRAEYEIKVICDKGFPSYFLIVADLINYARSVDIRVGPGRGSAAGSLVAYAMGITNIDPIPHGL  405 
ML_ML1207               336  G---YVERAAYEIDVICDKGFPAYFLIVADLVNHARSVGIRVGPGRGSAAGSLAAYALGITDIDPIPHGL  402 
Mkansasii_MkanA1_DnaE1  339  S---YVTRADYEIDVICAKGFPSYFLIVADLIGYAKSVGIRVGPGRGSAAGSLVAYALGITDIDPIPHGL  405 
MTB_DnaE1_Rv1547        340  G---YRERAAYEIDVICSKGFPSYFLIVADLISYARSAGIRVGPGRGSAAGSLVAYALGITDIDPIPHGL  406 
Mbovis_Mb1574           340  G---YRERAAYEIDVICSKGFPSYFLIVADLISYARSAGIRVGPGRGSAAGSLVAYALGITDIDPIPHGL  406 
BCG_Pasteur_BCG1600     340  G---YRERAAYEIDVICSKGFPSYFLIVADLISYARSAGIRVGPGRGSAAGSLVAYALGITDIDPIPHGL  406 
Mcanettii_DnaE1         340  G---YRERAAYEIDVICSKGFPSYFLIVADLISYARSAGIRVGPGRGSAAGSLVAYALGITDIDPIPHGL  406 
CDC1551_MT1598          340  G---YRERAAYEIDVICSKGFPSYFLIVADLISYARSAGIRVGPGRGSAAGSLVAYALGITDIDPIPHGL  406 
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Conservation:                 
Mavium_MaviaA2_DnaE2    437  LFERFLSPARDGPPDIDMDIESDQREKVIQYVYDRYGRDYAAQVANVITYRGKIAVRDMARALG--YSQG  504 
Maviumparatub_MAP3476c  437  LFERFLSPARDGPPDIDMDIESDQREKVIQYVYDRYGRDYAAQVANVITYRGKIAVRDMARALG--YSQG  504 
Mavium_104_MAV4335      437  LFERFLSPARDGPPDIDMDIESDQREKVIQYVYDRYGRDYAAQVANVITYRGKIAVRDMARALG--FSQG  504 
CDC1551_MT3480          444  LFERFLSPARDGPPDIDIDIESDQREKVIQYVYHKYGRDYAAQVANVITYRGRSAVRDMARALG--FSPG  511 
MTB_DnaE2_Rv3370c       425  LFERFLSPARDGPPDIDIDIESDQREKVIQYVYHKYGRDYAAQVANVITYRGRSAVRDMARALG--FSPG  492 
Mbovis_Mb3405c          437  LFERFLSPARDGPPDIDIDIESDQREKVIQYVYHKYGRDYAAQVANVITYRGRSAVRDMARALG--FSPG  504 
BCG_Pasteur_BCG3442c    425  LFERFLSPARDGPPDIDIDIESDQREKVIQYVYHKYGRDYAAQVANVITYRGRSAVRDMARALG--FSPG  492 
Mcanettii_DnaE2         428  LFERFLSPARDGPPDIDIDIESDQREKVIQYVYDKYGRDYAAQVANVITYRGRSAVRDMARALG--FSPG  495 
MintA_DnaE2             439  LFERFLSPARDGPPDIDMDIESDQREKVIQYVYDKYGRDYAAQVANVITYRGKIAVRDMARALG--FSQG  506 
Mkansasii_MkanA1_DnaE2  442  LFERFLSPARDGPPDIDIDIESDRREKVIQYVYDKYGRDYAAQVANVITYRGRSAVRDMARALG--FSQG  509 
Mmarinum_MMAR1158       446  LFERFLSPERDGPPDIDIDIESDQREKVIQYVYNKYGRDYAAQVANVITYRGRSAVRDMARALG--FSQG  513 
Mulcerans_MUL0923       434  LFERFLSPERDGPPDIDIDIESDQREKVIQYVYNKYGRDYAAQVANVITYRGRSAVRDMARALG--FSQG  501 
Myco_sp_Mmcs_1183       443  LFERFLSPARDGPPDIDIDIESDLREQAIQYVYDRYGRDYAAQVANVITYRGRSAIRDMARALG--FSQG  510 
Myco_sp_Mjls_1210       443  LFERFLSPARDGPPDIDIDIESDLREQAIQYVYDRYGRDYAAQVANVITYRGRSAIRDMARALG--FSQG  510 
Mvanbaalenii_Mvan1530   442  LFERFLSPARDGPPDIDIDIESDLRENAIQYVYQRYGREYAAQVANVITYRGRSAVRDMARALG--FSQG  509 
Mgilvum_Mflv4893        431  LFERFLSPARDGPPDIDIDIESDLREKAIQYVYERYGREYAAQVANVITYRGRSAVRDMARALG--FSQG  498 
MSMEG_DnaE2_MSMEG_1633  427  LFERFLSPARDGPPDIDIDIESDLRENVIQYVYERYGRDYAAQVANVITYRGRSAIRDMARALG--FSQG  494 
Mabscessus_MAB3703c     421  LFERFLSPARDGPPDIDIDIESDEREQAIQYVYNKYGREYAAQVANVITYRGRMAVRDMAKALG--FAQG  488 
Maviumparatub_MAP1257   403  LFERFLNPERPSAPDIDIDFDDRRRGEMVRYAADKWGSDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  472 
Mavium_104_MAV3224      403  LFERFLNPERPSAPDIDIDFDDRRRGEMVRYAADKWGSDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  472 
MintA_DnaE1             403  LFERFLNPERPSAPDIDIDFDDRRRGEMVRYAADKWGSDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  472 
Mabscessus_MAB2696c     408  LFERFLNPERPSAPDIDIDFDDRRRGEMVRYATEKWGSDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  477 
Myco_sp_Mmcs_3087       413  LFERFLNPERPSAPDIDIDFDDRRRGEMLRYAANKWGSDRVAQVITFGTIKTKAALKDSARVHYGQPGFA  482 
Myco_sp_Mjls_3107       413  LFERFLNPERPSAPDIDIDFDDRRRGEMLRYAANKWGSDRVAQVITFGTIKTKAALKDSARVHYGQPGFA  482 
Mgilvum_Mflv3636        406  LFERFLNPERPSAPDIDIDFDDRRRGEMLRYAANKWGSDRVAQVITFGTIKTKAALKDSARVHYGQPGFA  475 
Mvanbaalenii_Mvan2777   404  LFERFLNPERPSAPDIDIDFDDRRRGEMLRYAANKWGSDRVAQVITFGTIKTKAALKDSARVHYGQPGFA  473 
MSM_MSMEG3178           410  LFERFLNPERPSAPDIDIDFDDRRRGEMLRYAANRWGSERVAQVITFGTIKTKAALKDSARVNFGQPGFA  479 
Mmarinum_MMAR2369       406  LFERFLNPERPSAPDIDIDFDDRRRGEMVRYAADKWGQDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  475 
Mulcerans_MUL1545       406  LFERFLNPERPSAPDIDIDFDDRRRGEMVRYAADKWGQDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  475 
ML_ML1207               403  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  472 
Mkansasii_MkanA1_DnaE1  406  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  475 
MTB_DnaE1_Rv1547        407  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  476 
Mbovis_Mb1574           407  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  476 
BCG_Pasteur_BCG1600     407  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  476 
Mcanettii_DnaE1         407  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  476 
CDC1551_MT1598          407  LFERFLNPERTSMPDIDIDFDDRRRGEMVRYAADKWGHDRVAQVITFGTIKTKAALKDSARIHYGQPGFA  476 
Palm Thumb 
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Conservation:                 
Mavium_MaviaA2_DnaE2    505  QQDAWSKQISSWSGL----------------------ADSPDVEGIPPQVIDLANQVRNLPRHLGIHSGG  552 
Maviumparatub_MAP3476c  505  QQDAWSKQISSWSGP----------------------ADSPDVEGIPPQVIDLANQVRNLPRHLGIHSGG  552 
Mavium_104_MAV4335      505  QQDAWSKQISSWSGL----------------------ADSPDVEGIPPQVIDLANQVRNLPRHLGIHSGG  552 
CDC1551_MT3480          512  QQDAWSKQVSHWTGQ------------------------ADDVDGIPEQVIDLATQIRNLPRHLGIHSGG  557 
MTB_DnaE2_Rv3370c       493  QQDAWSKQVSHWTGQ------------------------ADDVDGIPEQVIDLATQIRNLPRHLGIHSGG  538 
Mbovis_Mb3405c          505  QQDAWSKQVSHWTGQ------------------------ADDVDGIPEQVIDLATQIRNLPRHLGIHSGG  550 
BCG_Pasteur_BCG3442c    493  QQDAWSKQVSHWTGQ------------------------ADDVDGIPEQVIDLATQIRSLPRHLGIHSGG  538 
Mcanettii_DnaE2         496  QQDAWSKQIGHWTGR------------------------ADDTDGIPEQVLDLATQIRNLPRHLGIHSGG  541 
MintA_DnaE2             507  QQDAWSKQISHWGGL----------------------ADSPEVEDIPEPVIDLANQIRNLPRHMGIHSGG  554 
Mkansasii_MkanA1_DnaE2  510  QQDAWSKQISHWNGQ------------------------AAEVDGIPEQVVDLATQIRNLPRHMGIHSGG  555 
Mmarinum_MMAR1158       514  QQDAWSKQIGHWNAT------------------------PDDVEGIPEQVIDLAAQIRNLPRHMGIHSGG  559 
Mulcerans_MUL0923       502  QQDAWSKQIGHWNAT------------------------LDDVEGIPEQVIDLAAQIRNLPRHMGIHSGG  547 
Myco_sp_Mmcs_1183       511  QQDAWSKQLSKWNGL----------------------ADSPDIEGIPEPVVDLALQISNLPRHMGIHSGG  558 
Myco_sp_Mjls_1210       511  QQDAWSKQLSKWNGL----------------------ADSPDIEGIPEPVVDLALQISNLPRHMGIHSGG  558 
Mvanbaalenii_Mvan1530   510  QQDAWSKQVSQWGNL----------------------ADATHVEDIPGPVVDLAKQISNLPRHMGIHSGG  557 
Mgilvum_Mflv4893        499  QQDAWSKQISQWGNL----------------------ADATHVEDIPEPVIDLAMQISHLPRHMGIHSGG  546 
MSMEG_DnaE2_MSMEG_1633  495  QQDAWSKHLSRWDGR----------------------PDSPDVAEIPEQVIELANQIANLPRHMGIHSGG  542 
Mabscessus_MAB3703c     489  QQDAWSKQMGHWGGL----------------------ADAAAVDGIPPQVIQLARQIKDFPRHMGIHSGG  536 
Maviumparatub_MAP1257   473  IADRITKALPPPIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  542 
Mavium_104_MAV3224      473  IADRITKALPPPIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  542 
MintA_DnaE1             473  IADRITKALPPPIMAKDIPLSGITDPAHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  542 
Mabscessus_MAB2696c     478  IADRITKALPPPIMAKDIPVWGITNPEHERYKEAAEVRTLIDTDPDVRNIYQTALGLEGLIRNAGVHACA  547 
Myco_sp_Mmcs_3087       483  IADRITKALPPPIMAKDIPVSGITDPTHERYKEAAEVRALIDTDPDVRTIYETARGLEGLVRNAGVHACA  552 
Myco_sp_Mjls_3107       483  IADRITKALPPPIMAKDIPVSGITDPTHERYKEAAEVRALIDTDPDVRTIYETARGLEGLVRNAGVHACA  552 
Mgilvum_Mflv3636        476  IADRITKALPPPIMAKDIPVSGITDPTHERYKEAAEVRALIDTDPDVRTIYETARGLEGLVRNAGVHACA  545 
Mvanbaalenii_Mvan2777   474  IADRITKALPPPIMAKDIPVSGITDPTHERYKEAAEVRALIDTDPDVRTIYETARGLEGLVRNAGVHACA  543 
MSM_MSMEG3178           480  IADRITKALPPPIMAKDIPLSGITDPNHERYKEAAEVRGLIDTDPDVRTIYETARGLEGLVRNAGVHACA  549 
Mmarinum_MMAR2369       476  IADRITKALPPPIMAKDIPLSGITDPAHERFKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  545 
Mulcerans_MUL1545       476  IADRITKALPPPIMAKDIPLSGITDPAHERFKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  545 
ML_ML1207               473  MADRITKALPPAIMAKDIPLSGITDPAHERFKEAAEVRSLIETDSDVRIIYQTARGLEGLIRNAGVHACA  542 
Mkansasii_MkanA1_DnaE1  476  IADRITKALPPAIMAKDIPLSGITDPAHERYKEAAEVRGLIETDPDVRTIYQTALGLEGLIRNAGVHACA  545 
MTB_DnaE1_Rv1547        477  IADRITKALPPAIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  546 
Mbovis_Mb1574           477  IADRITKALPPAIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  546 
BCG_Pasteur_BCG1600     477  IADRITKALPPAIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  546 
Mcanettii_DnaE1         477  IADRITKALPPAIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  546 
CDC1551_MT1598          477  IADRITKALPPAIMAKDIPLSGITDPSHERYKEAAEVRGLIETDPDVRTIYQTARGLEGLIRNAGVHACA  546 
Thumb  
118 
 
 
 
Conservation:                   
Mavium_MaviaA2_DnaE2    553  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAIDLVAEHKGIEVDLSR  622 
Maviumparatub_MAP3476c  553  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAIDLVAEHKGIEVDLAR  622 
Mavium_104_MAV4335      553  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAIDLVAEHKGIEVDLAR  622 
CDC1551_MT3480          558  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAKDLVAEHKGIEVDLAR  627 
MTB_DnaE2_Rv3370c       539  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAKDLVAEHKGIEVDLAR  608 
Mbovis_Mb3405c          551  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAKDLVAEHKGIEVDLAR  620 
BCG_Pasteur_BCG3442c    539  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAKDLVAEHKGIEVDLAR  608 
Mcanettii_DnaE2         542  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAKDLVAEHKGIEVDLAR  611 
MintA_DnaE2             555  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAIDLVAEHKGIEVDLAR  624 
Mkansasii_MkanA1_DnaE2  556  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAMDLVAEHKGLEVDLAK  625 
Mmarinum_MMAR1158       560  MVICDRPIADVCPVEWARMADRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYARDLVAEHKGIEVDLAR  629 
Mulcerans_MUL0923       548  MVICDRPIADVCPVEWARMADRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYARDLVAEHKGIEVDLAR  617 
Myco_sp_Mmcs_1183       559  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDMLGLGMLSALHYCIDLVREHKGLDVDLAK  628 
Myco_sp_Mjls_1210       559  MVICDRPIADVCPVEWARMANRSVLQWDKDDCAAIGLVKFDMLGLGMLSALHYCIDLVREHKGLDVDLAK  628 
Mvanbaalenii_Mvan1530   558  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAIDLVAEHKGIEVDLAK  627 
Mgilvum_Mflv4893        547  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDLLGLGMLSALHYAIDLVAEHKGLEVDLAK  616 
MSMEG_DnaE2_MSMEG_1633  543  MVICDRPIADVCPVEWARMENRSVLQWDKDDCAAIGLVKFDMLGLGMLSALHYAIDLVAEHKGIEVDLAT  612 
Mabscessus_MAB3703c     537  MVICDRPLADVVPVEWARMENRSVLQWDKDDCAAVGLVKFDLLGLGMLSALHYCIDLVREHKGIDVDLAH  606 
Maviumparatub_MAP1257   543  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDALDNIKANRGIDLDLES  612 
Mavium_104_MAV3224      543  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDALDNIKANRGIDLDLES  612 
MintA_DnaE1             543  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDALDNIKANRGIDLDLES  612 
Mabscessus_MAB2696c     548  VIMSSEPLTDAIPLWKRAQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTVIGDALDNIKANRGIDLDLDH  617 
Myco_sp_Mmcs_3087       553  VIMSSEPLIDAIPLWRRPQDGAVITGWDYPSCEAIGLLKMDFLGLRNLTIIGDCIENIKANRGVDLDLES  622 
Myco_sp_Mjls_3107       553  VIMSSEPLIDAIPLWRRPQDGAVITGWDYPSCEAIGLLKMDFLGLRNLTIIGDCIENIKANRGVDLDLES  622 
Mgilvum_Mflv3636        546  VIMSSEPLIDAIPLWKRPQDGAVITGWDYPSCEAIGLLKMDFLGLRNLTIIGDCIENIKANRGVDVDLES  615 
Mvanbaalenii_Mvan2777   544  VIMSSEPLIDAIPLWKRPQDGAVITGWDYPSCEAIGLLKMDFLGLRNLTIIGDCIENIKANRGIDVDLES  613 
MSM_MSMEG3178           550  VIMSSEPLIDAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDAIANIKANRGIDLDLET  619 
Mmarinum_MMAR2369       546  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDAIENIKANRGIDLDLES  615 
Mulcerans_MUL1545       546  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDAIENIEANRGIDLDLES  615 
ML_ML1207               543  VILSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIENIKTNRGIDLDLES  612 
Mkansasii_MkanA1_DnaE1  546  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPSCEAIGLLKMDFLGLRNLTIIGDAIDNIKANKGIDLDLES  615 
MTB_DnaE1_Rv1547        547  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIDNVRANRGIDLDLES  616 
Mbovis_Mb1574           547  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIDNVRANRGIDLDLES  616 
BCG_Pasteur_BCG1600     547  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIDNVRANRGIDLDLES  616 
Mcanettii_DnaE1         547  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIDNVRANRGIDLDLES  616 
CDC1551_MT1598          547  VIMSSEPLTEAIPLWKRPQDGAIITGWDYPACEAIGLLKMDFLGLRNLTIIGDAIDNVRANRGIDLDLES  616 
Fingers Palm 
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Conservation:                 
Mavium_MaviaA2_DnaE2    623  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  692 
Maviumparatub_MAP3476c  623  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  692 
Mavium_104_MAV4335      623  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  692 
CDC1551_MT3480          628  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  697 
MTB_DnaE2_Rv3370c       609  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  678 
Mbovis_Mb3405c          621  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  690 
BCG_Pasteur_BCG3442c    609  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  678 
Mcanettii_DnaE2         612  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLRPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGV  681 
MintA_DnaE2             625  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGE  694 
Mkansasii_MkanA1_DnaE2  626  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLRPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGI  695 
Mmarinum_MMAR1158       630  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRNGI  699 
Mulcerans_MUL0923       618  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIRRRSGI  687 
Myco_sp_Mmcs_1183       629  LDLSEPAVYEMLQRADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIKRRNGE  698 
Myco_sp_Mjls_1210       629  LDLSEPAVYEMLQRADSVGVFQVESRAQMATLPRLKPRVFYDLVVEVALIRPGPIQGGSVHPYIKRRNGE  698 
Mvanbaalenii_Mvan1530   628  LDLSEPAVYEMLARADSVGVFQVESRAQMATLPRLKPRMFYDLVVEVALIRPGPIQGGSVHPYIKRRNGQ  697 
Mgilvum_Mflv4893        617  LDLSEPAVYEMLQRADSVGVFQVESRAQMATLPRLKPRMFYDLVVEVALIRPGPIQGGSVHPYIKRRNGQ  686 
MSMEG_DnaE2_MSMEG_1633  613  LDLSEPAVYEMLQRADSVGVFQVESRAQMATLPRLKPREFYDLVVEVALIRPGPIQGGSVHPYIKRRNGQ  682 
Mabscessus_MAB3703c     607  INLKEQAVYEMLARADSVGVFQVESRAQMATLPRLKPKCFYDLVVEVALIRPGPIQGGSVHPYIRRYNKI  676 
Maviumparatub_MAP1257   613  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  682 
Mavium_104_MAV3224      613  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  682 
MintA_DnaE1             613  VPLDDGPTYELLGRGDTLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  682 
Mabscessus_MAB2696c     618  LPLDDPATYELLSRGDTLGVFQLDGGPMRDLLRRMQPTGFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  687 
Myco_sp_Mmcs_3087       623  LALDDPKAYELLGRGDTLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  692 
Myco_sp_Mjls_3107       623  LALDDPKAYELLGRGDTLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  692 
Mgilvum_Mflv3636        616  LALDDPKAYELLGRGDTLGVFQLDGSAMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  685 
Mvanbaalenii_Mvan2777   614  LTLDDPKAYELLGRGDTLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  683 
MSM_MSMEG3178           620  LPLDDPAAYELLSRGDTLGVFQLDGGPMRDLLRRMQPTGFNDIVAVLALYRPGPMGMNAHNDYADRKNGR  689 
Mmarinum_MMAR2369       616  LPLDDKPTYELLGRGETLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNNR  685 
Mulcerans_MUL1545       616  LPLDDKPTYELLGRGETLGVFQLDGGPMRDLLRRMQPTEFNDIVAVLALYRPGPMGMNAHNDYADRKNNR  685 
ML_ML1207               613  VPLDDQATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDIVAVLALYRPGPMGMNAHNDYADRKNNR  682 
Mkansasii_MkanA1_DnaE1  616  VPLDDKPTYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDIVAVLALYRPGPMGQNAHNDYADRKNGR  685 
MTB_DnaE1_Rv1547        617  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDVVAVIALYRPGPMGMNAHNDYADRKNNR  686 
Mbovis_Mb1574           617  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDVVAVIALYRPGPMGMNAHNDYADRKNNR  686 
BCG_Pasteur_BCG1600     617  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDVVAVIALYRPGPMGMNAHNDYADRKNNR  686 
Mcanettii_DnaE1         617  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDVVAVIALYRPGPMGMNAHNDYADRKNNR  686 
CDC1551_MT1598          617  VPLDDKATYELLGRGDTLGVFQLDGGPMRDLLRRMQPTGFEDVVAVIALYRPGPMGMNAHNDYADRKNNR  686 
Fingers 
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Conservation:                    
Mavium_MaviaA2_DnaE2    693  DP-VLYDH----PSMEPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  757 
Maviumparatub_MAP3476c  693  DP-VLYDH----PSMEPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRSRF  757 
Mavium_104_MAV4335      693  DP-VLYDH----PSMEPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  757 
CDC1551_MT3480          698  DP-VIYEH----PSMAPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  762 
MTB_DnaE2_Rv3370c       679  DP-VIYEH----PSMAPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  743 
Mbovis_Mb3405c          691  DP-VIYEH----PSMAPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  755 
BCG_Pasteur_BCG3442c    679  DP-VIYEH----PSMAPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  743 
Mcanettii_DnaE2         682  DP-VIYEH----PSMAPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  746 
MintA_DnaE2             695  DP-VVYDH----PSMEPALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTERMRRLRGRF  759 
Mkansasii_MkanA1_DnaE2  696  DP-VVYEH----PSMAPALRKTLGVPLFQEQLMQLAVDCAGFTAAEADQLRRAMGSKRSTERMQRLRGRF  760 
Mmarinum_MMAR1158       700  DP-VVYEH----PSMESALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAIGSKRSTERMRRLRGRF  764 
Mulcerans_MUL0923       688  DP-VVYEH----PSMESALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAIGSKRSTERMRRLRGRF  752 
Myco_sp_Mmcs_1183       699  EP-VTYDH----PSMANALRKTLGVPLFQEQLMQLAVDCAGFTAAEADQLRRAMGSKRSTEKMRRLRGRF  763 
Myco_sp_Mjls_1210       699  EP-VTYDH----PSMANALRKTLGVPLFQEQLMQLAVDCAGFTAAEADQLRRAMGSKRSTEKMRRLRGRF  763 
Mvanbaalenii_Mvan1530   698  EA-VTYDH----PSMESALRKTLGVPLFQEQLMQLAVDCAGFTPAEADQLRRAMGSKRSTEKMRRLRGRF  762 
Mgilvum_Mflv4893        687  EP-VTYEH----PSMERALRKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTEKMRRLRGRF  751 
MSMEG_DnaE2_MSMEG_1633  683  EP-VTYDH----PSMEPALKKTLGVPLFQEQLMQLAVDCAGFSAAEADQLRRAMGSKRSTAKMRRLRSRF  747 
Mabscessus_MAB3703c     677  DKDWQHDH----PSMAAALDKTLGVPLFQEQLMQLAVDVAGFSPAESDQLRRAMGSKRSPERMERLRNRF  742 
Maviumparatub_MAP1257   683  QP-IKPIHPELEEPLREILAETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYKGF  750 
Mavium_104_MAV3224      683  QP-IKPIHPELEEPLREILAETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYKGF  750 
MintA_DnaE1             683  QP-IKPIHPELEEPLREILSETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYKGF  750 
Mabscessus_MAB2696c     688  QP-IKPIHPELEEPLKDILAETFGLIVYQEQIMFIAQKVASYSMGKADALRKAMGKKK-LEVLEAEYKGF  755 
Myco_sp_Mmcs_3087       693  QP-IKPIHPELEEPLKEILAETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYQGF  760 
Myco_sp_Mjls_3107       693  QP-IKPIHPELEEPLKEILAETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYQGF  760 
Mgilvum_Mflv3636        686  QP-IKPIHPELEEPLKDILAETYGLIVYQEQIMFIAQKVASYSMGKADALRKAMGKKK-LEVLEAEYKGF  753 
Mvanbaalenii_Mvan2777   684  QA-IKPIHPELEEPLKDILSETYGLIVYQEQIMFIAQKVASYSMGKADALRKAMGKKK-LEVLEAEYQGF  751 
MSM_MSMEG3178           690  QP-IKPIHPELEEPLKDILAETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYKGF  757 
Mmarinum_MMAR2369       686  QA-VKPIHPELEEPLREILSETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYKGF  753 
Mulcerans_MUL1545       686  QA-VKPIHPELEEPLREILSETYGLIVYQEQIMFIAQKVASYTMGKADALRKAMGKKK-LEVLEAEYKGF  753 
ML_ML1207               683  QV-IKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVAGYSLARADILRKAMGKKK-REVLEKEFEGF  750 
Mkansasii_MkanA1_DnaE1  686  QA-IKPIHPELAEPLEEILAETYGLIVYQEQIMRIAQKVAGYSLARADILRKAMGKKK-REVLDKEYEGF  753 
MTB_DnaE1_Rv1547        687  QA-IKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVASYSLARADILRKAMGKKK-REVLEKEFEGF  754 
Mbovis_Mb1574           687  QA-IKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVASYSLARADILRKAMGKKK-REVLEKEFEGF  754 
BCG_Pasteur_BCG1600     687  QA-IKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVASYSLARADILRKAMGKKK-REVLEKEFEGF  754 
Mcanettii_DnaE1         687  QA-IKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVASYSLARADILRKAMGKKK-REVLEKEFEGF  754 
CDC1551_MT1598          687  QA-IKPIHPELEEPLREILAETYGLIVYQEQIMRIAQKVASYSLARADILRKAMGKKK-REVLEKEFEGF  754 
Fingers 
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Conservation:                  
Mavium_MaviaA2_DnaE2    758  YDGMRALHGAPDEVIDRTYEKLEAFANFGFPESHALSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  827 
Maviumparatub_MAP3476c  758  YDGMRALHGAPDEVIDRTYEKLEAFANFGFPESHALSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  827 
Mavium_104_MAV4335      758  YDGMRALHGAPDEVIDRTYEKLEAFANFGFPESHALSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  827 
CDC1551_MT3480          763  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYS  832 
MTB_DnaE2_Rv3370c       744  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYS  813 
Mbovis_Mb3405c          756  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYS  825 
BCG_Pasteur_BCG3442c    744  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYS  813 
Mcanettii_DnaE2         747  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYS  816 
MintA_DnaE2             760  YEGMRALHGAPDEVIDRTYEKLEAFANFGFPESHALSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  829 
Mkansasii_MkanA1_DnaE2  761  YDGMRALHGTRDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSAWFKLHHPAAFCAALLRAQPMGFYS  830 
Mmarinum_MMAR1158       765  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  834 
Mulcerans_MUL0923       753  YDGMRALHGAPDEVIDRIYEKLEAFANFGFPESHALSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  822 
Myco_sp_Mmcs_1183       764  YDGMRQRHGITGEVADRIYDKLEAFANFGFPESHSLSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  833 
Myco_sp_Mjls_1210       764  YDGMRQRHGITGEVADRIYDKLEAFANFGFPESHSLSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  833 
Mvanbaalenii_Mvan1530   763  FDGMAELHGVTGDVAQRIYEKLEAFANFGFPESHSLSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  832 
Mgilvum_Mflv4893        752  FEGMAELHGISGDVARRIYEKLEAFANFGFPESHSLSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  821 
MSMEG_DnaE2_MSMEG_1633  748  YDGMRERHGITGVVADRIYEKLEAFANFGFPESHSLSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  817 
Mabscessus_MAB3703c     743  YEGMRNLHGITGELADRIYEKLYAFANFGFPESHAQSFASLVFYSSWFKLHHPAAFCAALLRAQPMGFYS  812 
Maviumparatub_MAP1257   751  YEGMT-ANGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  819 
Mavium_104_MAV3224      751  YEGMT-ANGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  819 
MintA_DnaE1             751  YEGMT-ANGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  819 
Mabscessus_MAB2696c     756  YEGMT-NNGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSFWTAYLKANYPAEYMAGLLTSVGDDKDK  824 
Myco_sp_Mmcs_3087       761  REGMT-ANGFSEAAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  829 
Myco_sp_Mjls_3107       761  REGMT-ANGFSEAAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  829 
Mgilvum_Mflv3636        754  KEGMT-ANGFSEGAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYQAEYMAGLLTSVGDDKDK  822 
Mvanbaalenii_Mvan2777   752  KEGMT-ANGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  820 
MSM_MSMEG3178           758  KEGMT-ANGFSEGAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  826 
Mmarinum_MMAR2369       754  YEGMT-ANGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  822 
Mulcerans_MUL1545       754  YEGMT-ANGFSEKAVKALWDTILPFAGYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  822 
ML_ML1207               751  SEGMQ-ANGFSVHAIKALWDIILPFADYAFNKSHAAGYGLISYWTAYLKANFAGEYMAGLLTSVGDDKDK  819 
Mkansasii_MkanA1_DnaE1  754  AQGMQ-ANGFSSGAIKALWDTILPFADYAFNKSHAAGYGLVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  822 
MTB_DnaE1_Rv1547        755  SDGMQ-ANGFSPAAIKALWDTILPFADYAFNKSHAAGYGMVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  823 
Mbovis_Mb1574           755  SDGMQ-ANGFSPAAIKALWDTILPFADYAFNKSHAAGYGMVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  823 
BCG_Pasteur_BCG1600     755  SDGMQ-ANGFSPAAIKALWDTILPFADYAFNKSHAAGYGMVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  823 
Mcanettii_DnaE1         755  SDGMQ-ANGFSPAAIKALWDTILPFADYAFNKSHAAGYGMVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  823 
CDC1551_MT1598          755  SDGMQ-ANGFSPAAIKALWDTILPFADYAFNKSHAAGYGMVSYWTAYLKANYPAEYMAGLLTSVGDDKDK  823 
Fingers β-binding 
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Conservation:                 
Mavium_MaviaA2_DnaE2    828  PQSLVADARRHGVTVHGPDVNASLAHATLENAGTEVRLGLGAVRHIGDDLAEKLVQERKANGPFASLLDL  897 
Maviumparatub_MAP3476c  828  PQSLVADARRHGVTVHGPDVNASLAHATLENAGTEVRLGLGAVRHIGDDLAEKLVQERKANGPFTSLLDL  897 
Mavium_104_MAV4335      828  PQSLVADARRHGVTVHGPDVNASLAHATLENAGTEVRLGLGAVRHIGDDLAEKLVQERKANGPFASLLDL  897 
CDC1551_MT3480          833  PQSLVADARRHGVAVHGPCVNASLAHATCENAGTEVRLGLGAVRYLGAELAEKLVAERTANGPFTSLPDL  902 
MTB_DnaE2_Rv3370c       814  PQSLVADARRHGVAVHGPCVNASLAHATCENAGTEVRLGLGAVRYLGAELAEKLVAERTANGPFTSLPDL  883 
Mbovis_Mb3405c          826  PQSLVADARRHGVAVHGPCVNASLAHATCENAGTEVRLGLGAVRYLGAELAEKLVAERTANGPFTSLPDL  895 
BCG_Pasteur_BCG3442c    814  PQSLVADARRHGVAVHGPCVNASLAHATCENAGTEVRLGLGAVRYLGAELAEKLVAERTANGPFTSLPDL  883 
Mcanettii_DnaE2         817  PQSLVADARRHGVVVHGPCVNASLAHATCENAGTEVRLGLGAVRYLGAKLAEKLVAERTANGPFTSLPDL  886 
MintA_DnaE2             830  PQSLVADARRHGVTVHGPDVNASLAHATLENTGTEVRLGLGAVRHIGDDLAEQLVEERKANGPFASLLDV  899 
Mkansasii_MkanA1_DnaE2  831  PQSLVADARRHGVVVHGPDVNASLAHATLENAGMEVRLGLGAVRHIGDDLAEKLVGERNANGPFASLLDL  900 
Mmarinum_MMAR1158       835  PQSLVADARRHGVLVHGPDVNASLAHATLENAGMQVRLGLGAVRHIGDDLAESLVAERNDNGPFASLLNL  904 
Mulcerans_MUL0923       823  PQSLVADARRHGVLVHGPDVNASLAHATLENAGMQVRLGLGAVRHIGDDLAESLVAERNDNGPFASLLNL  892 
Myco_sp_Mmcs_1183       834  PQSLVADARRHGVTVHGPDVNASLAYATLESAGTEVRLGLGAVRHIGDDLAERIVEERKANGPFESLLDL  903 
Myco_sp_Mjls_1210       834  PQSLVADARRHGVTVHGPDVNASLAYATLESAGTEVRLGLGAVRHIGDDLAERIVEERKANGPFESLLDL  903 
Mvanbaalenii_Mvan1530   833  PQSLVADARRHGVVVHGPDVNAGLAHATLENHGLDVRLGLGGVRHIGDELAERLVGERKAHGPFTSLTDL  902 
Mgilvum_Mflv4893        822  PQTLVADARRHGVDVHGPDVNASLAHATLENHGLDVRLGLGSIRHIGDELAQRLVEDRKLNGPFVSLTDL  891 
MSMEG_DnaE2_MSMEG_1633  818  PQSLVADARRHGVTVHGPDVNASLAHAGLENRGLDVRLGLGSVRHIGDDLAQRIVDEREANGQFTSLLDL  887 
Mabscessus_MAB3703c     813  PQSLVADARRHGVTVHGPDVNASLSYATLENAGLEVRIGLGAVRHIGDDLAQAIVEERKVRGPFVSLLDL  882 
Maviumparatub_MAP1257   820  AAVYLADCRKLGITVLPPDVNESLVNFASVG--QDIRFGLGAVRNVGANVVGSLIKTRNEKGKFTDFSDY  887 
Mavium_104_MAV3224      820  AAVYLADCRKLGITVLPPDVNESLVNFASVG--QDIRFGLGAVRNVGANVVGSLIKTREEKGKFTDFSDY  887 
MintA_DnaE1             820  AAVYLADCRKLGITVLPPDVNESLVNFASVG--TDIRFGLGAVRNVGANVVGSLISTRNGKGKFTDFSDY  887 
Mabscessus_MAB2696c     825  AAVYLADCRRLGITVLPPDVNESVHNFASVG--EDIRYGLGGVRNVGANVVQSLIATREEKGAFTDFSDY  892 
Myco_sp_Mmcs_3087       830  AAVYLADCRRLGITVLPPDVNESVQNFASVG--DDIRFGLGAVRNVGANVVASLVNTRAEKGKYSDFSDY  897 
Myco_sp_Mjls_3107       830  AAVYLADCRRLGITVLPPDVNESVQNFASVG--DDIRFGLGAVRNVGANVVASLVNTRAEKGKYSDFSDY  897 
Mgilvum_Mflv3636        823  AAIYLADCRRLGITVLPPDVNESVQNFASVG--DDIRFGLGAVRNVGANVVASLVSTREEKGKYTDFSDY  890 
Mvanbaalenii_Mvan2777   821  AAVYLADCRRLGITVLPPDVNESVQNFASVG--DDIRFGLGAVRNVGANVVSSLVATRKEKGKFADFSDY  888 
MSM_MSMEG3178           827  AAVYLADCRRLGITVLPPDVNESEHNFASVG--DDIRFGLGAIRNVGANVVSSLIKTRTEKGKFTDFSDY  894 
Mmarinum_MMAR2369       823  AAVYLADCRKLGITVLPPDVNESLVNFASVG--QDIRFGLGAVRNVGANVVGSLIGTRSGKGKFTDFSDY  890 
Mulcerans_MUL1545       823  AAVYLADCRKLGITVLPPDVNESLVNFASVG--QDIRFGLGAVRNVGANVVGSLIGTRSGKGKFTDFSDY  890 
ML_ML1207               820  AAVYLADCRKFGITVLPPDVNESVLDFASVG--ADIRYGLGAVRNVGANVVGSLIKTRNAKGKFADFSDY  887 
Mkansasii_MkanA1_DnaE1  823  AAVYLADCRKLGITVLPPDVNESGLNFASVG--EDIRYGLGAVRNVGANVVGSLIQTRSDKGKFTDFSDY  890 
MTB_DnaE1_Rv1547        824  AAVYLADCRKLGITVLPPDVNESGLNFASVG--QDIRYGLGAVRNVGANVVGSLLQTRNDKGKFTDFSDY  891 
Mbovis_Mb1574           824  AAVYLADCRKLGITVLPPDVNESGLNFASVG--QDIRYGLGAVRNVGANVVGSLLQTRNDKGKFTDFSDY  891 
BCG_Pasteur_BCG1600     824  AAVYLADCRKLGITVLPPDVNESGLNFASVG--QDIRYGLGAVRNVGANVVGSLLQTRNDKGKFTDFSDY  891 
Mcanettii_DnaE1         824  AAVYLADCRKLGITVLPPDVNESGLNFASVG--QDIRYGLGAVRNVGANVVGSLLQTRNDKGKFTDFSDY  891 
CDC1551_MT1598          824  AAVYLADCRKLGITVLPPDVNESGLNFASVG--QDIRYGLGAVRNVGANVVGSLLQTRNDKGKFTDFSDY  891 
β-binding 
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Conservation:                                     
Mavium_MaviaA2_DnaE2    898  TARLH---LSVPQTEALATAGAFGCFGMSRREALWAAGAAATQRPDRLPG--------------------  944 
Maviumparatub_MAP3476c  898  TARLQ---LSVQQTEALATAGAFGCFGMSRREALWAAGAAATQRPDRLPG--------------------  944 
Mavium_104_MAV4335      898  TARLQ---LSVPQTEALATAGAFGCFGMSRREALWAAGAAATQRPDRLPG--------------------  944 
CDC1551_MT3480          903  TSRVQ---LSVPQVEALATAGALGCFGMSRREALWAAGAAATGRPDRLPG--------------------  949 
MTB_DnaE2_Rv3370c       884  TSRVQ---LSVPQVEALATAGALGCFGMSRREALWAAGAAATGRPDRLPG--------------------  930 
Mbovis_Mb3405c          896  TSRVQ---LSVPQVEALATAGALGCFGMSRREALWAAGAAATGRPDRLPG--------------------  942 
BCG_Pasteur_BCG3442c    884  TSRVQ---LSVPQVEALATAGALGCFGMSRREALWAAGAAATGRPDRLPG--------------------  930 
Mcanettii_DnaE2         887  TSRVQ---LSVPQVEALATAGALGCFGMSRREALWAAGAAATGRPDRLPG--------------------  933 
MintA_DnaE2             900  TSRLQ---LSVPQTEALATAGAFACFGMSRREGLWAAGAAATQRPGRLPG--------------------  946 
Mkansasii_MkanA1_DnaE2  901  ASRVQ---LSVPQTEALATAGALGCFGMSRREALWAAGAAATQRPDRLPG--------------------  947 
Mmarinum_MMAR1158       905  TSRVQ---LSVPQTEALATAGALGCFGMSRREALWAAGAAATQRPDRLPG--------------------  951 
Mulcerans_MUL0923       893  TSRVQ---LSVPQTEALATTGALGCFGMSRREALWAAGAAATQRPDRLPG--------------------  939 
Myco_sp_Mmcs_1183       904  TGRVQ---LSVPQTEALATAGALGCFGVTRREGLWAAGAAAAERPDRLPG--------------------  950 
Myco_sp_Mjls_1210       904  TGRVQ---LSVPQTEALATAGALGCFGVTRREGLWAAGAAAAERPDRLPG--------------------  950 
Mvanbaalenii_Mvan1530   903  TRRVQ---LSVPQTEALATAGALGCFGITRREGLWAAGAAATERPDRLPG--------------------  949 
Mgilvum_Mflv4893        892  TRRVQ---LTVPQTEALATAGALGCFGITRREGLWAAGAAATERPDRLPG--------------------  938 
MSMEG_DnaE2_MSMEG_1633  888  TSRVQ---LTVPQTEALATAGALGCFGITRREGLWAAGAAATQRPDRLPG--------------------  934 
Mabscessus_MAB3703c     883  TGRIQ---LTTAQVEALATGGALGCFDMSRREALWVAGAAAAQRPDRLPG--------------------  929 
Maviumparatub_MAP1257   888  LNKIDISACNKKVTESLIKAGAFDSLKHARKGLFLVHTDAVDSVLGTKKAEAMGQFDLFG-GDGGC-T--  953 
Mavium_104_MAV3224      888  LNKIDISACNKKVTESLIKAGAFDSLKHARKGLFLVHTDAVDSVLGTKKAEAMGQFDLFG-GDGGC-T--  953 
MintA_DnaE1             888  LNKIDIAACNKKVTESLIKAGAFDSLGHARKGLFLVHTDAVDSVLGTKKAEAIGQFDLFG-GDDGC-T--  953 
Mabscessus_MAB2696c     893  LHKIDIAACNKKVTESLVKAGAFDSLGHPRKGLFLVQSDAVDSVLGTKKAEAMGQFDLFGGGGEDS-VPA  961 
Myco_sp_Mmcs_3087       898  LNKIDIAACNKKVTESLIKAGAFDSLGHPRKGLFLIHTDAVDSVLGTKKAEAMGQFDLFGSGDGSG-ADA  966 
Myco_sp_Mjls_3107       898  LNKIDIAACNKKVTESLIKAGAFDSLGHPRKGLFLIHTDAVDSVLGTKKAEAMGQFDLFGSGDGSG-ADA  966 
Mgilvum_Mflv3636        891  LNKIDITACTKKVTESLIKAGAFDSLGHPRKGLFLVHTDAVDSVLGTKKAEAMGQFDLFGGGDDDG-D-T  958 
Mvanbaalenii_Mvan2777   889  LNKIDIAACNKKVTESLVKAGAFDSLGHPRKGLFLVHTDAVDSVLGTKKAEAMGQFDLFGGADGSGAD-A  957 
MSM_MSMEG3178           895  LNKIDITACNKKVTESLIKAGAFDSLGHPRKGLFLVHTDAVDSVLGTKKAEAMGQFDLFGGGEDTG-T--  961 
Mmarinum_MMAR2369       891  LNKIDISACNKKVTESLIKAGAFDSLGHPRKGLFLVHTDAVDSVLGTKKAEAMGQFDLFG-GSDSG-A--  956 
Mulcerans_MUL1545       891  LNKIDISACNKKVTESLIKAGAFDSLGHPRKGLFLVHTDAVDSVLGTKKAEAMGQFDLFG-GSDSG-A--  956 
ML_ML1207               888  LNKIDITSCNKKVTESLIKAGAFDSLGHSRKGLFLVHADAVDSVLGTKKAEAIGQFDLFG-GTDGG-T--  953 
Mkansasii_MkanA1_DnaE1  891  LNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHTDAVDSVLGTKKAEAMGQFDLFG-GSDDG-TGA  958 
MTB_DnaE1_Rv1547        892  LNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHSDAVDSVLGTKKAEALGQFDLFG-SNDDG-TGT  959 
Mbovis_Mb1574           892  LNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHSDAVDSVLGTKKAEALGQFDLFG-SNDDG-TGT  959 
BCG_Pasteur_BCG1600     892  LNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHSDAVDSVLGTKKAEALGQFDLFG-SNDDG-TGT  959 
Mcanettii_DnaE1         892  LNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHSDAVDSVLGTKKAEALGQFDLFG-SNDDG-TGT  959 
CDC1551_MT1598          892  LNKIDISACNKKVTESLIKAGAFDSLGHARKGLFLVHSDAVDSVLGTKKAEALGQFDLFG-SNDDG-TGT  959 
β-binding 
124 
 
 
 
Conservation:                  
Mavium_MaviaA2_DnaE2    945  -VGS----SSHIPALPGMSELELAAADVWATGISPDSYPTQFLRDDLDAMGVVPAARLGSVP--DGDRVL 1007 
Maviumparatub_MAP3476c  945  -VGS----SSHIPALPGMSELELAAADVWATGISPDSYPTQFLRDDLDAMGVVPAARLGSVP--DGDRVL 1007 
Mavium_104_MAV4335      945  -VGS----SSHIPALPGMSELELAAADVWATGISPDSYPTQFLRDDLDAMGVVPAARLGSVP--DGDRVL 1007 
CDC1551_MT3480          950  -VGS----SSHIPALPGMSELELAAADVWATGVSPDSYPTQFLRADLDAMGVLPAERLGSVS--DGDRVL 1012 
MTB_DnaE2_Rv3370c       931  -VGS----SSHIPALPGMSELELAAADVWATGVSPDSYPTQFLRADLDAMGVLPAERLGSVS--DGDRVL  993 
Mbovis_Mb3405c          943  -VGS----SSHIPALPGMSELELAAADVWATGVSPDSYPTQFLRADLDAMGVLPAERLGSVS--DGDRVL 1005 
BCG_Pasteur_BCG3442c    931  -VGS----SSHIPALPGMSELELAAADVWATGVSPDSYPTQFLRADLDAMGVLPAERLGSVS--DGDRVL  993 
Mcanettii_DnaE2         934  -VGS----SSHIPALPGMSELELAAADVWATGVSPDSYPTQFLRADLDAMGVLPAERLGSVP--DGDRVL  996 
MintA_DnaE2             947  -VGS----SSHVPALPGMSELELAAADVWATGISPDSYPTQFLREDLDAMGVVPAEKLGSVP--DGDRVL 1009 
Mkansasii_MkanA1_DnaE2  948  -VGAQGADGSHIPVLPGMSELELAAADVWATGISPDSYPTQFLRADLDAMGVLPADALGSVP--DGDRVL 1014 
Mmarinum_MMAR1158       952  -VGS----SSHIPTLPGMSELELAASDVWATGISPDSYPTQFLRADLDALGVLAAAALLSVP--DGERVL 1014 
Mulcerans_MUL0923       940  -VGS----SSHIPTLPGMSELELAASDVWATGISPDSYPTQFLRADLDALGVLAAAALLSVP--DGERVL 1002 
Myco_sp_Mmcs_1183       951  -VGS----AGQVPSLPGMSKLELAAADVWATGVSPDSYPTQFLRENLDAMGVVPAGRLLDVP--DGTRVL 1013 
Myco_sp_Mjls_1210       951  -VGS----AGQVPSLPGMSKLELAAADVWATGVSPDSYPTQFLRENLDAMGVIPAGRLLDVP--DGTRVL 1013 
Mvanbaalenii_Mvan1530   950  -VGS----SSHVPSLPGMTELELTVADVWATGVSPDRYPTEFLREDLDAMGVVPADQLLSLP--DGTRVL 1012 
Mgilvum_Mflv4893        939  -VGS----SSQVPSLPGMTELELTAADVWATGVSPDRYPTEFLREDLDAMGVVPADRLLSVR--DGTRVL 1001 
MSMEG_DnaE2_MSMEG_1633  935  -VGS----STHIPPLPGMSALELSAADVWATGISPDSYPTEYLRKHLDSLGVVPTDRLLDVA--DGTRIL  997 
Mabscessus_MAB3703c     930  -VGV----SSRIPALPEMGEVTRAAADVWATGVSPDSYPTQFLRARLDAMGVVPAKGLFGVP--DGSRVL  992 
Maviumparatub_MAP1257   954  -ESV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTQIPAILDGDVPNETQVR 1018 
Mavium_104_MAV3224      954  -ESV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTQIPAILDGDVPNETQVR 1018 
MintA_DnaE1             954  -EAV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTQIPAILDGDVPNETQVR 1018 
Mabscessus_MAB2696c     962  SDI-----FAIKVPDDEWEEKHKLALEREMLGLYVSGHPLNGVAHLLSRQTDTQIPAILDGEVANDAVVK 1026 
Myco_sp_Mmcs_3087       967  GDSA----FSIKVPDEEWEDKHKLALEREMLGLYVSGHPLNGVAHLLANQVDTQIPAILDGDVANDAQVL 1032 
Myco_sp_Mjls_3107       967  GDSA----FSIKVPDEEWEDKHKLALEREMLGLYVSGHPLNGVAHLLANQVDTQIPAILDGDVANDAQVL 1032 
Mgilvum_Mflv3636        959  GDSA----FTIKVPDEEWEDKHKLALEREMLGLYVSGHPLNGIAHLLTAQVDTQIPAILEGAIPNDAQVR 1024 
Mvanbaalenii_Mvan2777   958  GDSA----FTIKVPDEEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTQIPAILDGDVANDTQVR 1023 
MSM_MSMEG3178           962  -DAV----FTIKVPDEEWEDKHKLALEREMLGLYVSGHPLNGVAHLLANQVDTQIPAILDGDVANDAQVL 1026 
Mmarinum_MMAR2369       957  -DAV----FTIKVPEDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVSNDAQVR 1021 
Mulcerans_MUL1545       957  -DAV----FTIKVPEDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLATQVDTAIPAILDGDVSNDAQVR 1021 
ML_ML1207               954  -DAV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPTILDGGVSNDTQVR 1018 
Mkansasii_MkanA1_DnaE1  959  ADPV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAGQVDTAIPAILDGDVPNDTQVR 1024 
MTB_DnaE1_Rv1547        960  ADPV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVPNDAQVR 1025 
Mbovis_Mb1574           960  ADPV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVPNDAQVR 1025 
BCG_Pasteur_BCG1600     960  ADPV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVPNDAQVR 1025 
Mcanettii_DnaE1         960  ADPV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVPNDAQVR 1025 
CDC1551_MT1598          960  ADPV----FTIKVPDDEWEDKHKLALEREMLGLYVSGHPLNGVAHLLAAQVDTAIPAILDGDVPNDAQVR 1025 
β-binding OB-fold 
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Conservation:                 
Mavium_MaviaA2_DnaE2   1008  IAGAVTHRQRPGTAQG--VTFLNLEDETGMVNVLCTPGVWARHRKLANTAPALLVRGQVQNASGAITVVA 1075 
Maviumparatub_MAP3476c 1008  IAGAVTHRQRPGTAQG--VTFLNLEDETGMVNVLCTPGVWARHRKLANTAPALLVRGQVQNASGAITVVA 1075 
Mavium_104_MAV4335     1008  IAGAVTHRQRPGTAQG--VTFLNLEDETGMVNVLCTPGVWARHRKLANTAPALLVRGQVQNASGAITVVA 1075 
CDC1551_MT3480         1013  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWARHRKLAHTAPALLIRGQVQNASGAITVVA 1080 
MTB_DnaE2_Rv3370c       994  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWARHRKLAHTAPALLIRGQVQNASGAITVVA 1061 
Mbovis_Mb3405c         1006  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWARHRKLAHTAPALLIRGQVQNASGAITVVA 1073 
BCG_Pasteur_BCG3442c    994  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWARHRKLAHTAPALLIRGQVQNASGAITVVA 1061 
Mcanettii_DnaE2         997  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWARHRKLAHTAPALLIRGQVQNASGAITVVA 1064 
MintA_DnaE2            1010  IAGAVTHRQRPGTAQG--VTFLNLEDETGMVNVLCAPGVWARHRKLANSAPALLVRGQVQNATGAITVVA 1077 
Mkansasii_MkanA1_DnaE2 1015  IAGAVTHRQRPGTAQG--VTFINLEDETGMVNVLCTPGVWARHRKLANTAPALLIRGQVQNASGAITVVA 1082 
Mmarinum_MMAR1158      1015  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWVRHRKLANTAPALLIRGQVQNASGAVTVVA 1082 
Mulcerans_MUL0923      1003  IAGAVTHRQRPATAQG--VTFINLEDETGMVNVLCTPGVWMRHRKLANTAPVLLIRGQVQNASSAVTVVA 1070 
Myco_sp_Mmcs_1183      1014  VAGAVTHRQRPATAQG--VTFLNLEDETGMVNVVCSPQLWSRQRRLAQTAPAMVIRGIVQNATGAVTVVA 1081 
Myco_sp_Mjls_1210      1014  VAGAVTHRQRPATAQG--VTFLNLEDETGMVNVVCSPQLWSRQRRLAQTAPAMVIRGIVQNATGAVTVVA 1081 
Mvanbaalenii_Mvan1530  1013  VAGAVTHRQRPATAQG--VTFMNLEDETGMVNVLCSQGVWARHRKLAQTASALVVRGIVQNATGAVTVVA 1080 
Mgilvum_Mflv4893       1002  VAGAVTHRQRPATAQG--VTFLNLEDETGMVNVLCSQGIWARHRKLAQTASALVVRGIVQNATGAVTVVA 1069 
MSMEG_DnaE2_MSMEG_1633  998  VAGAVTHRQRPATAQG--VTFINLEDEKGMVNVLCAPGVWSRYRKVAQTAPALIVRGIVQNATGAVTVVA 1065 
Mabscessus_MAB3703c     993  VAGAVTHRQRPATAAG--VTFINLEDETGMVNVVCSVGLWARYRKLAVTARALIIRGQVQNASGAVSVVA 1060 
Maviumparatub_MAP1257  1019  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHAYSTYGADIADDAVVLINAKVAIRDDRIALIA 1088 
Mavium_104_MAV3224     1019  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHAYSTYGADIADDAVVLINAKVAIRDDRIALIA 1088 
MintA_DnaE1            1019  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHAYSTYGADIADDTVVLINAKVAIRDDRISLIA 1088 
Mabscessus_MAB2696c    1027  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVLFFPQAYSVYGADIADDAVVLVNAKVAIRDDRVSLIA 1096 
Myco_sp_Mmcs_3087      1033  VGGILASVNRRVNKNGLPWASAQLEDLTGGIEVLFFPQTYSVFGAEIADDVVVLVKAKVAARDDRIALIA 1102 
Myco_sp_Mjls_3107      1033  VGGILASVNRRVNKNGLPWASAQLEDLTGGIEVLFFPQTYSVFGAEIADDVVVLVKAKVAARDDRIALIA 1102 
Mgilvum_Mflv3636       1025  VGGILASVNRRVNKNGLPWASAQIEDLSGGIEVLFFPQTYSMFGAEIADDVVVLVGAKVAKRDDRISLIA 1094 
Mvanbaalenii_Mvan2777  1024  VGGILASVNRRVNKNGLPWASAQIEDLTGGIEVLFFPQTYSMFGAEIADDVVVLVGAKVAIRDDRISLIA 1093 
MSM_MSMEG3178          1027  VGGILASVNRRVNKNGLPWASAQLEDLTGGIEVLFFPQTYSLFGADIADDVVVLVKAKVAARDDRIALIA 1096 
Mmarinum_MMAR2369      1022  VGGILAAVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSNYGADIADDAVVLVNAKVAIRDDRISLIA 1091 
Mulcerans_MUL1545      1022  VGGILAAVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSNYGADIADDAVVLVNAKVAIRDDRISLIA 1091 
ML_ML1207              1019  VGGILAAVNRRVNKNGIPWASAQLDDLTGGIEVMFFPHTYSSYGADIIDDAVVLVNAKVVVRDDRIALIA 1088 
Mkansasii_MkanA1_DnaE1 1025  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIADDAVVLVNAKVAIRDDRVSLIA 1094 
MTB_DnaE1_Rv1547       1026  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIVDDAVVLVNAKVAVRDDRIALIA 1095 
Mbovis_Mb1574          1026  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIVDDAVVLVNAKVAVRDDRIALIA 1095 
BCG_Pasteur_BCG1600    1026  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIVDDAVVLVNAKVAVRDDRIALIA 1095 
Mcanettii_DnaE1        1026  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIVDDAVVLVNAKVAVRDDRIALIA 1095 
CDC1551_MT1598         1026  VGGILASVNRRVNKNGMPWASAQLEDLTGGIEVMFFPHTYSSYGADIVDDAVVLVNAKVAVRDDRIALIA 1095 
OB-fold 
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Conservation:                   
Mavium_MaviaA2_DnaE2   1076  ERLGRITLAVGSRSRDFR---------------------------------------------------- 1093 
Maviumparatub_MAP3476c 1076  ERLGRITLAVGSRSRDFR---------------------------------------------------- 1093 
Mavium_104_MAV4335     1076  ERLGRITLAVGSRSRDFR---------------------------------------------------- 1093 
CDC1551_MT3480         1081  ERMGRLTLAVGARSRDFR---------------------------------------------------- 1098 
MTB_DnaE2_Rv3370c      1062  ERMGRLTLAVGARSRDFR---------------------------------------------------- 1079 
Mbovis_Mb3405c         1074  ERMGRLTLAVGARSRDFR---------------------------------------------------- 1091 
BCG_Pasteur_BCG3442c   1062  ERMGRLTLAVGARSRDFR---------------------------------------------------- 1079 
Mcanettii_DnaE2        1065  ERMGRLTLAVGARSRDFR---------------------------------------------------- 1082 
MintA_DnaE2            1078  ERLGRITLAVGSKSRDFR---------------------------------------------------- 1095 
Mkansasii_MkanA1_DnaE2 1083  ERLGRISLAVGSRSRDFR---------------------------------------------------- 1100 
Mmarinum_MMAR1158      1083  ERMGRISLAVGSRSRDFR---------------------------------------------------- 1100 
Mulcerans_MUL0923      1071  ERMGRISLAVGSRSRDFR---------------------------------------------------- 1088 
Myco_sp_Mmcs_1183      1082  DKLGKLDMRVGSKSRDFR---------------------------------------------------- 1099 
Myco_sp_Mjls_1210      1082  DKLGKLDMRVGSKSRDFR---------------------------------------------------- 1099 
Mvanbaalenii_Mvan1530  1081  DRMGRLSLRAASKSRDFR---------------------------------------------------- 1098 
Mgilvum_Mflv4893       1070  DRMGPINMKVASKSRDFR---------------------------------------------------- 1087 
MSMEG_DnaE2_MSMEG_1633 1066  DRMDAVNLRVGSRSRDFR---------------------------------------------------- 1083 
Mabscessus_MAB3703c    1061  DQLRPLDLQIRSTSRDFR---------------------------------------------------- 1078 
Maviumparatub_MAP1257  1089  NELVVPDFSTAQVDRPLAVSLPTRQCTIDKVTALKQVLARHPGTSQVHLRLISGDRITTLELDASLRVTP 1158 
Mavium_104_MAV3224     1089  NELVVPDFSIAQVDRPLAVSLPTRQCTIDKVTALKQVLARHPGTSQVHLRLISGDRITTLELDASLRVTP 1158 
MintA_DnaE1            1089  NELVVPDFSSAQVNRPIAVSLPTRQCTIDKVSALKQVLARHPGTSQVHLRLISGDRITTLELDASLRVTP 1158 
Mabscessus_MAB2696c    1097  NDLVVPDFSQAADDRPVAVTMPTRQCTIDKVTALKQVLTRHPGTNQVHLRLISGERVTTLELDQSLRVTP 1166 
Myco_sp_Mmcs_3087      1103  HELVVPDFSSAQADRPLAVSLPTRQCTVDKVTALKQVLANHPGTSQVHLRLISGERITTLELDQSLRVTP 1172 
Myco_sp_Mjls_3107      1103  HELVVPDFSSAQADRPLAVSLPTRQCTVDKVTALKQVLANHPGTSQVHLRLISGERITTLELDQSLRVTP 1172 
Mgilvum_Mflv3636       1095  NELIVPDFTSAQVNRPVAVSLPTRQCTVDKVTALKQVLARHPGTAQVHLRLISGERITTLELDQSLRVTP 1164 
Mvanbaalenii_Mvan2777  1094  NELVVPDFSSANVNRPVAVSLPTRQCTVDKVTALKQVLARHPGTAQVHLRLISGERITTLELDQSLRVTP 1163 
MSM_MSMEG3178          1097  HELIVPDFSSAQADRPLSVSLPTRQCTIDKVTALKQVLANHPGTSQVHLRLISGERITTLELDQSLRVTP 1166 
Mmarinum_MMAR2369      1092  NELVVPDFSNAQADRPLAVSLPTRQCTIDKVTALKQVLARHPGTSQVHLRLISGDRITTLELDQSLRVTP 1161 
Mulcerans_MUL1545      1092  NELVVPDFSNAQADRPLAVSLPTRQCTIDKVTALKQVLARHPGTSQVHLRLISGDRITTLELDQSLRVTP 1161 
ML_ML1207              1089  NQLVVPDFSNVQEDRPLAVSLLTRQCTFDKVNALKQVLARHPGTSQVHLRLISGDRITTLELDQSLRVTS 1158 
Mkansasii_MkanA1_DnaE1 1095  NELVIPDFSNAQVQRPLSVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLELDQSLRVTP 1164 
MTB_DnaE1_Rv1547       1096  NDLTVPDFSNAEVERPLAVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLALDQSLRVTP 1165 
Mbovis_Mb1574          1096  NDLTVPDFSNAEVERPLAVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLALDQSLRVTP 1165 
BCG_Pasteur_BCG1600    1096  NDLTVPDFSNAEVERPLAVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLALDQSLRVTP 1165 
Mcanettii_DnaE1        1096  NDLTVPDFSNAQVDRPLAVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLALDQSLRVTP 1165 
CDC1551_MT1598         1096  NDLTVPDFSNAEVERPLAVSLPTRQCTFDKVSALKQVLARHPGTSQVHLRLISGDRITTLALDQSLRVTP 1165 
OB-fold τ-binding 
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Conservation:                                    
Mavium_MaviaA2_DnaE2         -------------------      
Maviumparatub_MAP3476c       -------------------      
Mavium_104_MAV4335           -------------------      
CDC1551_MT3480               -------------------      
MTB_DnaE2_Rv3370c            -------------------      
Mbovis_Mb3405c               -------------------      
BCG_Pasteur_BCG3442c         -------------------      
Mcanettii_DnaE2              -------------------      
MintA_DnaE2                  -------------------      
Mkansasii_MkanA1_DnaE2       -------------------      
Mmarinum_MMAR1158            -------------------      
Mulcerans_MUL0923            -------------------      
Myco_sp_Mmcs_1183            -------------------      
Myco_sp_Mjls_1210            -------------------      
Mvanbaalenii_Mvan1530        -------------------      
Mgilvum_Mflv4893             -------------------      
MSMEG_DnaE2_MSMEG_1633       -------------------      
Mabscessus_MAB3703c          -------------------      
Maviumparatub_MAP1257  1159  SPALMGDLKELLGPGCLGG 1177 
Mavium_104_MAV3224     1159  SPALMGDLKELLGPGCLGG 1177 
MintA_DnaE1            1159  SPALMGDLKELLGPGCLGG 1177 
Mabscessus_MAB2696c    1167  SSALMGDLKALLGPGCLGG 1185 
Myco_sp_Mmcs_3087      1173  SSALMGDLKALLGPGCLGG 1191 
Myco_sp_Mjls_3107      1173  SSALMGDLKALLGPGCLGG 1191 
Mgilvum_Mflv3636       1165  SSALMGDLKELLGPGCLGG 1183 
Mvanbaalenii_Mvan2777  1164  SSALMGDLKELLGPGCLGG 1182 
MSM_MSMEG3178          1167  SSALMGDLKALLGPGCLG- 1184 
Mmarinum_MMAR2369      1162  SPALMGDLKELLGPGCLGS 1180 
Mulcerans_MUL1545      1162  SPALMGDLKELLGPGCLGS 1180 
ML_ML1207              1159  SPALMGDLKALLGPGCLGD 1177 
Mkansasii_MkanA1_DnaE1 1165  SPALMGDLKELLGPGCLGG 1183 
MTB_DnaE1_Rv1547       1166  SPALMGDLKELLGPGCLGS 1184 
Mbovis_Mb1574          1166  SPALMGDLKELLGPGCLGS 1184 
BCG_Pasteur_BCG1600    1166  SPALMGDLKELLGPGCLGS 1184 
Mcanettii_DnaE1        1166  SPALMGDLKELLGPGCLGS 1184 
CDC1551_MT1598         1166  SPALMGDLKELLGPGCLGS 1184 
τ-binding 
128 
 
 
Figure S1: Multiple sequence alignment of representative mycobacterial DnaE subunits. DnaE-type sequences from M. avium 104 [DnaE1 
(MAV_3224) and DnaE2 (MAV_4335)], M. avium paratuberculosis [DnaE1 (MAP1257) and DnaE2 (MAP3476c)], Mtb CDC1551 [DnaE1 
(MT1598) and DnaE2 (MT3480)], Mtb [DnaE1 (Rv1547) and DnaE2 (Rv3370c)], M. bovis [DnaE1 (Mb1574) and DnaE2 (Mb3405c)], M. bovis 
BCG_Pasteur [DnaE1 (BCG1600) and DnaE2 (BCG3442c)], M. canettii [DnaE1 (WP_015303087) and DnaE2 (WP_015303851)], M. intracellulare 
[DnaE1 (WP_014385147) and DnaE2 (AFC45412)], M. kansasii [DnaE1 (KEP42088) and DnaE2 (AIR29751)], M. marinum [DnaE1 (MMAR2369) 
and DnaE2 (MMAR1158)], M. ulcerans [DnaE1 (MUL1545) and DnaE2 (MUL0923)], Mycobacterium sp. MCS DnaE1 (Mmcs_3087) and DnaE2 
(Mmcs_1183)], M. vanbaalenii [DnaE1 (Mvan2777) and DnaE2 (Mvan1530)], M. gilvum [DnaE1 (Mflv3636) and DnaE2 (Mflv4893)], Msm 
[DnaE1 (MSMEG_3718) and DnaE2 (MSMEG_1633)], M. abscessus [DnaE1 (MAB2696c) and DnaE2 (MAB3703c)], Mycobacterium sp. JLS 
[DnaE1 (Mjls_3107) and DnaE2 (Mjls_1210)] and M. leprae (ML1207) were aligned using the PROMALS3D multiple sequence and structure 
alignment server (http://prodata.swmed.edu/promals3d/promals3d.php). (1) Bold red residues shaded in green are the conserved metal co-
ordinating residues [H H D/H H E H C/H D/N H] (Barros et al., 2013), (2) bold red residues shaded in grey are C-terminal amino acid motif -
[S/T/G]R[D/N]F[D/R/H]- conserved in DnaE2-type proteins (Timinskas et al., 2014, Warner et al., 2010), (3) bold blue residues inside red boxes 
are conserved in essential DnaE-type polymerases and absent in non-essential DnaE-type polymerases. The annotation of the polymerase 
domains is derived from crystal structures of E. coli (Lamers et al., 2006) and T. aquaticus (Bailey et al., 2006) PolIIIα subunits. 
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Figure S2: The conserved DnaE1 PHP domain residues are not required for UV-induced 
mutagenesis. UV-induced mutation frequencies of WT, ΔdnaE2, ZD 1, ZD 2, ZD 10 and ZD 11 
following UV-irradiation. Mycobacterial cultures of WT mc2155 and mutant strains were 
grown until log phase harvested, re-suspended and UV irradiated at 25 mJ/cm2. After 
irradiation, cells were rescued at 37°C for 4 h and plated on 7H10 OADC containing 200 
μg/ml Rif. Data are from a representative experiment performed in triplicate. Error bars 
represent the 95% confidence interval. 
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Figure S3: The conserved DnaE1 PHP domain residues are not required for damage 
tolerance. Log10-fold dilutions of the mycobacterial cultures (10
-1-10-5) were spotted on 
7H10 OADC media without MMC (top row for each strain), with 0.02 μg/ml MMC (second 
row for each strain); and 0.04 μg/ml MMC (third row for each strain).  
  
10-1       10-2   10-3     10-4    10-5  
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